Tredegar (TG) 10-K 2005 FY Annual report

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K

FOR ANNUAL AND TRANSACTION REPORTS PURSUANT TO SECTIONS 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

x     ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2005
OR

o     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to __________

Commission File Number 1-10258

TREDEGAR CORPORATION

(Exact name of registrant as specified in its charter)

Virginia	54-1497771
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
1100 Boulders Parkway, Richmond, Virginia	23225
(Address of principal executive offices)	(Zip Code)
Registrant’s telephone number, including area code:804-330-1000
Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Name of Each Exchange on Which Registered
Common Stock	New York Stock Exchange
Preferred Stock Purchase Rights	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes o  No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes o  No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at least the past 90 days. Yes x  No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-Ko.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  o Accelerated filer   x Non-accelerated filer  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Yes o  No x

Aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June 30, 2005: $479,481,397*

Number of shares of Common Stock outstanding as of January 31, 2006: 38,738,514 (38,627,094 as of June 30, 2005)

* In determining this figure, an aggregate of 7,891,107 shares of Common Stock beneficially owned by Floyd D. Gottwald, Jr., John D. Gottwald, William M. Gottwald and the members of their immediate families has been excluded because the shares are held by

affiliates. The aggregate market value has been computed based on the closing price in the New York Stock Exchange Composite Transactions on June 30, 2005, as reported byThe Wall Street Journal.

Documents Incorporated By Reference

          Portions of the Tredegar Corporation (“Tredegar”) Proxy Statement for the 2006 Annual Meeting of Shareholders (the “Proxy Statement”) are incorporated by reference into Part III of this Form 10-K. We expect to file our Proxy Statement with the Securities and Exchange Commission and mail it to shareholders on or about March 23, 2006.

Index to Annual Report on Form 10-K
Year Ended December 31, 2005

		Page
Part I
Item 1.	Business	1-3
Item 1A.	Risk Factors	3-5
Item 1B.	Unresolved Staff Comments	None
Item 2.	Properties	5-6
Item 3.	Legal Proceedings	6
Item 4.	Submission of Matters to a Vote of Security Holders	None
Part II
Item 5.	Market for Tredegar’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	7-8
Item 6.	Selected Financial Data	8-15
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16-35
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	35
Item 8.	Financial Statements and Supplementary Data	39-71
Item 9.	Changes In and Disagreements With Accountants on Accounting and Financial Disclosure	None
Item 9A.	Controls and Procedures	36
Item 9B.	Other Information	None
Part III
Item 10.	Directors and Executive Officers of Tredegar*	37-38
Item 11.	Executive Compensation	*
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	*
Item 13.	Certain Relationships and Related Transactions	38
Item 14.	Principal Accounting Fees and Services	*
Part IV
Item 15.	Exhibits and Financial Statement Schedules	39

* Items 11, 12 and 14 and portions of Item 10 are incorporated by reference from the Proxy Statement.

The Securities and Exchange Commission (the “SEC”) has not approved or disapproved of this report or passed upon its accuracy or adequacy.

PART I

Item 1. BUSINESS

Description of Business

          Tredegar Corporation (“Tredegar”) is engaged, through its subsidiaries, in the manufacture of plastic films and aluminum extrusions.

          On June 30, 2005, substantially all of the assets of AFBS, Inc. (formerly known as Therics, Inc.), a wholly-owned subsidiary of Tredegar, were sold or assigned to a newly-created limited liability company, Therics, LLC, controlled and managed by an individual not affiliated with Tredegar. AFBS received a 17.5% equity interest in Therics, LLC, valued at $170,000 and a 3.5% interest in Theken Spine, LLC, valued at $800,000, along with potential future payments based on the sale of certain products by Therics, LLC. AFBS had operating losses of $3.5 million during the first six months of 2005 and $9.8 million in 2004.

Film Products

          Tredegar Film Products Corporation and its subsidiaries (together, “Film Products”) manufacture plastic films, elastics, nonwovens and laminate materials primarily for personal and household care products and packaging and surface protection applications. These products are produced at locations in the United States and at plants in The Netherlands, Hungary, Italy, China and Brazil. Film Products competes in all of its markets on the basis of product innovation, quality, price and service.

Personal and Household Care Films. Film Products is one of the largest global suppliers of apertured, breathable, elastic and embossed films, and nonwovens and laminate materials for personal care markets, including:

• Apertured film and nonwoven materials for use as topsheet in feminine hygiene products, baby diapers and adult incontinent products (including materials sold under the ComfortQuilt^®and ComfortAire^TM brand names);

• Breathable, embossed and elastic materials for use as components for baby diapers, adult incontinent products and feminine hygiene products (including elastic components sold under the Fabriflex^TM, StretchTab^TMand FlexAire^TMbrand names); and

• Absorbent transfer layers for baby diapers and adult incontinent products sold under the AquiDry^TM and AquiSoft^TM brand names.

          In each of the last three years, personal care products accounted for more than 30% of Tredegar’s consolidated net sales.

          Film Products also makes apertured films, breathable barrier films and laminates that regulate vapor or fluid transmission. These products are typically used in industrial, medical, agricultural and household markets, including disposable mops, facial wipes, filter layers for personal protective suits, facial masks and landscaping fabric. Film Products supplies a family of laminates for use in protective apparel under the GuardDog Laminates^TM brand name.

Packaging and Protective Films.Film Products produces a broad line of packaging films with an emphasis on paper, as well as laminating films for food packaging applications. These products give our customers a competitive advantage by providing cost savings with thin-gauge films that are readily printable and convertible on conventional processing equipment. Major end uses include overwrap for bathroom tissue and paper towels, and retort pouches.

          Film Products also produces films that are disposable, protective coversheets for photopolymers used in the manufacture of circuit boards. Other films sold under the UltraMask^® and ForceField^TM brand names are used as protective films to protect flat panel display components during fabrication, shipping and handling.

Raw Materials. The primary raw materials used by Film Products are low density, linear low density and high

density polyethylene and polypropylene resins, which are obtained from domestic and foreign suppliers at competitive prices. We believe there will be an adequate supply of polyethylene and polypropylene resins in the immediate future. Film Products also buys nonwoven fabrics based on these same resins, and we believe there will be an adequate supply of these materials in the immediate future.

Customers. Film Products sells to many branded product producers throughout the world. Its largest customer is The Procter & Gamble Company (“P&G”). Net sales to P&G totaled $237 million in 2005, $226 million in 2004 and $207 million in 2003 (these amounts include film sold to third parties that converted the film into materials used in products manufactured by P&G).

          P&G and Tredegar have had a successful long-term relationship based on cooperation, product innovation and continuous process improvement. The loss or significant reduction in sales associated with P&G would have a material adverse effect on our business.

Research and Development and Intellectual Property. Film Products has technical centers in Richmond, Virginia; Terre Haute, Indiana; Chieti, Italy; and Shanghai, China; and holds 170 issued patents (73 of which are issued in the U.S.) and 90 trademarks (4 of which are issued in the U.S.). Expenditures for research and development (“R&D”) have averaged $7.2 million per year over the past three years.

          In September 2004, we announced that our technical centers in Terre Haute, Indiana and Lake Zurich, Illinois would be moved to Richmond, Virginia, where many of Film Products’ marketing, sales and senior management are located. The move is substantially complete.

Aluminum Extrusions

          The William L. Bonnell Company, Inc. and its subsidiaries (together, “Aluminum Extrusions”) produce soft-alloy aluminum extrusions primarily for building and construction, distribution, transportation, machinery and equipment, electrical and consumer durables markets.

          Aluminum Extrusions manufactures mill (unfinished), anodized (coated) and painted aluminum extrusions for sale directly to fabricators and distributors that use our extrusions to produce window components, curtain walls and storefronts, tub and shower doors, industrial and agricultural machinery and equipment, ladders, bus bars, automotive parts, snowmobiles and tractor-trailer shapes, among other products. Sales are made primarily in the United States and Canada, principally east of the Rocky Mountains. Aluminum Extrusions competes primarily on the basis of product quality, service and price.

          Aluminum Extrusions sales volume by market segment over the last three years is shown below:

% of Aluminum Extrusions Sales Volumeby Market Segment
	2005		2004		2003
Building and construction:
Commercial		44		41		39
Residential		18		21		23
Distribution		16		13		14
Transportation		9		10		10
Machinery and equipment		6		7		6
Electrical		4		5		5
Consumer durables		3		3		3
Total		100		100		100

2

Raw Materials. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and various alloys, which are purchased from domestic and foreign producers in open-market purchases and under short-term contracts. We believe there will be an adequate supply of aluminum and other required raw materials and supplies in the immediate future.

Intellectual Property. Aluminum Extrusions holds one U.S. patent and two U.S. trademarks.

General

Patents, Licenses and Trademarks. Tredegar considers patents, licenses and trademarks to be of significance for Film Products. We routinely apply for patents on significant developments in this business. Our patents have remaining terms ranging from 1 to 19 years. We also have licenses under patents owned by third parties.

Research and Development. Tredegar’s spending for R&D activities in 2005, 2004 and 2003 was related to Film Products and AFBS. R&D spending at Film Products was approximately $6.6 million in 2005, $7.5 million in 2004 and $7.6 million in 2003. R&D spending at AFBS was approximately $2.4 million in 2005, $7.8 million in 2004 and $11.2 million in 2003.

Backlog. Backlogs are not material to our operations.

Government Regulation. Laws concerning the environment that affect or could affect our domestic operations include, among others, the Clean Water Act, the Clean Air Act, the Resource Conservation Recovery Act, the Occupational Safety and Health Act, the National Environmental Policy Act, the Toxic Substances Control Act, the Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”), as amended, regulations promulgated under these acts, and any other federal, state or local laws or regulations governing environmental matters. We believe that we are in substantial compliance with all applicable laws, regulations and permits. In order to maintain substantial compliance with such standards, we may be required to incur expenditures, the amounts and timing of which are not presently determinable but which could be significant, in constructing new facilities or in modifying existing facilities.

Employees. Tredegar employed approximately 3,000 people at December 31, 2005.

Available Information and Corporate Governance Documents.Our Internet address iswww.tredegar.com. We make available, free of charge through our website, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after such documents are electronically filed with, or furnished to, the SEC. Information filed electronically with the SEC can be accessed on its website atwww.sec.gov. In addition, our Corporate Governance Guidelines, Code of Conduct and the charters of our Audit, Executive Compensation and Nominating and Governance Committees are available on our website and are available in print, without charge, to any shareholder upon request by contacting Tredegar’s Corporate Secretary at 1100 Boulders Parkway, Richmond, Virginia 23225. The information on our website is not, and shall not be deemed to be, a part of this report or incorporated into other filings we make with the SEC.

Item 1A. RISK FACTORS

          There are a number of risks and uncertainties that can have a material effect on the operating results of our businesses and our financial condition. These risk factors include, but are not limited to, the following:

General

• Our future performance is influenced by costs incurred by our operating companies including, for example, the cost of energy and raw materials.These costs include, without limitation, the cost of resin (the raw material on which Film Products primarily depends), natural gas (the principal fuel necessary for Aluminum Extrusions’ plants to operate), electricity and diesel fuel. Resin and natural gas prices have risen significantly,

3

	and may continue to do so in the future. Tredegar attempts to mitigate the effects of increased costs through price increases and contractual pass-through provisions, but there are no assurances that higher prices can effectively be passed through to our customers or that we will be able to offset fully or on a timely basis the effects of higher raw material costs through price increases or pass-through arrangements. Further, there is no assurance that cost control efforts will be sufficient to offset any additional future declines in revenue or increases in energy, raw material or other costs.
•	Our substantial international operations subject us to risks of doing business in foreign countries, which could adversely affect our business, financial condition and results of operations. Risks inherent in international operations include the following, by way of example: changes in general economic conditions, potential difficulty enforcing agreements and intellectual property rights, restrictions on foreign trade or investment, fluctuations in exchange rates, imposition of additional taxes on our foreign income, nationalization of private enterprises and unexpected adverse changes in foreign laws and regulatory requirements.
Film Products
•	Film Products is highly dependent on sales associated with one customer, P&G. P&G comprised approximately 25% of Tredegar’s net sales in 2005, 27% in 2004 and 29% in 2003. The loss or significant reduction of sales associated with P&G would have a material adverse effect on our business, as would delays in P&G rolling out products utilizing new technologies developed by Tredegar. While we have undertaken efforts to expand our customer base, there can be no assurance that such efforts will be successful, or that they will offset any delay or loss of sales and profits associated with P&G.
•	Growth of Film Products depends on our ability to develop and deliver new products at competitive prices, especially in the personal care market. Personal care products are now being made with a variety of new materials, replacing traditional backsheet and other components. While we have substantial technical resources, there can be no assurance that our new products can be brought to market successfully, or if brought to market successfully, at the same level of profitability and market share of replaced films. A shift in customer preferences away from our technologies, our inability to develop and deliver new profitable products, or delayed acceptance of our new products in domestic or foreign markets, could have a material adverse effect on our business. In the long term, growth will depend on our ability to provide innovative materials at or below existing material costs, including lowering equipment and other capital costs.
•	Film Products operates in a field where our significant customers and competitors have substantial intellectual property portfolios. The continued success of this business depends on our ability not only to protect our own technologies and trade secrets, but also to develop and sell new products that do not infringe upon existing patents. Although we are not currently involved in any patent litigation, an unfavorable outcome of any such action could have a significant adverse impact on Film Products.
•	As Film Products expands its personal care business, we have greater credit risk that is inherent in broadening our customer base.
Aluminum Extrusions
•	Sales volume and profitability of Aluminum Extrusions is cyclical and highly dependent on economic conditions of end-use markets in the United States and Canada, particularly in the construction, distribution and transportation industries. Our market segments are also subject to seasonal slowdowns during the winter months. Because of the high degree of operating leverage inherent in our operations (generally constant fixed costs until full capacity utilization is achieved), the percentage drop in operating profits in a cyclical downturn will likely exceed the percentage drop in volume. Any benefits associated with cost reductions and productivity improvements may not be sufficient to offset the adverse effects on profitability from pricing and margin pressure and higher bad debts that usually accompany a downturn. In addition, higher energy costs and the appreciation of the U.S. Dollar equivalent value of the Canadian Dollar can further reduce profits unless

4

	offset by price increases or cost reductions and productivity improvements.
	In 2004, operating profit from ongoing operations in Aluminum Extrusions increased to $22.6 million from $15.1 million in 2003. The $7.5 million or 50% increase in operating profit on 6.7% volume growth during this period was primarily due to operating leverage and pricing improvements. In 2005, operating profit from ongoing operations in Aluminum Extrusions decreased to $19.3 million (down $3.3 million from 2004 or 14.7%) despite higher selling prices and 1.2% volume growth due to higher energy costs (adverse impact estimated of approximately $7 million) and appreciation of the Canadian Dollar (adverse impact estimated of about $3.5 million).
•	The markets for our products are highly competitive with product quality, service, delivery performance and price being the principal competitive factors. Aluminum Extrusions has around 1,800 customers in a variety of end-use markets within the broad categories of building and construction, distribution, transportation, machinery and equipment, electrical and consumer durables. No single customer exceeds 4% of Aluminum Extrusion’s net sales. Due to the diverse customer mix across many end-use markets, we believe the industry generally tracks the real growth of the overall economy (historical cross-cycle volume growth has been in the 3% range).
	During improving economic conditions, excess industry capacity is absorbed and pricing pressure becomes less of a factor in many of our end-use markets. Conversely, during an economic slowdown, excess industry capacity often drives increased pricing pressure in many end-use markets as competitors protect their position with key customers. Because the business is susceptible to these changing economic conditions, Aluminum Extrusions targets complex, customized, service-intensive business with more challenging requirements which is competitively more defensible compared to higher volume, standard extrusion applications.
	Foreign imports, primarily from China, represent a growing portion of the North American aluminum extrusion market. Foreign competition to date has been primarily large volume, standard extrusion profiles that impact some of our less strategic end-use markets. Market share erosion in other end-use markets remains possible.
	There can be no assurance that we will be able to maintain current margins and profitability. Our continued success and prospects depend on our ability to retain existing customers and participate in overall industry cross-cycle growth.

Item 1B. UNRESOLVED STAFF COMMENTS

          None.

Item 2. PROPERTIES

General

          Most of the improved real property and the other assets used in our operations are owned, and none of the owned property is subject to an encumbrance that is material to our consolidated operations. We consider the plants, warehouses and other properties and assets owned or leased by us to be in generally good condition.

          We believe that the capacity of our plants is adequate to meet our immediate needs. Our plants generally have operated at 50-95% of capacity. Our corporate headquarters, which is leased, is located at 1100 Boulders Parkway, Richmond, Virginia 23225.

5

          Our principal plants and facilities are listed below:

Film Products
Locations in the United States	Locations in Foreign Countries	Principal Operations
LaGrange, Georgia* Lake Zurich, Illinois Pottsville, Pennsylvania Red Springs, North Carolina (leased) Richmond, Virginia    (technical center) (leased) Terre Haute, Indiana (technical   center and production facility)	Chieti, Italy (technical center) Guangzhou, China Kerkrade, The Netherlands Rétság, Hungary Roccamontepiano, Italy São Paulo, Brazil Shanghai, China	Production of plastic films and laminate materials
Aluminum Extrusions
Locations in the United States	Locations in Canada	Principal Operations
Carthage, Tennessee Kentland, Indiana Newnan, Georgia	Pickering, Ontario Richmond Hill, Ontario Ste Thérèse, Québec Woodbridge, Ontario (leased)	Production of aluminum extrusions, fabrication and finishing

* On February 2, 2006, we announced the expected shut down of the Film Products’ plant in LaGrange, Georgia. The facility, which is operating at about the break-even level, is expected to close by May 1, 2006. The plant had sales of commodity blown films of approximately $20 million in 2005.

Item 3. LEGAL PROCEEDINGS

          On June 23, 2005, the United States Environmental Protection Agency, Region 4 (“EPA”), issued an Administrative Order (Docket No. CAA-04-2005-1838, the “Order”) under the Clean Air Act (as amended from time to time, the “Act”) alleging certain violations by Aluminum Extrusions’ Carthage, Tennessee facility of the refrigerant management regulations promulgated pursuant to the Act. The Order alleged that the violations occurred primarily in 2002 and 2003.

          The Order required Aluminum Extrusions to either replace the cooling system at issue or retrofit it with an EPA approved non-ozone depleting substance. The Order further required Aluminum Extrusions to comply with certain applicable provisions of the Act and to provide certified documentation verifying compliance with the Order. Aluminum Extrusions was required to comply with all terms of the Order within 180 days from issuance.

          Aluminum Extrusions fulfilled all obligations imposed by the Order during 2005, and reported that fact in a letter to EPA dated October 25, 2005. Although Aluminum Extrusions has not admitted any violations to the EPA pursuant to the Order, Aluminum Extrusions elected to replace the affected cooling system and incurred related replacement costs of approximately $110,000.

          While the Order does not impose penalties or fines, EPA has reserved the right to do so in the future. To reduce any such claim for penalties or fines, Aluminum Extrusions may undertake a supplemental environmental project at a cost of up to $282,000. Management believes that future penalties or fines assessed by EPA relating to this matter, if any, should not exceed $40,000 (which has been reflected in the financial statements). Tredegar does not expect that the Order or any future fines or penalties assessed by EPA with respect to this matter will have a material adverse effect on Tredegar.

6

Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

          None.

PART II

Item 5. MARKET FOR TREDEGAR’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Prices of Common Stock and Shareholder Data

          Our common stock is traded on the New York Stock Exchange (“NYSE”) under the ticker symbol TG. We have no preferred stock outstanding. There were 38,737,016 shares of common stock held by 3,570 shareholders of record on December 31, 2005.

          The following table shows the reported high and low closing prices of our common stock by quarter for the past two years.

	2005				2004
	High		Low		High		Low
First quarter	$	20.19	$	16.08	$	17.80	$	13.20
Second quarter		17.56		14.52		16.13		13.00
Third quarter		16.67		12.09		18.38		14.75
Fourth quarter		13.16		11.76		20.25		16.68

Dividend Information

          We have paid a dividend every quarter since becoming a public company in July 1989. During 2005, 2004 and 2003, our quarterly dividend was 4 cents per share.

          All decisions with respect to payment of dividends will be made by the Board of Directors based upon earnings, financial condition, anticipated cash needs and such other considerations as the Board deems relevant. See Note 8 beginning on page 57 for minimum shareholders’ equity required and aggregate dividends permitted.

Issuer Purchases of Equity Securities

          During 2005 and 2004, we did not purchase any shares of our common stock in the open market. During 2003, we purchased 406,400 shares of our common stock in the open market for $5.2 million (an average price of $12.72 per share). Under a standing authorization from our board of directors, we may purchase an additional 3.4 million shares in the open market or in privately negotiated transactions at prices management deems appropriate.

Annual Meeting

          Our annual meeting of shareholders will be held on May 18, 2006, beginning at 8:30 a.m. EDT at a location that will be disclosed in the Proxy Statement. We expect to mail formal notice of the annual meeting, proxies and proxy statements to shareholders on or about March 23, 2006.

7

Inquiries

          Inquiries concerning stock transfers, dividends, dividend reinvestment, consolidating accounts, changes of address, or lost or stolen stock certificates should be directed to:

National City Bank
Dept. 5352
Corporate Trust Operations
P.O. Box 92301
Cleveland, Ohio 44193-0900
Phone: 800-622-6757
E-mail: shareholder.inquiries@nationalcity.com

          All other inquiries should be directed to:

Tredegar Corporation
Investor Relations Department
1100 Boulders Parkway
Richmond, Virginia 23225
Phone: 800-411-7441
E-mail: invest@tredegar.com
Web site: www.tredegar.com

Quarterly Information

          We do not generate or distribute quarterly reports to shareholders. Information on quarterly results can be obtained from our website. In addition, we file quarterly, annual and other information electronically with the SEC, which can be accessed on its website atwww.sec.gov.

Legal Counsel	Independent Registered Public Accounting Firm
Hunton & Williams LLP	PricewaterhouseCoopers LLP
Richmond, Virginia	Richmond, Virginia

Item 6. SELECTED FINANCIAL DATA

          The tables that follow on pages 9-15 present certain selected financial and segment information for the eight years ended December 31, 2005.

8

EIGHT-YEAR SUMMARY
Tredegar Corporation and Subsidiaries
Years Ended December 31	2005			2004			2003			2002
(In Thousands, Except Per-Share Data)
Results of Operations (a):
Sales	$	956,969		$	861,165		$	738,651		$	753,724
Other income (expense), net		(544	) (b)		15,604	(c)		7,853			546
		956,425			876,769			746,504			754,270
Cost of goods sold		810,621	(b)		717,120	(c)		606,242			582,658
Freight		24,691			22,398			18,557			16,319
Selling, general & administrative expenses		64,723	(b)		60,030	(c)		53,341			52,252
Research and development expenses		8,982			15,265			18,774			20,346
Amortization of intangibles		299			330			268			100
Interest expense		4,573			3,171			6,785			9,352
Asset impairments and costs associated with exit and disposal activities		16,334	(b)		22,973	(c)		11,426	(d)		3,884	(e)
Unusual items		—			—			1,067	(d)		(6,147	(e)
		930,223			841,287			716,460			678,764
Income from continuing operations before income taxes		26,202			35,482			30,044			75,506
Income taxes		9,973			9,222	(c)		10,717			26,881
Income from continuing operations (a)		16,229			26,260			19,327			48,625
Discontinued operations (a):
Income (loss) from venture capital investment activities		—			2,921			(46,569	)		(42,428	)
Income (loss) from operations of Molecumetics		—			—			891			(8,728	)
Income from discontinued energy segment		—			—			—			—
Income (loss) from discontinued operations (a)		—			2,921			(45,678	)		(51,156	)
Net income (loss)	$	16,229		$	29,181		$	(26,351	)	$	(2,531	)
Diluted earnings (loss) per share:
Continuing operations (a)	$	.42		$	.68		$	.50		$	1.25
Discontinued operations (a)		—			.08			(1.19	)		(1.32	)
Net income (loss)	$	.42		$	.76		$	(.69	)	$	(.07	)

Years Ended December 31	2001			2000			1999			1998
(In Thousands, Except Per-Share Data)
Results of Operations (a):
Sales	$	779,157		$	879,475		$	828,015		$	705,024
Other income (expense), net		1,255			1,914			972			1,749
		780,412			881,389			828,987			706,773
Cost of goods sold		618,323			706,817			648,254			553,184
Freight		15,580			17,125			15,221			10,946
Selling, general & administrative expenses		47,954			47,321			44,675			37,127
Research and development expenses		20,305			15,305			11,500			5,995
Amortization of intangibles		4,914			5,025			3,430			205
Interest expense		12,671			17,319			9,088			1,318
Asset impairments and costs associated with exit and disposal activities		16,935	(f)		23,791	(g)		4,628	(h)		664	(i)
Unusual items		(971	) (f)		(762	) (g)		—			(765	) (i)
		735,711			831,941			736,796			608,674
Income from continuing operations before income taxes		44,701			49,448			92,191			98,099
Income taxes		13,950	(f)		18,135			32,728			32,094	(i)
Income from continuing operations (a)		30,751			31,313			59,463			66,005
Discontinued operations (a):
Income (loss) from venture capital investment activities		(16,627	)		83,640			(4,626	)		394
Income (loss) from operations of Molecumetics		(5,768	)		(3,577	)		(2,189	)		(2,243	)
Income from discontinued energy segment		1,396			—			—			4,713
Income (loss) from discontinued operations (a)		(20,999	)		80,063			(6,815	)		2,864
Net income (loss)	$	9,752		$	111,376		$	52,648		$	68,869
Diluted earnings (loss) per share:
Continuing operations (a)	$	.79		$	.80		$	1.54		$	1.71
Discontinued operations (a)		(.54	)		2.06			(.18	)		.07
Net income (loss)	$	.25		$	2.86		$	1.36		$	1.78

Refer to notes to financial tables on page 15.

9

EIGHT-YEAR SUMMARY
Tredegar Corporation and Subsidiaries
Years Ended December 31	2005			2004			2003			2002
(In Thousands, Except Per-Share Data)
Share Data:
Equity per share	$	12.53		$	12.45		$	11.72		$	12.08
Cash dividends declared per share		.16			.16			.16			.16
Weighted average common shares outstanding during the period		38,471			38,295			38,096			38,268
Shares used to compute diluted earnings per share during the period		38,597			38,507			38,441			38,869
Shares outstanding at end of period		38,737			38,598			38,177			38,323
Closing market price per share:
High		20.19			20.25			16.76			24.72
Low		11.76			13.00			10.60			12.25
End of year		12.89			20.21			15.53			15.00
Total return to shareholders (j)		(35.4	)%		31.2	%		4.6	%		(20.2	)%
Financial Position:
Total assets		781,758			769,474			753,025			837,962
Cash and cash equivalents		23,434			22,994			19,943			109,928
Income taxes recoverable from sale of venture capital portfolio		—			—			55,000			—
Debt		113,050			103,452			139,629			259,280
Shareholders’ equity (net book value)		485,362			480,442			447,399			462,932
Equity market capitalization (k)		499,320			780,066			592,889			574,845

Years Ended December 31	2001			2000			1999			1998
(In Thousands, Except Per-Share Data)
Share Data:
Equity per share	$	12.53		$	13.07		$	9.88		$	8.46
Cash dividends declared per share		.16			.16			.16			.15
Weighted average common shares outstanding during the period		38,061			37,885			36,992			36,286
Shares used to compute diluted earnings per share during the period		38,824			38,908			38,739			38,670
Shares outstanding at end of period		38,142			38,084			37,661			36,661
Closing market price per share:
High		21.70			32.00			32.94			30.67
Low		15.30			15.00			16.06			16.13
End of year		19.00			17.44			20.69			22.50
Total return to shareholders (j)		9.9	%		(14.9	)%		(7.3	)%		3.1	%
Financial Position:
Total assets		865,031			903,768			792,487			457,178
Cash and cash equivalents		96,810			44,530			25,752			25,409
Income taxes recoverable from sale of venture capital portfolio		—			—			—			—
Debt		264,498			268,102			270,000			25,000
Shareholders’ equity (net book value)		477,899			497,728			372,228			310,295
Equity market capitalization (k)		724,706			664,090			779,112			824,873

Refer to notes to financial tables on page 15.

10

SEGMENT TABLES
Tredegar Corporation and Subsidiaries
Net Sales (l)
Segment	2005		2004		2003		2002
(In Thousands)
Film Products	$	460,277	$	413,257	$	365,501	$	376,904
Aluminum Extrusions		471,749		425,130		354,593		360,293
AFBS (formerly Therics)		252		380		—		208
Total ongoing operations (n)		932,278		838,767		720,094		737,405
Divested operations (a):
Fiberlux		—		—		—		—
Other (m)		—		—		—		—
Total net sales		932,278		838,767		720,094		737,405
Add back freight		24,691		22,398		18,557		16,319
Sales as shown in Consolidated
Statements of Income	$	956,969	$	861,165	$	738,651	$	753,724

Segment	2001		2000		1999		1998
(In Thousands)
Film Products	$	382,740	$	380,202	$	342,300	$	286,965
Aluminum Extrusions		380,387		479,889		461,241		395,455
AFBS (formerly Therics)		450		403		161		—
Total ongoing operations (n)		763,577		860,494		803,702		682,420
Divested operations (a):
Fiberlux		—		1,856		9,092		11,629
Other (m)		—		—		—		29
Total net sales		763,577		862,350		812,794		694,078
Add back freight		15,580		17,125		15,221		10,946
Sales as shown in Consolidated
Statements of Income	$	779,157	$	879,475	$	828,015	$	705,024

Refer to notes to financial tables on page 15.

11

SEGMENT TABLES
Tredegar Corporation and Subsidiaries

Operating Profit
Segment	2005			2004			2003			2002
(In Thousands)
Film Products:
Ongoing operations	$	44,946		$	43,259		$	45,676		$	72,307
Plant shutdowns, asset impairments and restructurings, net of gains on sale of assets		(3,955	) (b)		(10,438	) (c)		(5,746	) (d)		(3,397	) (e)
Unusual items		—			—			—			6,147	(e)
Aluminum Extrusions:
Ongoing operations		19,302			22,637			15,117			27,304
Plant shutdowns, asset impairments and restructurings, net of gains on sale of assets		122	(b)		(10,553	) (c)		(644)	(d)		(487	) (e)
Gain on sale of land		—			—			1,385			—
Other		—			7,316	) (c)		—			—
AFBS (formerly Therics):
Ongoing operations		(3,467	)		(9,763	)		(11,651	)		(13,116	)
Loss on investment in Therics, LLC		(145	)		—			—			—
Plant shutdowns, asset impairments and restructurings		(10,318	) (b)		(2,041	) (c)		(3,855)	(d)		—
Unusual items		—			—			(1,067)	(d)		—
Divested operations (a):
Fiberlux		—			—			—			—
Other (m)		—			—			—			—
Unusual items		—			—			—			—
Total		46,485			40,417			39,215			88,758
Interest income		586			350			1,183			1,934
Interest expense		4,573			3,171			6,785			9,352
Gain on sale of corporate assets		61			7,560			5,155			—
Loss from write-down of investment in Novalux		5,000	(b)		—			—			—
Corporate expenses, net		11,357			9,674			8,724	(d)		5,834
Income from continuing operations before income taxes		26,202			35,482			30,044			75,506
Income taxes		9,973			9,222			10,717			26,881
Income from continuing operations		16,229			26,260			19,327			48,625
Income (loss) from discontinued operations (a)		—			2,921			(45,678	)		(51,156	)
Net income (loss)	$	16,229		$	29,181		$	(26,351	)	$	(2,531	)

Segment	2001			2000			1999			1998
(In Thousands)
Film Products:
Ongoing operations	$	61,787		$	47,112		$	59,554		$	53,786
Plant shutdowns, asset impairments and restructurings, net of gains on sale of assets		(9,136	) (f)		(22,163	) (g)		(1,170	) (h)		—
Unusual items		—			—			—			—
Aluminum Extrusions:
Ongoing operations		25,407			52,953			56,501			47,091
Plant shutdowns, asset impairments and restructurings, net of gains on sale of assets		(7,799	) (f)		(1,628	) (g)		—			(664	) (i)
Gain on sale of land		—			—			—
Other		—			—			—			—
AFBS (formerly Therics):
Ongoing operations		(12,861	)		(8,024	)		(5,235	)		—
Loss on investment in Therics, LLC		—			—			—			—
Plant shutdowns, asset impairments and restructurings		—			—			(3,458	)  (h)		—
Unusual items		—			—			—			—
Divested operations (a):
Fiberlux		—			(264	)		57			1,433
Other (m)		—			—			—			(428	)
Unusual items		—			762	(g)		—			765	(i)
Total		57,398			68,748			106,249			101,983
Interest income		2,720			2,578			1,419			2,279
Interest expense		12,671			17,319			9,088			1,318
Gain on sale of corporate assets		—			—			712			—
Loss from write-down of investment in Novalux		—			—			—			—
Corporate expenses, net		2,746	(f)		4,559			7,101			4,845
Income from continuing operations before income taxes		44,701			49,448			92,191			98,099
Income taxes		13,950	(f)		18,135			32,728			32,094	(i)
Income from continuing operations		30,751			31,313			59,463			66,005
Income (loss) from discontinued operations (a)		(20,999	)		80,063			(6,815	)		2,864
Net income (loss)	$	9,752		$	111,376		$	52,648		$	68,869

Refer to notes to financial tables on page 15.

12

SEGMENT TABLES
Tredegar Corporation and Subsidiaries

Identifiable Assets
Segment	2005		2004		2003		2002
(In Thousands)
Film Products	$	479,286	$	472,810	$	422,321	$	379,635
Aluminum Extrusions		214,374		210,894		185,336		176,631
AFBS (formerly Therics)		2,759		8,613		8,917		10,643
Subtotal		696,419		692,317		616,574		566,909
General corporate		61,905		54,163		61,508		52,412
Income taxes recoverable from sale of venture capital investment portfolio		—		—		55,000		—
Cash and cash equivalents		23,434		22,994		19,943		109,928
Identifiable assets from ongoing operations		781,758		769,474		753,025		729,249
Divested operations (a):
Fiberlux		—		—		—		—
Discontinued operations (a):
Venture capital		—		—		—		108,713
Molecumetics		—		—		—		—
Total	$	781,758	$	769,474	$	753,025	$	837,962

Segment	2001		2000		1999		1998
(In Thousands)
Film Products	$	367,291	$	367,526	$	360,517	$	132,241
Aluminum Extrusions		185,927		210,434		216,258		201,518
AFBS (formerly Therics)		9,931		9,609		9,905		—
Subtotal		563,149		587,569		586,680		333,759
General corporate		40,577		30,214		22,419		23,905
Income taxes recoverable from sale of venture capital investment portfolio		—		—		—		—
Cash and cash equivalents		96,810		44,530		25,752		25,409
Identifiable assets from ongoing operations		700,536		662,313		634,851		383,073
Divested operations (a):
Fiberlux		—		—		7,859		7,811
Discontinued operations (a):
Venture capital		158,887		236,698		145,028		61,098
Molecumetics		5,608		4,757		4,749		5,196
Total	$	865,031	$	903,768	$	792,487	$	457,178

Refer to notes to financial tables on page 15.

13

SEGMENT TABLES
Tredegar Corporation and Subsidiaries

Depreciation and Amortization
Segment	2005		2004		2003		2002
(In Thousands)
Film Products	$	26,673	$	21,967	$	19,828	$	20,085
Aluminum Extrusions		11,484		10,914		10,883		10,506
AFBS (formerly Therics)		437		1,300		1,641		463
Subtotal		38,594		34,181		32,352		31,054
General corporate		195		241		270		353
Total ongoing operations		38,789		34,422		32,622		31,407
Divested operations (a):
Fiberlux		—		—		—		—
Discontinued operations (a):
Venture capital		—		—		—		—
Molecumetics		—		—		—		527
Total	$	38,789	$	34,422	$	32,622	$	31,934

Segment	2001		2000		1999		1998
(In Thousands)
Film Products	$	22,047	$	23,122	$	18,751	$	11,993
Aluminum Extrusions		11,216		9,862		9,484		8,393
AFBS (formerly Therics)		2,262		1,782		1,195		—
Subtotal		35,525		34,766		29,430		20,386
General corporate		329		315		253		254
Total ongoing operations		35,854		35,081		29,683		20,640
Divested operations (a):
Fiberlux		—		151		498		544
Discontinued operations (a):
Venture capital		—		18		22		21
Molecumetics		2,055		1,734		1,490		1,260
Total	$	37,909	$	36,984	$	31,693	$	22,465

Capital Expenditures, Acquisitions and Investments

Segment		2005		2004		2003		2002
(In Thousands)
Film Products	$	50,466	$	44,797	$	57,203	$	24,063
Aluminum Extrusions		11,968		10,007		8,293		4,799
AFBS (formerly Therics)		36		275		219		1,621
Subtotal		62,470		55,079		65,715		30,483
General corporate		73		572		93		60
Capital expenditures for ongoing operations		62,543		55,651		65,808		30,543
Divested operations (a):
Fiberlux		—		—		—		—
Discontinued operations (a):
Venture capital		—		—		—		—
Molecumetics		—		—		—		793
Total capital expenditures		62,543		55,651		65,808		31,336
Acquisitions and other		—		1,420		1,579		—
Novalux investment		1,095		5,000		—		—
Venture capital investments		—		—		2,807		20,373
Total	$	63,638	$	62,071	$	70,194	$	51,709

Segment		2001		2000		1999		1998
(In Thousands)
Film Products	$	24,775	$	53,161	$	25,296	$	18,456
Aluminum Extrusions		8,506		21,911		16,388		10,407
AFBS (formerly Therics)		2,340		1,730		757		—
Subtotal		35,621		76,802		42,441		28,863
General corporate		519		384		606		115
Capital expenditures for ongoing operations		36,140		77,186		43,047		28,978
Divested operations (a):
Fiberlux		—		425		812		1,477
Discontinued operations (a):
Venture capital		—		86		—		54
Molecumetics		2,850		2,133		1,362		3,561
Total capital expenditures		38,990		79,830		45,221		34,070
Acquisitions and other		1,918		6,316		215,227		72,102
Novalux investment		—		—		—		—
Venture capital investments		24,504		93,058		81,747		35,399
Total	$	65,412	$	179,204	$	342,195	$	141,571

Refer to notes to financial tables on page 15.

14

NOTES TO FINANCIAL TABLES

(In Thousands, Except Per-Share Data)

(a)	In 2004, discontinued operations include a gain of $2,921 after-taxes primarily related to the reversal of a business and occupancy tax contingency accrual upon favorable resolution. The accrual was originally recorded in connection with our venture capital investment operation. In 2003, we sold substantially all of our venture capital investment portfolio. In 2002, we ceased operations at Molecumetics, one of our biotechnology units, and sold its tangible assets. The operating results associated with the venture capital investment portfolio and Molecumetics have been reported as discontinued operations. In 2003, discontinued operations also include a gain of $891 after-taxes on the sale of intellectual property of Molecumetics and a loss on the divestiture of the venture capital investment portfolio of $46,269 after-taxes. Discontinued operations in 2002 also include a loss on the disposal of Molecumetics of $4,875 after-taxes. In 2001, discontinued operations include a gain of $1,396 for the reversal of an income tax contingency accrual upon favorable conclusion of IRS examinations through 1997. The accrual was originally recorded in conjunction with the sale of The Elk Horn Coal Corporation. We divested our coal subsidiary, The Elk Horn Coal Corporation, and our remaining oil and gas properties in 1994. As a result of these events, we report the Energy segment as discontinued operations. In 1998, discontinued operations include gains for the reimbursement of payments made by us to the United Mine Workers of America Combined Benefit Fund (the “Fund”) and the reversal of a related accrued liability established to cover future payments to the Fund. On April 10, 2000, we sold Fiberlux. The operating results of Fiberlux were historically reported as part of the Plastics segment on a combined basis with Film Products.
(b)	Plant shutdowns, asset impairments and restructurings for 2005 include charges of $10,318 related to the sale or assignment of substantially all of AFBS’ assets, charges of $2,221 related to severance and other employee-related costs in connection with restructurings in Film Products ($1,118), Aluminum Extrusions ($648) and corporate headquarters ($455, included in “Corporate expenses, net” in the operating profit by segment table), a charge of $2,101 related to the planned shutdown of the films manufacturing facility in LaGrange, Georgia, a net gain of $1,667 related to the shutdown of the films manufacturing facility in New Bern, North Carolina, including a gain on the sale of the facility ($1,816, included in “Other income (expense), net” in the consolidated statements of income), partially offset by shutdown-related expenses ($225), a net gain of $1,265 related to the shutdown of the aluminum extrusions facility in Aurora, Ontario, including a gain on the sale of the facility ($1,667, included in “Other income (expense), net” in the consolidated statements of income), shutdown-related costs ($1,111), partially offset by the reversal to income of certain accruals associated with severance and other costs ($709), a charge of $1,019 for process reengineering costs associated with the implementation of a global information system in Film Products (included in “Costs of goods sold” in the consolidated statements of income), a net charge of $843 related to severance and other employee-related costs associated with the restructuring of the research and development operations in Film Products (of this amount, $1,363 in charges for employee relocation and recruitment is included in “Selling, general & administrative expenses” in the consolidated statements of income); a gain of $653 related to the shutdown of the films manufacturing facility in Carbondale, Pennsylvania, including a gain on the sale of the facility ($630, included in “Other income (expense), net” in the consolidated statements of income), and the reversal to income of certain shutdown-related accruals ($23), charges of $583 for asset impairments in Film Products, a gain of $508 for interest receivable on tax refund claims (included in “Corporate expenses, net” in the operating profit by segment table and “Other income (expense), net” in the consolidated statements of income), a charge of $495 in Aluminum Extrusions, including an asset impairment ($597), partially offset by the reversal to income of certain shutdown-related accruals ($102), charges of $353 for accelerated depreciation related to restructurings in Film Products, and a charge of $182 in Film Products related to the write-off of an investment. As of December 31, 2005, the investment in Novalux, Inc. of $6,095 was written down to estimated fair value of $1,095. The loss from the write-down, $5,000, is included in “Other income (expense), net” in the consolidated statements of income.
(c)	Plant shutdowns, asset impairments and restructurings for 2004 include a charge of $10,127 related to the planned shutdown of the aluminum extrusions plant in Aurora, Ontario, a charge of $3,022 related to the sale of the films business in Argentina, charges of $2,572 related to accelerated depreciation from plant shutdowns and restructurings in Film Products, charges of $2,459 related to severance and other costs associated with plant shutdowns in Film Products, charges of $1,547 for severance and other employee-related costs associated with restructurings in AFBS ($735), Film Products ($532) and Aluminum Extrusions ($280), a charge of $1,306 related to the estimated loss on the sub-lease of a portion of the AFBS facility in Princeton, New Jersey, a charge of $1,278 (of this amount, $59 for employee relocation is included in “Selling, general & administrative expenses” in the consolidated statements of income) related to severance and other employee-related costs associated with the restructuring of the research and development operations in Film Products and charges of $575 in Film Products and $146 in Aluminum Extrusions related to asset impairments. Income taxes in 2004 include a tax benefit of $4,000 related to the reversal of income tax contingency accruals upon favorable conclusion of IRS and state examinations through 2000. The other pretax gain of $7,316 included in the Aluminum Extrusions section of the operating profit by segment table is comprised of the present value of an insurance settlement of $8,357 (future value of $8,455) associated with environmental costs related to prior years, partially offset by accruals for expected future environmental costs of $1,041. The company received $5,143 of the $8,455 insurance settlement in 2004 and recognized receivables at present value for future amounts due ($1,497 received in February of 2005 and $1,717 received in February 2006). The gain from the insurance settlement is included in “Other income (expense), net” in the consolidated statements of income, while the accruals for expected future environmental costs are included in “Cost of goods sold.”
(d)	Plant shutdowns, asset impairments and restructurings for 2003 include charges of $4,514 for severance costs in connection with restructurings in Film Products ($1,922), Aluminum Extrusions ($256), AFBS ($1,155) and corporate headquarters ($1,181, included in “Corporate expenses, net” in the operating profit by segment table), charges of $2,776 for asset impairments in the films business, charges of $2,700 related to the estimated loss on the sub-lease of a portion of the AFBS facility in Princeton, New Jersey, a charge of $611 primarily related to severance costs associated with the shutdown of the films plant in New Bern, North Carolina, a charge of $388 related to an early retirement program in our aluminum business and charges of $437 for additional costs incurred related to plant shutdowns in our films business. Unusual items for 2003 include a charge of $1,067 related to an adjustment for depreciation and amortization at AFBS based on our decision to suspend divestiture efforts.
(e)	Plant shutdowns, asset impairments and restructurings for 2002 include a charge of $1,457 for asset impairments in the films business, a charge of $1,007 for additional costs related to the shutdown of the films plant in Carbondale, Pennsylvania, a charge of $541 for additional costs related to the shutdown of the films plant in Tacoma, Washington, a charge of $487 for additional costs related to the shutdown of the aluminum extrusions plant in El Campo, Texas, and a charge of $392 for additional costs related to the 2000 shutdown of the films plant in Manchester, Iowa. Unusual items for 2002 include a net gain of $5,618 for payments received from P&G related to terminations and revisions to contracts and related asset writedowns, and a gain of $529 related to the sale of assets.
(f)	Plant shutdowns, asset impairments and restructurings for 2001 include a charge of $7,799 for the shutdown of the aluminum extrusions plant in El Campo, Texas, a charge of $3,386 for the shutdown of the films plant in Tacoma, Washington, a charge of $2,877 for the shutdown of the films plant in Carbondale, Pennsylvania, a charge of $1,505 for severance costs related to further rationalization in the films business, and a charge of $1,368 for impairment of our films business in Argentina. Unusual items in 2001 include a gain of $971 (included in “Corporate expenses, net” in the operating profit by segment table) for interest received on tax overpayments. Income taxes in 2001 include a benefit of $1,904 for the reversal of income tax contingency accruals upon favorable conclusion of IRS examinations through 1997.
(g)	Plant shutdowns, asset impairments and restructurings for 2000 include a charge of $17,870 related to excess capacity in the films business, a charge of $1,628 related to restructuring at our aluminum extrusions plant in El Campo, Texas, and a charge of $4,293 for the shutdown of the films plant in Manchester, Iowa. Unusual items in 2000 include a gain of $762 for the sale of Fiberlux.
(h)	Plant shutdowns, asset impairments and restructurings for 1999 include a charge of $3,458 related to a write-off of in-process research and development expenses associated with the AFBS acquisition and a charge of $1,170 for the write-off of excess packaging film capacity.
(i)	Plant shutdowns, asset impairments and restructurings for 1998 include a charge of $664 related to the shutdown of the powder-coat paint line in our aluminum extrusions plant in Newnan, Georgia. Unusual items for 1998 include a gain of $765 on the sale of APPX Software. Income taxes in 1998 include a tax benefit of $2,001 related to the sale, including a tax benefit for the excess of APPX Software’s income tax basis over its financial reporting basis.
(j)	Total return to shareholders is computed as the sum of the change in stock price during the year plus dividends per share, divided by the stock price at the beginning of the year.
	��
(k)	Equity market capitalization is the closing market price per share for the period times the shares outstanding at the end of the period.
(l)	Net sales represent gross sales less freight. Net sales is the measure used by the chief operating decision maker of each segment for purposes of assessing performance.
(m)	Other includes primarily APPX Software (sold in 1998 - see (i)).
(n)	Net sales include sales to P&G totaling $236,554 in 2005, $226,122 in 2004, and $207,049 in 2003. These amounts include plastic film sold to others who converted the film into materials used in products manufactured by P&G.

15

Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-looking and Cautionary Statements

          From time to time, we may make statements that may constitute “forward-looking statements” within the meaning of the “safe-harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. Risk factors that may cause such a difference are summarized on pages 3-5 and are incorporated herein.

Executive Summary

          Tredegar is a manufacturer of plastic films and aluminum extrusions. Descriptions of our businesses are provided on pages 1-5.

          Income from continuing operations was $16.2 million (42 cents per diluted share) in 2005 compared with $26.3 million (68 cents per diluted share) in 2004. Gains on the sale of assets, investment write-downs and other items and losses related to plant shutdowns, assets impairments and restructurings are described in results of operations beginning on page 19. The business segment review begins on page 31.

          In Film Products, operating profit from ongoing operations was $44.9 million in 2005 compared with $43.3 million in 2004. The improvement over last year was due primarily to growth in higher value-added products including apertured, elastic and surface protection materials, partially offset by higher resin costs. We estimate that the adverse impact on operating profit of the lag in passing through higher resin costs (net of the favorable effect of a decline in inventories accounted for under the last-in first-out method) in the fourth quarter of 2005 compared with the third quarter of 2005 was approximately $5.5 million. Fourth quarter 2004 operating profit was also adversely affected by the lag of passing through higher resin prices of around $2 million compared with the third quarter of 2004.

          Resin prices continued to escalate to record high levels in the fourth quarter of 2005 due to supply shortages related to the gulf coast hurricanes. Average quarterly prices of low-density polyethylene resin in the U.S. increased 21 cents per pound or 32% in the quarter (see the chart on page 28). Resin prices in Europe and South America exhibited similar trends. To reduce the impact of resin price fluctuations, we have index-based pass-through agreements for the majority of our business. However, under certain agreements, changes in resin costs are not passed through for an average period of 90 days. For non-indexed customers, we have implemented price increases to reduce the negative impact of higher resin costs.

          Capital expenditures in 2005 in Film Products were $50 million and primarily supported capacity expansions for higher value-added materials and a new global information system. Aggregate capital spending for years 2003-2005 totaled approximately $150 million. About one-third of this capital spending relates to customer-specific opportunities that are covered by capital indemnification, contractual volume commitments or similar arrangements. Capital expenditures are expected to be about $50 million in 2006, about half of which is for additional capacity to meet growing demand for surface protection films. These films are primarily used to protect flat panel display components during fabrication, shipping and handling. Sales of surface protection films totaled approximately $30 million in 2005, up from $16 million in 2004, and are expected to grow further. Planned capital expenditures also include expansion of capacity to support elastic material growth opportunities. Sales of elastic materials are expected to continue growing as manufacturers of diapers and adult incontinence products add more stretch to their products to improve comfort and fit.

          In Aluminum Extrusions, operating profit from ongoing operations declined 15% to $19.3 million in 2005 from $22.6 million in 2004 due mainly to higher energy costs (approximately $7 million) and strength of the Canadian Dollar (about $3.5 million), partially offset by price increases, higher volume and an energy surcharge. Annual volume increased to 246.4 million pounds in 2005 from 243.4 million pounds in 2004.

16

          The average costs for natural gas, electricity and diesel fuel were significantly higher in 2005 compared with 2004 (see the natural gas price chart on page 29). For every $1 per mmBtu change in the price of natural gas, the company expects a corresponding operating profit impact in Aluminum Extrusions of approximately $150,000 per month.

          During 2005, we announced price increases in Aluminum Extrusions in April and September. In September 2005, we also announced an energy surcharge in the U.S. to be applied when the previous quarter’s NYMEX natural gas average settlement price is in excess of $8.85 per mmBtu.

          Capital expenditures in Aluminum Extrusions were $12 million in 2005 and are expected to be approximately $10 million in 2006. Profit growth in 2006 is expected to be driven by focusing on improving volume for operations in Canada, higher volume anticipated from hurricane-related rebuilding, price increases, the energy surcharge and cost reductions from productivity enhancements.

          On June 30, 2005, substantially all of the assets of AFBS, Inc. (formerly known as Therics, Inc.), a wholly-owned subsidiary of Tredegar, were sold or assigned to a newly-created limited liability company, Therics, LLC, controlled and managed by an individual not affiliated with Tredegar. For more information, see the business segment review beginning on page 31.

          We refinanced our debt in December 2005 with a $300 million five-year unsecured revolving credit facility. Net capitalization and other credit measures are provided in the liabilities, credit and long-term obligations section beginning on page 24.

Critical Accounting Policies

          In the ordinary course of business, we make a number of estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of financial statements in conformity with generally accepted accounting principles. Actual results could differ significantly from those estimates under different assumptions and conditions. We believe the following discussion addresses our most critical accounting policies. These policies require management to exercise judgments that are often difficult, subjective and complex due to the necessity of estimating the effect of matters that are inherently uncertain.

Impairment and Useful Lives of Long-lived Identifiable Assets and Goodwill

          We regularly assess our long-lived identifiable assets for impairment when events or circumstances indicate that their carrying value may not be recoverable from future cash flows. Any necessary impairment charges are recorded when we do not believe the carrying value of the long-lived asset will be recoverable. We also reassess the useful lives of our long-lived assets based on changes in our business and technologies.

          We assess goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1 of each year). We have made determinations as to what our reporting units are and what amounts of goodwill and intangible assets should be allocated to those reporting units.

          In assessing the recoverability of long-lived identifiable assets and goodwill, we must make assumptions regarding estimated future cash flows, discount rates and other factors to determine if impairment tests are met or the fair value of the respective assets. If these estimates or their related assumptions change in the future, we may be required to record additional impairment charges. Based upon assessments performed, we recorded asset impairment losses for continuing operations related to long-lived identifiable assets of $8.6 million in 2005, $14.1 million in 2004 and $2.8 million in 2003.

Pension Benefits

          We have noncontributory and contributory defined benefit (pension) plans that have significant net pension income developed from actuarial valuations. Inherent in these valuations are key assumptions including discount rates,

17

expected return on plan assets and rate of future compensation increases. We are required to consider current market conditions, including changes in interest rates and plan asset investment returns, in determining these assumptions. Actuarial assumptions may differ materially from actual results due to changing market and economic conditions, higher or lower withdrawal rates or longer or shorter life spans of participants. These differences may result in a significant impact to the amount of net pension income recorded in future periods.

          The discount rate is used to determine the present value of future payments. The discount rate is the single rate that, when applied to expected benefit payments, provides a present value equal to the present value of expected benefit payments determined by using the AA-rated bond yield curve. In general, our liability increases as the discount rate decreases and vice versa. We reduced our weighted average discount rate in each of the last three years (the rate was 5.70% at the end of 2005, 6.00% at the end of 2004 and 6.25% at the end of 2003) due to the decline in market interest rates. The compensation increase assumption affects the estimate of future payments, and was 4% at the end of 2005, 2004 and 2003. A lower expected return on plan assets increases the amount of expense and vice versa. Decreases in the level of actual plan assets will also serve to increase the amount of pension expense. During 2005, 2004 and 2003, the value of our plan assets increased due to improved general market conditions after declining in 2002, 2001 and 2000. Our expected long-term return on plan assets has been 8.4% since 2004 based on market and economic conditions and asset mix (our expected return was 8.6% in 2003 and 9% in 2002 and prior years). See page 62 for more information on expected long-term return on plan assets and asset mix.

          We currently expect net pension income to decline in 2006 by approximately $5 million compared with 2005 after declining by approximately $2 million in 2005 compared with 2004 and $800,000 in 2004 compared with 2003. We expect our minimum cash-funding requirement to be about $800,000 in 2006.

Income Taxes

          Many deductions for tax return purposes cannot be taken until the expenses are actually paid, rather than when the expenses are recorded for book purposes. In these circumstances, we accrue for the tax benefit expected to be received in future years if, in our judgment, it is more likely than not that we will receive such benefits. In addition, the amount and timing of certain current deductions (which reduce taxes currently payable or generate income tax refunds) require interpretation of tax laws. In these circumstances, we estimate and accrue income tax contingencies for differences in interpretation that may exist with tax authorities. On a quarterly basis, we review our judgments regarding income tax contingency accruals and the likelihood the benefits of a deferred tax asset will be realized. During the periodic reviews, we must consider a variety of factors, including the nature and amount of the tax income and expense items, the current tax statutes, the current status of audits performed by tax authorities and the projected future earnings. We believe the realization of our net deferred tax assets is reasonably assured and that our income tax contingency accruals are adequate. If circumstances change, our valuation allowances for deferred tax assets, income tax contingency accruals and net earnings are adjusted accordingly in that period.

Recently Issued Accounting Standards

          In May 2005, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 154,Accounting Changes and Error Corrections - a replacement of APB Opinion No. 20 and FASB Statement No. 3. This statement provides guidance on the accounting for and reporting of changes in accounting principles and error corrections. It requires retrospective application to prior periods’ financial statements of changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. The statement is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. Early adoption is permitted. The adoption of this standard will have no impact on cash flow, and we do not expect it to have an impact on amounts reported in the consolidated statement of income and balance sheet.

          In December 2004, the FASB revised SFAS No. 123,Share-Based Payment. This statement requires that the cost of employee services received in exchange for equity instruments be measured based on the fair value of the award on the grant date. The statement also requires that the cost be recognized over the employee service period required to receive the award. The statement applies to awards granted after the effective date and to awards modified, repurchased or cancelled after that date. The statement is effective beginning the first fiscal year that begins after June

18

15, 2005. Early adoption is permitted. The adoption of this standard will have no impact on cash flow. The primary impact of adoption on Tredegar will be the recognition of compensation expense for stock options granted. Currently, we disclose the pro forma effects of treating stock option grants as compensation expense under the fair value-based method (see pages 47-49). We will transition to the new standard during the first quarter of 2006 using the modified prospective method and continue to use the Black-Scholes options-pricing model to determine the estimated fair value of option grants. We believe that the pro forma effects that have been disclosed are not materially different from compensation expense that would have been recognized if this standard had been previously adopted.

          In November 2004, the FASB issued SFAS No. 151,Inventory Costs – An Amendment of ARB No. 43, Chapter 4. This statement clarifies that abnormal amounts of idle facility expense, freight, handling costs and wasted material (spoilage) should be expensed as current-period charges. In addition, this statement requires that allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. The statement is effective for inventory costs incurred during the fiscal years beginning after June 15, 2005. Early adoption is permitted. The adoption of this standard will have no impact on cash flow, and we do not expect it to have a significant impact on amounts reported in the consolidated statement of income and balance sheet.

          In October 2004, the American Jobs Creation Act of 2004 (“AJCA”) was signed into law. In December 2004, the FASB issued Staff Position No. 109-1 (“FSP 109-1”),Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004and Staff Position No. 109-2 (“FSP 109-2”),Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004. FSP 109-1 clarifies that the manufacturer’s tax deduction provided for under the AJCA should be accounted for as a special deduction in accordance with SFAS No. 109 and not as a tax rate reduction. FSP 109-2 provides accounting and disclosure guidance for the repatriation of certain foreign earnings to a U.S. taxpayer as provided for in the AJCA. We do not expect that the tax benefits resulting from the AJCA will have a material impact on our financial statements.

Results of Operations

2005 versus 2004

Revenues. Overall, sales for 2005 increased 11.1% compared with 2004. Net sales (sales less freight) for Film Products increased 11.4% primarily due to sales of higher value-added products (mainly apertured, elastic and surface protection materials) and higher selling prices driven by higher raw material costs. Net sales for Aluminum Extrusions increased 11% primarily due to higher selling prices driven by higher raw material and energy costs and higher sales volume (volume was up 1.2%). For more information on net sales, see the business segment review beginning on page 31.

Operating Costs and Expenses. Gross profit (sales less cost of goods sold and freight) as a percentage of sales decreased to 12.7% from 14.1% in 2004. At Film Products, the lower gross profit margin was driven primarily by higher resin costs, partially offset by higher overall gross profit from sales of higher value-added products. For more information on resin costs, see the executive summary beginning on page 16. At Aluminum Extrusions, the gross profit margin decreased primarily due to higher energy costs and strength of the Canadian Dollar, partially offset by price increases, higher volume and an energy surcharge.

          As a percentage of sales, selling, general and administrative (“SG&A”) expenses decreased to 6.8% in 2005 compared with 7.0% in 2004 due to higher sales and the divestiture of substantially all of our interest in AFBS at the end of the second quarter of 2005, partially offset by the classification of certain costs at AFBS as operating versus R&D consistent with the commercialization of the company’s bone void filler products last year.

          R&D expenses declined to $9.0 million in 2005 from $15.3 million in 2004. R&D spending at AFBS declined to $2.4 million in 2005 from $7.8 million in 2004 due to the divestiture of substantially all of our interest in AFBS at the end of the second quarter of 2005. Further contributing to lower R&D expenses at AFBS were cost reduction efforts and the classification of certain costs as operating versus R&D consistent with the commercialization of the company’s bone void filler products last year. R&D spending at Film Products dropped to $6.6 million in 2005 compared with $7.5 million in 2004 due to restructuring.

19

          Losses associated with plant shutdowns, asset impairments and restructurings, net of gains on sale of related assets, in 2005 totaled $14.6 million ($9.4 million after taxes) and included:

•	A fourth-quarter charge of $269,000 ($174,000 after taxes) and a second-quarter charge of $10 million ($6.5 million after taxes) related to the sale or assignment of substantially all of AFBS’ (formerly Therics) assets, including asset impairment charges of $5.6 million, lease-related losses of $3.3 million and severance (31 people) and other transaction-related costs of $1.4 million (see page 34 for additional information on the transaction);
•	Fourth-quarter charges of $397,000 ($256,000 after taxes), third-quarter charges of $906,000 ($570,000 after taxes), second-quarter charges of $500,000 ($317,000 after taxes) and first-quarter charges of $418,000 ($266,000 after taxes) related to severance and other employee-related costs associated with restructurings in Film Products ($1.1 million before taxes) and Aluminum Extrusions ($648,000 before taxes) and at corporate headquarters ($455,000 before taxes; included in “Corporate expenses, net” in the operating profit by segment table on page 12) (an aggregate of 21 people were affected by these restructurings);
•	A fourth-quarter charge of $2.1 million ($1.3 million after taxes) related to the planned shutdown of the films manufacturing facility in LaGrange, Georgia, including asset impairment charges of $1.6 million and severance (15 people) and other costs of $486,000 (we anticipate recognizing additional shutdown-related costs of about $1.7 million in the first half of 2006);
•	A fourth-quarter gain of $1.9 million ($1.2 million after taxes), a third-quarter charge of $198,000 ($127,000 after taxes), a second-quarter net gain of $71,000 ($46,000 after taxes) and a first-quarter charge of $470,000 ($301,000 after taxes) related to the shutdown of the aluminum extrusions facility in Aurora, Ontario, including a $1.7 million gain on the sale of the facility (included in “Other income (expense), net” in the consolidated statements of income) and $1.1 million of shutdown-related costs partially offset by the reversal to income of certain accruals associated with severance and other costs of $709,000;
•	A second-quarter charge of $27,000 ($16,000 after taxes) and a first-quarter gain of $1.6 million ($973,000 after taxes) related to the shutdown of the films manufacturing facility in New Bern, North Carolina, including a $1.8 million gain on the sale of the facility (included in “Other income (expense), net” in the consolidated statements of income), partially offset by shutdown-related expenses of $225,000;
•	A first-quarter charge of $1 million ($653,000 after taxes) for process reengineering costs associated with the implementation of a global information system in Film Products (included in “Costs of goods sold” in the consolidated statements of income);
•	Fourth-quarter charges of $118,000 ($72,000 after taxes), third-quarter charges of $595,000 ($359,000 after taxes), second-quarter charges of $250,000 ($150,000 after taxes) partially offset by a net first-quarter gain of $120,000 ($72,000 after taxes) related to severance and other employee-related accruals associated with the restructuring of the research and development operations in Film Products (of this amount, $1.4 million in pretax charges for employee relocation and recruitment is included in SG&A expenses in the consolidated statements of income);
•	A second-quarter gain of $653,000 ($392,000 after taxes) related to the shutdown of the films manufacturing facility in Carbondale, Pennsylvania, including a $630,000 gain on the sale of the facility (included in “Other income (expense), net” in the consolidated statements on income), and the reversal to income of certain
	shutdown-related accruals of $23,000;
•	Fourth-quarter charges of $583,000 ($351,000 after taxes) for asset impairments in Film Products;
•	A net fourth-quarter charge of $495,000 ($310,000 after taxes) in Aluminum Extrusions, including an asset impairment of $597,000, partially offset by the reversal to income of certain shutdown-related accruals of $102,000;
•	Fourth-quarter charges of $31,000 ($19,000 after taxes), third-quarter charges of $117,000 ($70,000 after taxes), second-quarter charges of $105,000 ($63,000 after taxes) and first-quarter charges of $100,000 ($60,000 after taxes) for accelerated depreciation related to restructurings in Film Products; and
•	A fourth-quarter charge of $182,000 ($119,000 after taxes) in Film Products related to the write-off of an investment.

          Gain on sale of corporate assets in 2005 includes a pretax gain of $61,000 related to the sale of corporate real estate. This gain is included in “Other income (expense), net” in the consolidated statements of income and separately shown in the operating profit by segment table on page 12.

20

          During the first quarter of 2005, we recognized a pretax gain for interest receivable on tax refund claims of $508,000 ($327,000 after taxes) (included in “Other income (expense), net” in the consolidated statements of income and “Corporate expenses, net” in the operating profit by segment table on page 12).

          During the fourth quarter of 2005, we recognized a pretax loss of $5 million ($3.8 million after taxes) from the write-down of our investment in Novalux, Inc. to estimated fair value of $1.1 million. Novalux is a developer of laser technology for potential use in a variety of applications. The reduction in estimated fair value was due to longer than anticipated delays both in bringing the company’s technology to market and in obtaining key development partnerships as well as liquidity issues. The loss from the write-down is included in “Other income (expense), net” in the consolidated statements of income and separately shown in the operating profit by segment table on page 12.

          On June 30, 2005, substantially all of the assets of AFBS, Inc. (formerly known as Therics, Inc.), a wholly-owned subsidiary of Tredegar, were sold or assigned to a newly-created limited liability company, Therics, LLC, controlled and managed by an individual not affiliated with Tredegar. For more information, see the business segment review beginning on page 31.

          For more information on costs and expenses, see the business segment review beginning on page 31.

Interest Income and Expense. Interest income, which is included in “Other income (expense), net” in the consolidated statements of income, was $586,000 in 2005 and $350,000 in 2004. Interest income was up primarily due to a higher average yield earned on cash equivalents. Our policy permits investment of excess cash in marketable securities that have the highest credit ratings and maturities of less than one year with the primary objectives being safety of principal and liquidity.

          Interest expense increased to $4.6 million in 2005 compared with $3.2 million in 2004. Average debt outstanding and interest rates were as follows:

(In Millions)	2005			2004
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:
Average outstanding debt balance	$	110.0		$	105.2
Average interest rate		4.5	%		2.7	%
Fixed-rate and other debt:
Average outstanding debt balance	$	5.9		$	5.6
Average interest rate		5.5	%		6.0	%
Total debt:
Average outstanding debt balance	$	115.9		$	110.8
Average interest rate		4.6	%		2.8	%

Income Taxes. The effective tax rate from continuing operations was 38.1% in 2005, up from 26.0% in 2004. The lower rate in 2004 reflects a tax benefit of $4 million related to the reversal of income tax contingency accruals upon favorable conclusion of IRS and state examinations through 2000.

2004 versus 2003

Revenues. Overall, sales for 2004 increased 17% compared with 2003. Net sales (sales less freight) for Film Products and Aluminum Extrusions increased primarily due to higher sales volume and mix, including sales of new value-added products in Film Products, and higher selling prices driven by higher raw material costs. For more information on net sales, see the business segment review beginning on page 31.

Operating Costs and Expenses. Gross profit (sales less cost of goods sold and freight) as a percentage of sales decreased to 14.1% from 15.4% in 2003. At Film Products, the lower gross profit margin was driven primarily by higher resin costs and the loss of certain domestic backsheet business at the end of the first quarter of 2003, partially offset by higher overall gross profit. At Aluminum Extrusions, the gross profit margin increased primarily due to

21

higher volume, operating leverage (generally constant fixed costs until full capacity utilization is achieved) and selling price increases above raw material cost increases, partially offset by appreciation of the Canadian Dollar.

          As a percentage of sales, SG&A expenses decreased to 7.0% in 2004 compared with 7.2% in 2003 primarily due to higher sales. Overall SG&A expenses were up by $6.7 million partially due to the classification of certain costs at AFBS as operating versus R&D consistent with the commercialization of the company’s initial line of bone graft substitutes. SG&A expenses also increased in equivalent U.S. Dollars as a result of the appreciation of the Euro, Hungarian Forint and Canadian Dollar.

          R&D expenses declined to $15.3 million in 2004 from $18.8 million in 2003. R&D spending at AFBS declined to $7.8 million in 2004 from $11.2 million in 2003 due to cost reduction efforts and the classification of certain costs as operating versus R&D consistent with the commercialization of the company’s initial line of bone graft substitutes. R&D spending at Film Products was $7.5 million in 2004 compared with $7.6 million in 2003.

          Losses associated with plant shutdowns, asset impairments and restructurings in 2004 totaled $23 million ($15.2 million after taxes) and included:

• A fourth-quarter charge of $84,000 ($56,000 after taxes), a third-quarter charge of $828,000 ($537,000 after taxes), a second-quarter charge of $994,000 ($647,000 after taxes) and a first-quarter charge of $666,000 ($432,000 after taxes) related to accelerated depreciation from plant shutdowns and restructurings in Film Products;

• A fourth-quarter charge of $569,000 (of this amount, $59,000 for employee relocation is included in SG&A expenses in the consolidated statements of income) ($369,000 after taxes) and a third-quarter charge of $709,000 ($461,000 after taxes) related to severance for 30 people and other employee-related costs associated with the restructuring of the R&D operations in Film Products;

• A fourth-quarter charge of $639,000 ($415,000 after taxes), a third-quarter charge of $617,000 ($401,000 after taxes), a second-quarter charge of $300,000 ($195,000 after taxes) and a first-quarter charge of $537,000 ($349,000 after taxes) primarily related to severance (63 people) and other employee-related costs associated with the shutdown of the films manufacturing facility in New Bern, North Carolina;

• A third-quarter charge of $357,000 ($329,000 after taxes) and a second-quarter charge of $2.7 million ($1.9 million after taxes) for the loss on the sale of the films business in Argentina (proceeds net of transaction costs were $803,000 ($401,000 net of cash included in business sold));

• A fourth-quarter charge of $352,000 ($228,000 after taxes), a third-quarter charge of $195,000 ($127,000 after taxes) and a first-quarter charge of $9.6 million ($6.2 million after taxes) related to the shutdown of the aluminum extrusions facility in Aurora, Ontario, including asset impairment charges of $7.1 million and severance and other employee-related costs of $2.5 million (these costs were contractually-related for about 100 people and were immediately accrued);

• A third-quarter charge of $170,000 ($111,000 after taxes) for additional costs incurred related to a plant shutdown in Film Products;

• A second-quarter charge of $300,000 ($195,000 after taxes), partially offset by a fourth-quarter gain of $104,000 ($68,000 after taxes), related to the loss on the sale of the previously shutdown films manufacturing facility in Manchester, Iowa;

• A fourth-quarter charge of $427,000 ($277,000 after taxes) and a second-quarter charge of $879,000 ($571,000 after taxes) related to the estimated loss on the sub-lease of a portion of the AFBS facility in Princeton, New Jersey;

• Second-quarter charges of $575,000 ($374,000 after taxes) in Film Products and $146,000 ($95,000 after taxes) in Aluminum Extrusions related to asset impairments; and

• Fourth-quarter charges of $1.4 million ($912,000 after taxes) related to severance and other employee-related costs associated with restructurings in AFBS ($590,000 before taxes), Film Products ($532,000 before taxes) and Aluminum Extrusions ($280,000 before taxes) and a second-quarter charge of $145,000 ($94,000 after taxes) related to severance at AFBS (an aggregate of 24 people were affected by these restructurings).

          Gain on sale of corporate assets in 2004 includes a fourth-quarter gain on the sale of land of $1 million ($649,000 after taxes and proceeds of $1.3 million), a second-quarter gain on the sale of land of $413,000 ($268,000 after taxes and proceeds of $647,000) and a first-quarter gain on the sale of public equity securities of $6.1 million ($4

22

million after taxes and proceeds of $7.2 million). These gains are included in “Other income (expense), net” in the consolidated statements of income and separately shown in the operating profit by segment table on page 12.

          Income taxes in 2004 include a third-quarter tax benefit of $4 million related to the reversal of income tax contingency accruals upon the favorable conclusion of IRS and state examinations through 2000.

          The other gain of $7.3 million ($4.8 million after taxes) included in the Aluminum Extrusions section of the operating profit by segment table on page 12 is comprised of the present value of an insurance settlement of $8.4 million (future value of $8.5 million) associated with environmental matters related to prior years, partially offset by accruals for expected future environmental costs of $1 million. The company received $5.2 million of the $8.5 million insurance settlement in September of 2004 and recognized receivables at present value for future amounts due ($1.5 million received in February 2005 and $1.8 million received in February 2006). The gain from the insurance settlement is included in “Other income (expense), net” in the consolidated statements of income, while the accruals for expected future environmental costs are included in “Cost of goods sold.”

          For more information on costs and expenses, see the business segment review beginning on page 31.

Interest Income and Expense. Interest income, which is included in “Other income (expense), net” in the consolidated statements of income, was $350,000 in 2004 and $1.2 million in 2003. Interest income was down primarily due to lower average cash and cash equivalents balances (excess cash was used to repay debt in conjunction with our debt refinancing in October 2003).

          Interest expense declined to $3.2 million in 2004 compared with $6.8 million in 2003. Average debt outstanding and interest rates were as follows:

(In Millions)	2004			2003
Floating-rate debt with interest charged on a rollover basis at one-month LIBOR plus a credit spread:
Average outstanding debt balance	$	105.2		$	180.8
Average interest rate		2.7	%		2.0	%
Floating-rate debt fixed via interest rate swaps in the second quarter of 2001 and maturing in the second quarter of 2003:
Average outstanding debt balance	$	—		$	28.9
Average interest rate		—			5.4	%
Fixed-rate and other debt:
Average outstanding debt balance	$	5.6		$	7.2
Average interest rate		6.0	%		6.4	%
Total debt:
Average outstanding debt balance	$	110.8		$	216.9
Average interest rate		2.8	%		2.6	%

Income Taxes. The effective tax rate from continuing operations was 26.0% in 2004, down from 35.7% in 2003. The decrease is primarily due to a tax benefit of $4 million in 2004 related to the reversal of income tax contingency accruals upon favorable conclusion of IRS and state examinations through 2000, partially offset by tax benefits of about $600,000 not recognized on 2004 operating losses of certain foreign subsidiaries that may not be recoverable in the carryforward period.

Discontinued Operations. On March 7, 2003, Tredegar Investments, Inc. reached definitive agreements to sell substantially all of its venture capital investment portfolio. For more information on the sale (including a summary of venture capital investment activities through disposal in 2003), see the business segment review beginning on page 31. The results for venture capital investment activities have been reported as discontinued operations and include an after-tax gain of $2.9 million in 2004 primarily related to the reversal of business and occupancy tax contingency accruals upon favorable resolution.

23

Financial Condition

Assets

          Tredegar’s total assets increased to $781.8 million at December 31, 2005, from $769.5 million at December 31, 2004. Significant changes in balance sheet items since December 31, 2004, are summarized below:

• Accounts receivable increased by $2.0 million (1.7%).

– Days sales outstanding in Film Products was 45 days, about 5 days below the average for the last several quarters.

– Days sales outstanding in Aluminum Extrusions was 46 days consistent with last year.

• Current income taxes recoverable increased by $7.2 million, primarily reflecting amounts recoverable at Film Products’ subsidiary in The Netherlands.

• Inventories decreased by $2.9 million (4.5%).

– Inventory days were 48 days in Film Products and 32 days in Aluminum Extrusions consistent with last year.

• Net property, plant and equipment (“PP&E”) was up $6.2 million (2.0%) due primarily to capital expenditures of $62.5 million in excess of depreciation of $38.5 million (a $24.0 million net addition to PP&E), partially offset by the effects of foreign exchange rate changes of $7.5 million and asset impairments and disposals during the year totaling $4.3 million in Film Products, $3.1 million in Aluminum Extrusions and $2.1 million in AFBS.

• Other assets increased by $7.3 million (8.1%) due to higher prepaid pension assets (up $2.0 million), higher noncurrent income taxes recoverable (up $5.8 million), the carrying value of investments in Therics, LLC and Theken Spine, LLC ($825,000), higher interest on tax overpayments (up $598,000), higher deferred financing costs (up $481,000) and lower deferred revenue relating to a customer contract (down $1.5 million; recognized as a credit in other assets), partially offset by lower carrying value for our investment in Novalux, Inc. (down $3.9 million).

Liabilities, Credit and Long-Term Obligations

          Total liabilities were $296.4 million at December 31, 2005, up from $289.0 million at December 31, 2004, primarily due to higher debt (up $9.6 million), partially offset by lower accounts payable and accrued expenses (down $4.2 million) due to the timing of accruals and payments.

          Debt outstanding at December 31, 2005 of $113.1 million consisted of $107 million borrowed under our new (originated December 2005) $300 million five-year unsecured revolving credit facility and other debt of $6.1 million. At December 31, 2005, available credit under the revolving credit facility was $154.3 million.

          The credit spread over LIBOR and commitment fees charged on the unused amount under the credit agreement at various indebtedness-to-adjusted EBITDA levels is as follows:

Pricing Under Credit Agreement (Basis Points)
	Credit Spread Over LIBOR
Indebtedness-to- Adjusted EBITDA Ratio	($107 Million Outstanding at 12/31/05)	Commitment Fee
> 2.50x but <= 3x	125	25
> 1.75x but <= 2.50x	100	20
> 1x but <= 1.75x	87.5	17.5
<= 1x	75	15

          At December 31, 2005, we had no interest rate swaps outstanding and the interest cost on debt was priced at one-month LIBOR plus the applicable credit spread of 87.5 basis points.

24

          The computations of adjusted EBITDA, adjusted EBIT, the leverage ratio and interest coverage ratio as defined in the credit agreement are presented below along with the related most restrictive covenants. Adjusted EBITDA and adjusted EBIT as defined in the credit agreement are not intended to represent cash flow from operations as defined by GAAP and should not be considered as either an alternative to net income or to cash flow.

Computations of Adjusted EBITDA, Adjusted EBIT, Leverage Ratio and Interest Coverage Ratio as Defined in Credit Agreement Along with Related Most Restrictive Covenants For the Year Ended December 31, 2005 (In Thousands)
Computations of adjusted EBITDA and adjusted EBIT as defined in Credit Agreement:
Net income	$	16,229
Plus:
After-tax losses related to discontinued operations		—
Total income tax expense for continuing operations		9,973
Interest expense		4,573
Losses related to the application of the equity method of accounting		145
Depreciation and amortization expense for continuing operations		38,789
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $8,834)		23,719
Minus:
After-tax income related to discontinued operations		—
Total income tax benefits for continuing operations		—
Interest income		(586	)
All non-cash gains and income, plus cash gains and income not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (all cash-related)		(4,682	)
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions		3,030
Adjusted EBITDA as defined in Credit Agreement		91,190
Less: Depreciation and amortization expense for continuing operations (including pro forma for acquisitions and asset dispositions)		(38,352	)
Adjusted EBIT as defined in Credit Agreement	$	52,838
Indebtedness:
Total debt	$	113,050
Face value of letters of credit		6,259
Indebtedness	$	119,309
Shareholders’ equity at December 31, 2005	$	485,362
Computations of leverage and interest coverage ratios as defined in Credit Agreement:
Leverage ratio (indebtedness-to-adjusted EBITDA)		1.31	x
Interest coverage ratio (adjusted EBIT-to-interest expense)		11.55	x
Most restrictive covenants as defined in Credit Agreement:
Maximum permitted aggregate amount of dividends that can be paid by Tredegar during the term of the Credit Agreement ($100,000 plus 50% of net income generated after October 1, 2005)	$	100,445
Minimum adjusted shareholders’ equity permitted ($351,918 plus 50% of net income generated after October 1, 2005)	$	352,363
Maximum leverage ratio permitted:
Ongoing		3.00	x
Pro forma for acquisitions		2.50	x
Minimum interest coverage ratio permitted		2.50	x

25

          Noncompliance with any one or more of the debt covenants may have a material adverse effect on financial condition or liquidity in the event such noncompliance cannot be cured or should we be unable to obtain a waiver from the lenders. Renegotiation of the covenant(s) through an amendment to the credit agreement may effectively cure the noncompliance, but may have an effect on financial condition or liquidity depending upon how the covenant is renegotiated.

          We are obligated to make future payments under various contracts as set forth below:

	Payments Due by Period
(In Millions)	2006		2007		2008		2009		2010		Remainder		Total
Debt	$	—	$	4.7	$	.4	$	.4	$	107.2	$	.3	$	113.0
Operating leases:
AFBS (formerly Therics)		1.5		1.6		1.6		1.6		1.6		0.4		8.3
Other		2.1		1.9		1.5		.4		.5		1.5		7.9
Capital expenditure commitments *		14.6		—		—		—		—		—		14.6
Total	$	18.2	$	8.2	$	3.5	$	2.4	$	109.3	$	2.2	$	143.8

* Represents contractual obligations for plant construction and purchases of real property and equipment. See Note 13 on page 63.

          We believe that existing borrowing availability, our current cash balances and our cash flow from operations will be sufficient to satisfy our working capital, capital expenditure and dividend requirements for the foreseeable future.

          From time to time, we enter into transactions with third parties in connection with the sale of assets or businesses in which we agree to indemnify the buyers or third parties involved in the sale for certain liabilities or risks related to the assets or business. Also, in the ordinary course of our business, we may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, we are unable to estimate the maximum potential amount of the potential future liability under the indemnity provisions of these agreements. We do, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable. We disclose contingent liabilities if the probability of loss is reasonably possible and significant.

Shareholders’ Equity

          At December 31, 2005, we had 38,737,016 shares of common stock outstanding and a total market capitalization of $499.3 million, compared with 38,597,522 shares of common stock outstanding and a total market capitalization of $780.1 million at December 31, 2004.

          During 2005 and 2004, we did not purchase any shares of our common stock in the open market. During 2003, we purchased 406,400 shares of our common stock in the open market for $5.2 million (an average price of $12.72 per share). Since becoming an independent company in 1989, we have purchased a total of 20.8 million shares for $122.8 million (an average price of $5.90 per share). Under a standing authorization from our board of directors, we may purchase an additional 3.4 million shares in the open market or in privately negotiated transactions at prices management deems appropriate.

Cash Flows

          The discussion below supplements the information presented in the consolidated statements of cash flows on page 43.

          Cash provided by operating activities was $53.7 million in 2005 compared with $93.8 million in 2004. The decrease is due primarily to the income tax refund received in 2004 related to the sale in 2003 of our venture capital portfolio, partially offset by lower working capital investment in 2005 compared with 2004 (see assets section on page 24 for discussion of working capital trends).

26

          Cash used in investing activities was $55.0 million in 2005 compared with $52.2 million in 2004. The change is primarily attributable to higher capital expenditures (up $6.9 million) and lower proceeds from the sale of assets and property disposals (down $2.2 million), partially offset by a small acquisition in Film Products in 2004 ($1.4 million) and higher investment in Novalux, Inc. in 2004 ($5.0 million invested in 2004 compared with $1.1 million invested in 2005).

          Capital expenditures in 2005 included the normal replacement of machinery and equipment and primarily:

• Continued expansion of capacity for apertured and elastic materials and surface protection films and a new global information system in Film Products; and

• Moving and upgrading the largest aluminum extrusions press at the facility shut down in Aurora, Ontario to the plant in Pickering, Ontario, and enlargement of the Pickering facility.

          See the executive summary beginning on page 16 and the business segment review beginning on page 31 for more information on capital expenditures.

          Net cash provided by financing activities was $3.6 million in 2005 and included the refinancing of our debt in December 2005 (see the section on liabilities, credit and long-term obligations beginning on page 24 for more information).

          In 2004, cash provided by operating activities was $93.8 million compared with $76.4 million in 2003. The increase is due primarily to the income tax refund related to the sale of the venture capital portfolio (see the business segment review beginning on page 31) partially offset by higher primary working capital (accounts receivable, inventories and accounts payable) needed to support higher sales.

           Cash used in investing activities was $52.2 million in 2004 compared with $38.5 million in 2003. The change is primarily attributable to proceeds from the sale of venture capital investments, net of investments made, of $18.7 million in 2003, and the $5 million investment in Novalux, Inc. made in the third quarter of 2004, partially offset by lower capital expenditures of $10.2 million. See the business segment review beginning on page 31 regarding capital expenditures in 2004 and 2003.

          Net cash used in financing activities was $40.5 million in 2004 compared with $129.9 million in 2003. In 2004, we used $50 million from tax refunds related to the sale of the venture capital portfolio to pay down debt. Additional net borrowings of $13.8 million related primarily to capital expenditures and higher primary working capital needed to support higher sales. Net cash used in financing activities in 2003 was driven by scheduled debt payments and debt payments made in conjunction with our refinancing in 2003.

          In 2003, net cash provided by operating activities was $76.4 million compared with $65.3 million in 2002. The increase is due to a decrease in the level of primary working capital partially offset by lower income from ongoing operations. Accounts receivable declined mainly from volume shortfall payments and contract terminations and revisions in Film Products accrued at the end of 2002 and received in 2003 (about $15 million in accounts receivable at the end of 2002 versus none at the end of 2003). Accounts payable increased due to the timing of payments. Inventories increased primarily due to the appreciation of the Euro and the Canadian Dollar.

          Net cash used in investing activities was $38.5 million in 2003 compared with $46.0 million in 2002. This decrease was due to positive cash flow from venture capital activities in 2003 versus negative cash flow in 2002 and higher proceeds from the sale of corporate assets and property disposals (see Note 15 on page 66 for more information), partially offset by higher capital expenditures and acquisitions (up $36.1 million).

27

          Net cash used in financing activities was $129.9 million in 2003 compared with $10.1 million in 2002. This increase was driven by scheduled debt payments and debt payments made in conjunction with our refinancing in 2003.

Quantitative and Qualitative Disclosures about Market Risk

          Tredegar has exposure to the volatility of interest rates, polyethylene and polypropylene resin prices, aluminum ingot and scrap prices, energy prices, foreign currencies and emerging markets. See the section on liabilities, credit and long-term obligations beginning on page 24 regarding credit agreements and interest rate exposures.

          Changes in resin prices, and the timing of those changes, could have a significant impact on profit margins in Film Products. Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate our casting furnaces). There is no assurance of our ability to pass through higher raw material and energy costs to our customers.

          We estimate that resin price increases in the fourth quarter of 2005 and 2004 resulted in a negative operating profit impact of about $5.5 million and $2 million, respectively, compared with the related third quarters of those years. The significant increases in the U.S. since 2002 in average quarterly prices of low density polyethylene resin (a primary raw material for Film Products) are shown in the chart below.

Source: Quarterly averages computed by Tredegar using monthly data provided by Chemical Data Inc. ("CDI"). In January 2005, CDI reflected a 4 cents per pound non-market adjustment based on their estimate of the growth of discounts over the 2000 to 2003 period. The 4th quarter 2004 average rate of 67 cents per pound is shown on a pro forma basis as if the non-market adjustment was made in October 2004.

          Resin prices in Europe, Asia and South America have exhibited similar trends. The price of resin is driven by several factors including supply and demand and the price of oil, ethylene and natural gas. To address fluctuating resin prices, we have pass-through or cost-sharing agreements covering about 65% of our sales, but many have a 90-day lag. We have implemented price increases for customers that are currently not subject to pass-through arrangements. Most new customer contracts contain resin pass-through arrangements.

28

          In the normal course of business, we enter into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge our exposure to aluminum price volatility (see the chart below) under these fixed-price arrangements, which generally have a duration of not more than 12 months, we enter into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled deliveries. See Note 6 on page 55 for more information.

Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.

          In Aluminum Extrusions, we hedge from time-to-time a portion of our exposure to natural gas price volatility by entering into fixed-price forward purchase contracts with our natural gas suppliers. We estimate that, in an unhedged situation, every $1 per mmBtu per month change in the market price of natural gas has a $150,000 impact on the monthly operating profit in Aluminum Extrusions. Substantially higher energy costs (primarily natural gas) in 2005 resulted in a reduction in operating profit in Aluminum Extrusions of approximately $7 million in 2005 compared with 2004. In September 2005, we announced an energy surcharge for our aluminum extrusions business in the U.S. to be applied when the previous quarter’s NYMEX natural gas average settlement price is in excess of $8.85 per mmBtu.

Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.

29

          We sell to customers in foreign markets through our foreign operations and through exports from U.S. plants. The percentage of sales and total assets for manufacturing operations related to foreign markets for 2005 and 2004 are as follows:

Tredegar Corporation - Manufacturing Operations Percentage of Net Sales and Total Assets Related to Foreign Markets
	2005			2004
	% of Total Net Sales *		% Total Assets - Foreign Operations *	% of Total Net Sales *		% Total Assets - Foreign Operations *
	Exports From U.S.	Foreign Operations		Exports From U.S.	Foreign Operations
Canada	5	16	12	3	18	13
Europe	1	14	14	2	14	17
Latin America	1	2	2	2	2	1
Asia	4	4	5	4	3	5
Total % exposure to foreign markets	11	36	33	11	37	36

* The percentages for foreign markets are relative to Tredegar’s total net sales and total assets from manufacturing operations (consolidated net sales and total assets from continuing operations excluding cash and cash equivalents and AFBS (formerly Therics)).

          We attempt to match the pricing and cost of our products in the same currency (except in Canada where about 75% of our sales of aluminum extrusions are U.S. Dollar-based) and generally view the volatility of foreign currencies (see trends for the Euro, Canadian Dollar and Hungarian Forint in the chart below) and emerging markets, and the corresponding impact on earnings and cash flow, as part of the overall risk of operating in a global environment. Exports from the U.S. are generally denominated in U.S. Dollars. Our foreign currency exposure on income from foreign operations relates to the Canadian Dollar, the Euro, the Hungarian Forint, the Chinese Yuan and the Brazilian Real.

          The relatively high percentage of U.S. Dollar-priced sales in Canada is partly due to the shifting of a large portion of the customers previously served by the aluminum extrusions plant in El Campo, Texas, in 2001. The resulting mismatch between the currency denomination of sales and costs causes lower U.S. Dollar translated profits when the Canadian Dollar appreciates since our costs are higher in U.S. Dollar equivalent terms while sales are mostly unaffected (the opposite effect occurs when the Canadian Dollar depreciates in value relative to the U.S. Dollar). We estimate that the appreciation of the Canadian Dollar relative to the U.S. Dollar had an adverse impact on operating profit of about $3.5 million in 2005 compared with 2004, and $2.4 million in 2004 compared with 2003. In Film Products, where we have been able to better match the currency of our sales and costs, we estimate that the appreciation of foreign currencies (primarily the Euro and Hungarian Forint and to a lesser extent the Chinese Yuan and Brazilian Real) relative to the U.S. Dollar had a positive impact on operating profit of about $600,000 in 2005 compared with 2004, and $1 million in 2004 compared with 2003.

30

          We continue to review the loading of our aluminum extrusions plants in North America to optimize production mix and minimize cost in light of the increase in the U.S. Dollar equivalent cost structure of our plants in Canada.

Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.

Business Segment Review

          Net sales (sales less freight) and operating profit from ongoing operations are the measures of sales and operating profit used by the chief operating decision maker for purposes of assessing performance.

Film Products

Net Sales. Net sales in Film Products were $460.3 million in 2005, $413.3 million in 2004 and $365.5 million in 2003. The increases in net sales (sales less freight) in Film Products in the last two years is primarily due to growth in higher value-added products, including apertured, elastic and surface protection materials, and higher selling prices, which were driven by the pass-through of higher raw material costs. Total volume was 261.1 million pounds in 2005, 278.7 million pounds in 2004 and 274.2 million pounds in 2003. Total volume related to the business in Argentina sold in the third quarter of 2004 was 9.4 million pounds in 2004 and 10.8 million pounds in 2003. We estimate that the growth in net sales excluding the effects of the pass-through of resin price changes, foreign exchange rate changes and divestitures was about 7% in 2005 and 9% in 2004.

          On February 2, 2006, we announced the expected shut down of the Film Products’ plant in LaGrange, Georgia. The facility, which is operating at about the break-even level, is expected to close by May 1, 2006. The plant had sales of commodity blown films of approximately $20 million in 2005.

Operating Profit. Operating profit from ongoing operations in Film Products was $44.9 million in 2005, $43.3 million in 2004 and $45.7 million in 2003. The improvement in 2005 over 2004 was due primarily to growth in higher value-added products partially offset by higher resin costs. We estimate that the adverse impact on operating profit of the lag in passing through higher resin costs (net of the favorable effect of a decline in inventories accounted for under the last-in first-out method) in the fourth quarter of 2005 compared with the third quarter of 2005 was approximately $5.5 million. Fourth quarter 2004 operating profit was also adversely affected by the lag of passing through higher resin prices of around $2 million compared with the third quarter of 2004. The decline in operating profit from ongoing operations in 2004 compared with 2003 was primarily due to higher resin costs and the loss of certain domestic backsheet business at the end of the first quarter of 2003, partially offset by the positive effects of sales growth for new value-added products.

          Resin prices continued to escalate to record high levels in the fourth quarter of 2005 due to supply

31

shortages related to the gulf coast hurricanes (see the chart on page 28). To address fluctuating resin prices, we have pass-through or cost-sharing agreements covering about 65% of our sales, but many have a 90-day lag. We have implemented price increases for customers that are currently not subject to pass-through arrangements. Most new customer contracts contain resin pass-through arrangements.

Identifiable Assets.Identifiable assets in Film Products increased to $479.3 million at December 31, 2005, from $472.8 million at December 31, 2004, due primarily to capital expenditures in excess of depreciation of $24.0 million (see the depreciation, amortization and capital expenditures section below for more information) partially offset by lower accounts receivable (down $4.9 million) due to lower days sales outstanding (down about 5 days since the end of last year), the effects of foreign exchange rate changes of $9.8 million and asset impairments and disposals during the year totaling $4.3 million.

          Identifiable assets in Film Products increased to $472.8 million at December 31, 2004, from $422.3 million at December 31, 2003, due primarily to capital expenditures in excess of depreciation of $22.9 million (see the depreciation, amortization and capital expenditures section below for more information), higher accounts receivable and inventories supporting higher sales and appreciation of the Euro and Hungarian Forint relative to the U.S. Dollar.

Depreciation, Amortization and Capital Expenditures. Depreciation and amortization for Film Products was $26.7 million in 2005, up from $22 million in 2004 and $19.8 million in 2003 due to the relatively high level of capital expenditures in the last three years. We expect depreciation and amortization expense for Film Products to increase to about $30 million in 2006.

          Capital expenditures in Film Products in 2005 totaled $50.5 million and reflect the normal replacement of machinery and equipment and:

• Expansion of production capacity at our films plant in Kerkrade, The Netherlands, including capacity for an apertured topsheet product for P&G’s sanitary napkin business;

• Expansion of production capacity at our films plant in Lake Zurich, Illinois, including capacity for elastic materials used in baby diapers and adult incontinent products;

• Expansion of production capacity at our films plant in Guangzhou, China, including capacity for surface protection films;

• Leasehold improvements and the addition of laminating capacity at our new films plant in Red Springs, North Carolina;

• Expansion of production capacity at our plant in Pottsville, Pennsylvania, including capacity for polyethylene film used for packaging and masking film used for surface protection;

• Leasehold improvements and equipment upgrades at our new R&D facility in Richmond, Virginia; and

• A new global information system.

          Capital expenditures in Film Products in 2004 totaled $44.8 million and reflect the normal replacement of machinery and equipment and:

• Expansion of production capacity at our films plant in Kerkrade, The Netherlands, including capacity for an apertured topsheet product for P&G’s sanitary napkin business;

• Construction of a new films plant in Guangzhou, China, including production capacity for apertured film used in feminine hygiene products;

• Expansion of production capacity at our films plant in Shanghai, China, including capacity for breathable film used in personal care products and protective clothing;

• Expansion of production capacity at our films plant in Lake Zurich, Illinois, including capacity for elastic materials used in baby diapers and surface protection films;

• Expansion of production capacity at our plant in Pottsville, Pennsylvania, including capacity for polyethylene film used for packaging and surface protection films; and

• A new global information system.

32

          See the executive summary beginning on page 16 for further discussion of historical and projected capital expenditures (including information on related capital indemnification, take-or-pay or similar arrangements) for Film Products.

Aluminum Extrusions

Net Sales and Operating Profit. Net sales in Aluminum Extrusions were $471.7 million in 2005, up 11% from $425.1 million in 2004 primarily due to higher selling prices driven by higher raw material and energy costs. Annual volume increased to 246.4 million pounds in 2005 from 243.4 million pounds in 2004, as stronger shipments in commercial construction and hurricane protection products were offset by lower shipments in other end markets (see our market segments in the table on page 2). Operating profit from ongoing operations declined 15% to $19.3 million in 2005 from $22.6 million in 2004 due mainly to higher energy costs (approximately $7 million) and strength of the Canadian Dollar (about $3.5 million), partially offset by price increases, higher volume and an energy surcharge.

          The average costs for natural gas (the principal energy source used to operate our casting furnaces), electricity and diesel fuel were significantly higher in 2005 compared with 2004 (see the natural gas price chart on page 29). For every $1 per mmBtu change in the price of natural gas, the company expects a corresponding operating profit impact in Aluminum Extrusions of approximately $150,000 per month.

          During 2005, we announced price increases in April and September. In September 2005, we also announced an energy surcharge in the U.S. to be applied when the previous quarter’s NYMEX natural gas average settlement price is in excess of $8.85 per mmBtu.

          Profit growth in 2006 is expected to be driven by focusing on improving volume for the company’s operations in Canada, higher volume anticipated from hurricane-related rebuilding, price increases, the energy surcharge and cost reductions from productivity enhancements.

          Net sales in Aluminum Extrusions increased by 20% in 2004 compared with 2003 primarily due to higher raw material-driven selling prices and higher volume. Annual volume was 243.4 million pounds in 2004 compared with 228.2 million pounds in 2003. Operating profit from ongoing operations increased to $22.6 million in 2004 from $15.1 million in 2003. The $7.5 million or 50% increase in operating profit on 6.7% volume growth was primarily due to operating leverage and pricing improvements, partially offset by the adverse effects of appreciation of the Canadian Dollar (about $2.4 million). Volume in 2004 was up in most markets after declining by about 30% from the last cyclical peak around 1999. Volume in our largest market, commercial construction, improved by about 13% in 2004 compared with 2003. Historically, cyclical upturns in the aluminum extrusions industry last several years with overall cross-cycle volume growth in the 3% range.

Identifiable Assets. Identifiable assets in Aluminum Extrusions increased to $214.4 million at December 31, 2005, from $210.9 million at December 31, 2004, due primarily to higher accounts receivable. See discussion regarding assets on page 24 for further information.

          Identifiable assets in Aluminum Extrusions increased to $210.9 million at December 31, 2004, from $185.3 million at December 31, 2003, due primarily to higher accounts receivable and inventories supporting higher sales and appreciation of the Canadian Dollar relative to the U.S. Dollar.

Depreciation, Amortization and Capital Expenditures. Depreciation and amortization for Aluminum Extrusions was $11.5 million in 2005, $10.9 million in 2004 and $10.9 million in 2003. The increase in 2005 is primarily due to the start of depreciation of capital expenditures associated with moving and upgrading the largest extrusions press at the facility shut down in Aurora, Ontario to the plant in Pickering, Ontario, and enlargement of the Pickering facility. We expect depreciation and amortization expense for Aluminum Extrusions to increase to about $12 million in 2006.

          Capital expenditures totaled $12.0 million in 2005, $10 million in 2004 and $8.3 million in 2003, and reflect the normal replacement of machinery and equipment plus capital expenditures associated with the plant in Pickering, Ontario described above. Capital expenditures are expected to be approximately $10 million in 2006.

33

          On November 21, 2003, we announced the acquisition of Apolo Tool and Die Manufacturing Inc. (“Apolo”) of Woodbridge, Ontario. The purchase price consisted of cash consideration of $1.6 million (including transaction costs of $110,000 and net cash acquired of $343,000). Apolo’s key capabilities include bending, CNC machining, drilling, mitering, punching, riveting, sawing and welding of aluminum extrusions and other materials. The company also has in-house tool and die design and manufacturing capability to support its fabrication services.

AFBS

          On June 30, 2005, substantially all of the assets of AFBS, Inc. (formerly known as Therics, Inc.), a wholly-owned subsidiary of Tredegar, were sold or assigned to a newly-created limited liability company, Therics, LLC, controlled and managed by an individual not affiliated with Tredegar. AFBS received a 17.5% equity interest in Therics, LLC, valued at $170,000 and a 3.5% interest in Theken Spine, LLC, valued at $800,000, along with potential future payments based on the sale of certain products by Therics, LLC. AFBS retained substantially all of its liabilities in the transaction, which included customary indemnification provisions for pre-transaction liabilities. Tredegar has no obligation or intent to fund any future losses that may occur at Therics, LLC or Theken Spine, LLC. The ownership interest in Therics, LLC is accounted for under the equity method of accounting with losses limited to its initial carrying value of $170,000. The ownership interest in Theken Spine, LLC is accounted for under the cost method, with an impairment loss recognized and a new cost basis established for any write-down to estimated fair value, if necessary. The potential future payments due from Therics, LLC based on the sale of certain products will be recognized as income when earned. AFBS had operating losses of $3.5 million during the first six months of 2005 and $9.8 million in 2004.

Molecumetics

          Operations at Molecumetics, a healthcare-related biotech company, ceased on July 2, 2002, and results have been reported as discontinued operations. Discontinued operations in 2003 include a gain from the sale of intellectual property of $1.4 million ($891,000 after taxes). Cash flows relating to Molecumetics have not been separately disclosed in the consolidated statements of cash flows.

Venture Capital Investment Activities

          On March 7, 2003, Tredegar Investments reached definitive agreements to sell substantially all of its portfolio of private equity partnership interests to GS Vintage Funds II, which are investment partnerships managed by Goldman Sachs Asset Management’s Private Equity Group. On the same date and in a separate transaction, Tredegar Investments also agreed to sell to W Capital Partners, an independent private equity manager, the subsidiary funds that hold substantially all of Tredegar Investments’ direct venture capital investments. The sale of these fund interests included the assumption by the buyer of Tredegar Investments’ obligations to make additional capital contributions to those funds in the future.

          The sale to W Capital Partners of the subsidiary funds that hold the direct investments occurred on March 7, 2003. The sale of the private equity fund interests occurred in a series of closings.

          Net proceeds from the sales totaled approximately $21.5 million. Additionally, in the first quarter of 2004 we received income tax recoveries of approximately $55 million from the carry-back of 2003 capital losses generated by these sales against gains realized in 2000 by Tredegar Investments.

   ��      The agreements governing these transactions contain customary contingent indemnification provisions that Tredegar believes will not have a material effect on its financial position or results of operations.

34

          The operating results from venture capital investment activities have been reported as discontinued operations. Cash flows from venture capital investment activities have not been separately disclosed in the consolidated statements of cash flows. A summary of venture capital investment activities through disposal in 2003 is provided below:

(In Thousands)	2003
Carrying value of venture capital investments, beginning of period	$	93,765
Venture capital investment activity for period:
(pre-tax amounts):
New investments		2,807
Proceeds from the sale of investments, including broker receivables at end of period		(21,504	)
Realized gains		—
Realized losses, write-offs and write-downs		(70,256	)
(Decrease) increase in unrealized gain on available-for-sale securities		(917	)
Carrying value of public securities retained by Tredegar Investments*		(3,895	)
Carrying value of venture capital investments, end of period	$	—
Summary of amounts reported as discontinued operations in the consolidated statements of income:
Pretax gains (losses), net	$	(70,256	)
Operating expenses (primarily management fee expenses)		(599	)
Loss before income taxes		(70,855	)
Income tax benefits		24,286
Loss from venture capital investment activities	$	(46,569	)

* At December 31,2003, Tredegar Investments held 596,492 shares of Vascular Solutions, Inc. (NASDAQ: VASC) and 265,955 shares of Illumina, Inc. (NASDAQ: ILMN). These securities, which were related to Tredegar Investments' earlier venture capital investment activities, were sold in 2004 for $7.2 million, including gains recognized of $6.1 million ($4 million after taxes).

          Discontinued operations in 2004 include an after-tax gain associated with venture capital investment activities of $2.9 million primarily related to the reversal of business and occupancy tax contingency accruals upon favorable resolution.

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

          See discussion of quantitative and qualitative disclosures about market risk beginning on page 28 in Management’s Discussion and Analysis.

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

          See the index on page 39 for references to management’s report on internal control over financial reporting, report of the independent registered public accounting firm, the consolidated financial statements and selected quarterly financial data.

Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

          None.

35

Item 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

          Pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, we carried out an evaluation, with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

          There has been no change in our internal control over financial reporting during the quarter ended December 31, 2005, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Management’s Report on Internal Control Over Financial Reporting

          Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended. The Company’s internal control over financial reporting is designed to provide reasonable assurance to the Company’s management and board of directors regarding the reliability of financial reporting and the preparation and fair presentation of published financial statements in accordance with generally accepted accounting principles in the United States of America and includes policies and procedures that:

• Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;

• Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States of America, and that our receipts and expenditures are being made only in accordance with authorization of our management and directors; and

• Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the consolidated financial statements.

          Internal control over financial reporting includes the controls themselves, monitoring (including internal auditing practices) and actions taken to correct deficiencies as identified.

          Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

          Management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework inInternal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on their evaluation under the framework inInternal Control — Integrated Framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2005.

          Our management’s assessment of the effectiveness of our internal control over financial reporting as of December 31, 2005, has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which is included on pages 39-40.

36

Item 9B. OTHER INFORMATION

                    None.

PART III

Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF TREDEGAR

          The information concerning directors and persons nominated to become directors of Tredegar included in the Proxy Statement under the heading “Election of Directors” is incorporated herein by reference.

          The information included in the Proxy Statement under the heading “Stock Ownership” and the subheading “Audit Committee Matters” (under the “Board Committees” heading) is incorporated herein by reference.

          Set forth below are the names, ages and titles of our executive officers:

Name	Age	Title
John D. Gottwald	51	President and Chief Executive Officer effective March 1, 2006
Norman A. Scher	68	President and Chief Executive Officer until March 1, 2006
Nancy M. Taylor	46	President, Tredegar Film Products and Corporate Senior Vice President
Tammy H. Cummings	42	Vice President, Human Resources
D. Andrew Edwards	47	Vice President, Chief Financial Officer and Treasurer
Larry J. Scott	55	Vice President, Audit
W. Hildebrandt Surgner, Jr.	40	Vice President, General Counsel and Corporate Secretary

John D. Gottwald. On January 16, 2006, Mr. Gottwald was elected President and Chief Executive Officer effective March 1, 2006. Mr. Gottwald had served as Chairman of the Board of Directors since September 10, 2001. Mr. Gottwald served as President and Chief Executive Officer from July 10, 1989 until September 10, 2001.

Norman A. Scher. On March 1, 2006, Mr. Scher retired as President and Chief Executive Officer and became Vice Chairman of the Board of Directors. He continues to serve on the Executive Committee of the Board of Directors. Mr. Scher will remain an employee (non-executive) and assist with special projects throughout 2006. Mr. Scher had served as President and Chief Executive Officer since September 10, 2001. Mr. Scher served as Executive Vice President and Chief Financial Officer from July 10, 1989 until September 10, 2001. From July 10, 1989 until May 22, 1997, he also served as Treasurer.

Nancy M. Taylor. Ms. Taylor was elected President of Tredegar Film Products effective April 5, 2005. She was elected Senior Vice President effective November 1, 2004. Ms. Taylor served as Senior Vice President, Strategy and Special Projects from November 1, 2004 until April 5, 2005. Ms. Taylor served as Managing Director, European Operations, of Tredegar Film Products from January 1, 2003 until November 1, 2004. Ms. Taylor served as Vice President, Administration and Corporate Development from September 10, 2001 until February 12, 2003. Ms. Taylor served as Secretary from February 24, 1994 until February 12, 2003. She served as Vice President, Law, from November 18, 1998 until September 10, 2001, and served as General Counsel from May 22, 1997 until July 25, 2000.

Tammy H. Cummings.Ms. Cummings was elected Vice President, Human Resources, on August 28, 2003. Ms. Cummings served as Director of Human Resources from June 1, 2002 until August 28, 2003. Prior to her employment with Tredegar, she served as Vice President, Human Resources/Organization Development for Luck Stone Corporation from 1998 until 2002 and served as Human Resources Director of Luck Stone Corporation from 1996 until 1998.

37

D. Andrew Edwards. Mr. Edwards was elected Vice President, Chief Financial Officer and Treasurer on August 28, 2003. Mr. Edwards has served as Vice President, Finance since November 18, 1998. Mr. Edwards has served as Treasurer since May 22, 1997. From October 19, 1992 until July 10, 2000, Mr. Edwards served as Controller.

Larry J. Scott. Mr. Scott was elected Vice President, Audit, on May 24, 2000. Mr. Scott served as Director of Internal Audit from February 24, 1994 until May 24, 2000.

W. Hildebrandt Surgner, Jr.Mr. Surgner was elected Corporate Secretary on February 12, 2003. He was elected Vice President and General Counsel on December 16, 2002. Prior to his employment with Tredegar, he served as Senior Counsel to Philip Morris U.S.A. in 2002 and served as Counsel to Philip Morris U.S.A. from 1999 until 2001. In this capacity, Mr. Surgner was employed by Philip Morris Management Corporation. He was an Associate at the law firm of Hunton & Williams LLP from 1994 until 1999.

          We have adopted a Code of Conduct that applies to all of our directors, officers and employees (including our Chief Executive Officer, Chief Financial Officer and principal accounting officer) and have posted the Code of Conduct on our web site. We intend to satisfy the disclosure requirement under Item 10 of Form 8-K relating to amendments to or waivers from any provision of our Code of Conduct applicable to Chief Executive Officer, Chief Financial Officer and principal accounting officer by posting this information on our website. Our Internet address iswww.tredegar.com.The information on our website is not, and shall not be deemed to be, a part of this report or incorporated into other filings we make with the SEC.

          Because our common stock is listed on the NYSE, our chief executive officer is required to make, and he has made, an annual certification to the NYSE stating that he was not aware of any violation by us of the corporate governance listing standards of the NYSE. Our chief executive officer made his annual certification to that effect to the NYSE as of May 17, 2005. In addition, we have filed, as exhibits to this Annual Report on Form 10-K, the certifications of our principal executive officer and principal financial officer required under Section 302 of the Sarbanes Oxley Act of 2002 to be filed with the SEC regarding the quality of our public disclosure.

          The information included in the Proxy Statement under the heading “Section 16(a) Beneficial Ownership Reporting Requirements” is incorporated herein by reference.

Item 11. EXECUTIVE COMPENSATION

          The information included in the Proxy Statement under the headings “Compensation of Directors” and “Compensation of Executive Officers” is incorporated herein by reference.

Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

          The information included in the Proxy Statement under the heading “Stock Ownership” and “Equity Compensation Plan Table” is incorporated herein by reference.

Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

          Mr. Thomas G. Slater, Jr., a member of our board of directors, is married to Mr. John D. Gottwald’s sister-in-law and is a partner of the law firm of Hunton & Williams LLP, which provides legal services to Tredegar on a variety of matters.

Item 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

          The following is incorporated herein by reference:

• Information on accounting fees and services included in the Proxy Statement under the heading “Audit Fees;” and

• Information on the Audit Committee’s procedures for pre-approving certain audit and non-audit services included in the Proxy Statement under the subheading “Audit Committee Matters” (under the “Board Committees” heading).

38

PART IV

Item 15.	EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
	(a)	List of documents filed as a part of the report:
		(1)	Financial statements:

Tredegar Corporation

Index to Financial Statements and Supplementary Data

	Page
Management’s Report on Internal Control Over Financial Reporting	36
Report of Independent Registered Public Accounting Firm	39-40
Financial Statements:
Consolidated Statements of Income for the Years Ended December 31, 2005, 2004 and 2003	41
Consolidated Balance Sheets as of December 31, 2005 and 2004	42
Consolidated Statements of Cash Flows for the Years Ended December 31, 2005, 2004 and 2003	43
Consolidated Statements of Shareholders’ Equity for the Years Ended December 31, 2005, 2004 and 2003	44
Notes to Financial Statements	45-70
Selected Quarterly Financial Data (Unaudited)	71

(2)	Financial statement schedules:
	None.
(3)	Exhibits:
	See Exhibit Index on pages 78-79.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of
Tredegar Corporation

We have completed integrated audits of Tredegar Corporation’s 2005 and 2004 consolidated financial statements and of its internal control over financial reporting as of December 31, 2005, and an audit of its 2003 consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Our opinions, based on our audits, are presented below.

Consolidated Financial Statements

In our opinion, the consolidated financial statements listed in the index appearing under Item 15(a)(1) present fairly, in all material respects, the financial position of Tredegar Corporation and its subsidiaries at December 31, 2005 and 2004, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2005 in conformity with accounting principles generally accepted in the United States of America.

39

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit of financial statements includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

Internal Control Over Financial Reporting

Also, in our opinion, management’s assessment, included in Management’s Report on Internal Control Over Financial Reporting appearing under Item 9A, that the Company maintained effective internal control over financial reporting as of December 31, 2005 based on criteria established inInternal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), is fairly stated, in all material respects, based on those criteria. Furthermore, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2005 based on criteria established inInternal Control – Integrated Framework issued by the COSO. The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express opinions on management’s assessment and on the effectiveness of the Company’s internal control over financial reporting based on our audit. We conducted our audit of internal control over financial reporting in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. An audit of internal control over financial reporting includes obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we consider necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

PricewaterhouseCoopers LLP
Richmond, Virginia
March 1, 2006

40

CONSOLIDATED STATEMENTS OF INCOME

Tredegar Corporation and Subsidiaries

Years Ended December 31	2005			2004		2003
(In Thousands, Except Per-Share Data)
Revenues and other:
Sales	$	956,969		$	861,165	$	738,651
Other income (expense), net		(544	)		15,604		7,853
		956,425			876,769		746,504
Costs and expenses:
Cost of goods sold		810,621			717,120		606,242
Freight		24,691			22,398		18,557
Selling, general and administrative		64,723			60,030		53,341
Research and development		8,982			15,265		18,774
Amortization of intangibles		299			330		268
Interest		4,573			3,171		6,785
Asset impairments and costs associated with exit and disposal activities		16,334			22,973		11,426
Unusual items		—			—		1,067
Total		930,223			841,287		716,460
Income from continuing operations before income taxes		26,202			35,482		30,044
Income taxes		9,973			9,222		10,717
Income from continuing operations		16,229			26,260		19,327
Discontinued operations:
Gain (loss) from venture capital investment activities (including an after-tax gain on a tax-related item of $2,275 in 2004 and an after-tax loss on the sale of the venture capital investment portfolio of $46,269 in 2003)		—			2,921		(46,569	)
Income (loss) from operations of Molecumetics		—			—		891
Income (loss) from discontinued operations		—			2,921		(45,678	)
Net income (loss)	$	16,229		$	29,181	$	(26,351	)
Earnings (loss) per share:
Basic:
Continuing operations	$	.42		$	.69	$	.51
Discontinued operations		—			.08		(1.20	)
Net income (loss)	$	.42		$	.77	$	(.69	)
Diluted:
Continuing operations	$	.42		$	.68	$	.50
Discontinued operations		—			.08		(1.19	)
Net income (loss)	$	.42		$	.76	$	(.69	)

See accompanying notes to financial statements.

41

CONSOLIDATED BALANCE SHEETS

Tredegar Corporation and Subsidiaries

December 31	2005			2004
(In Thousands, Except Share Data)
Assets
Current assets:
Cash and cash equivalents	$	23,434		$	22,994
Accounts and notes receivable, net of allowance for doubtful accounts and sales returns of $5,423 in 2005 and $5,313 in 2004		119,330			117,314
Income taxes recoverable		7,163			—
Inventories		62,438			65,360
Deferred income taxes		7,778			10,181
Prepaid expenses and other		4,224			4,689
Total current assets		224,367			220,538
Property, plant and equipment, at cost:
Land and land improvements		12,496			12,637
Buildings		91,400			90,830
Machinery and equipment		528,821			518,258
Total property, plant and equipment		632,717			621,725
Less accumulated depreciation		309,841			305,033
Net property, plant and equipment		322,876			316,692
Other assets and deferred charges		96,527			89,261
Goodwill and other intangibles (other intangibles of $712 in 2005 and $1,939 in 2004)		137,988			142,983
Total assets	$	781,758		$	769,474
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable	$	61,731		$	63,852
Accrued expenses		36,031			38,141
Income taxes payable		—			1,446
Current portion of long-term debt		—			13,125
Total current liabilities		97,762			116,564
Long-term debt		113,050			90,327
Deferred income taxes		74,287			71,141
Other noncurrent liabilities		11,297			11,000
Total liabilities		296,396			289,032
Commitments and contingencies (Notes 13 and 16)
Shareholders’ equity:
Common stock (no par value):
Authorized 150,000,000 shares;
Issued and outstanding - 38,737,016 shares in 2005 and 38,597,522 in 2004 (including restricted stock)		110,706			109,450
Common stock held in trust for savings restoration plan (58,156 shares in 2005 and 57,489 in 2004)		(1,284	)		(1,274	)
Unearned compensation on restricted stock (109,000 shares in 2005 and 120,000 in 2004)		(966	)		(1,402	)
Accumulated other comprehensive income (loss):
Unrealized gain on available-for-sale securities		23			—
Foreign currency translation adjustment		14,114			19,562
Gain on derivative financial instruments		776			884
Minimum pension liability		(2,434	)		(1,156	)
Retained earnings		364,427			354,378
Total shareholders’ equity		485,362			480,442
Total liabilities and shareholders’ equity	$	781,758		$	769,474

See accompanying notes to financial statements.

42

CONSOLIDATED STATEMENTS OF CASH FLOWS

Tredegar Corporation and Subsidiaries

Years Ended December 31	2005			2004			2003
(In Thousands)
Cash flows from operating activities:
Net income (loss)	$	16,229		$	29,181		$	(26,351	)
Adjustments for noncash items:
Depreciation		38,490			34,092			32,354
Amortization of intangibles		299			330			268
Deferred income taxes		9,217			1,947			37,370
Accrued pension income and postretirement benefits		(1,979	)		(3,999	)		(4,812	)
Loss from write-down of investment in Novalux		5,000			—			—
Loss on venture capital investments		—			—			70,256
Gain on sale of assets		(4,174	)		(7,560	)		(5,155	)
Loss on asset impairments and divestitures		9,378			13,811			2,456
Changes in assets and liabilities, net of effects from acquisitions and divestitures:
Accounts and notes receivable		(3,361	)		(31,711	)		14,649
Inventories		2,803			(13,962	)		(2,294	)
Income taxes recoverable		(12,966	)		61,538			(48,737	)
Prepaid expenses and other		530			(258	)		(763	)
Accounts payable and accrued expenses		(3,590	)		12,269			7,801
Other, net		(2,173	)		(1,858	)		(661	)
Net cash provided by operating activities		53,703			93,820			76,381
Cash flows from investing activities:
Capital expenditures		(62,543	)		(55,651	)		(65,808	)
Acquisitions (net of cash acquired of $343 in 2003)		—			(1,420	)		(1,579	)
Novalux investment in 2005 and 2004 and venture capital investments in 2003		(1,095	)		(5,000	)		(2,807	)
Proceeds from the sale of venture capital investments		—			—			21,504
Proceeds from the sale of assets and property disposals		8,018			10,209			9,602
Other, net		636			(310	)		630
Net cash used in investing activities		(54,984	)		(52,172	)		(38,458	)
Cash flows from financing activities:
Dividends paid		(6,190	)		(6,154	)		(6,103	)
Debt principal payments and financing costs		(147,846	)		(72,750	)		(255,000	)
Borrowings		156,500			36,573			135,349
Repurchases of Tredegar common stock		—			—			(5,170	)
Proceeds from exercise of stock options		1,130			1,871			1,046
Net cash provided by (used in) financing activities		3,594			(40,460	)		(129,878	)
Effect of exchange rate changes on cash		(1,873	)		1,863			1,970
Increase (decrease) in cash and cash equivalents		440			3,051			(89,985	)
Cash and cash equivalents at beginning of period		22,994			19,943			109,928
Cash and cash equivalents at end of period	$	23,434		$	22,994		$	19,943
Supplemental cash flow information:
Interest payments (net of amount capitalized)	$	4,388		$	3,264		$	6,709
Income tax payments (refunds), net	$	14,915		$	(50,006	)	$	(1,701	)

See accompanying notes to financial statements.

43

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

Tredegar Corporation and Subsidiaries

	Common Stock						Retained Earnings			Trust for Savings Restora- tion Plan			Unearned Restricted Stock Compensation
	Shares			Amount
(In Thousands, Except Share and Per-Share Data)
Balance December 31, 2002		38,323,025		$	108,389		$	363,743		$	(1,212	)		$	—
Comprehensive income (loss):
Net loss		—			—			(26,351	)		—				—
Other comprehensive income (loss):
Available-for-sale securities adjustment, net of reclassification adjustment (net of tax of $1,228)		—			—			—			—				—
Foreign currency translation adjustment (net of tax of $7,788)		—			—			—			—				—
Derivative financial instruments adjustment (net of tax of $715)		—			—			—			—				—
Minimum pension liability adjustment (net of tax of $1,347)		—			—			—			—				—
Comprehensive loss
Cash dividends declared ($.16 per share)		—			—			(6,103	)		—				—
Repurchases of Tredegar common stock		(406,400	)		(5,170	)		—			—				—
Issued upon exercise of stock options (including related income tax benefits of $726) & other		260,196			1,772			—			—				—
Balance December 31, 2003		38,176,821			104,991			331,289			(1,212	)			—
Comprehensive income (loss):
Net income		—			—			29,181			—				—
Other comprehensive income (loss):
Available-for-sale securities adjustment, net of reclassification adjustment (net of tax of $1,556)		—			—			—			—				—
Foreign currency translation adjustment (net of tax of $4,500)		—			—			—			—				—
Reclassification of foreign currency translation loss realized on the sale of the films business in Argentina (net of tax of $625)		—			—			—			—				—
Derivative financial instruments adjustment (net of tax of $247)		—			—			—			—				—
Minimum pension liability adjustment (net of tax of $149)		—			—			—			—				—
Comprehensive income
Cash dividends declared ($.16 per share)		—			—			(6,154	)		—				—
Restricted stock grant, net of forfeitures		120,000			1,674			—			—				(1,674	)
Restricted stock amortization		—			—			—			—				272
Issued upon exercise of stock options (including related income tax benefits of $868) & other		300,701			2,785			—			—				—
Tredegar common stock purchased by trust for savings restoration plan		—			—			62			(62	)			—
Balance December 31, 2004		38,597,522			109,450			354,378			(1,274	)			(1,402	)
Comprehensive income (loss):
Net income		—			—			16,229			—				—
Other comprehensive income (loss):
Available-for-sale securities adjustment, net of reclassification adjustment (net of tax of $13)		—			—			—			—				—
Foreign currency translation adjustment (net of tax of $2,933)		—			—			—			—				—
Derivative financial instruments adjustment (net of tax of $60)		—			—			—			—				—
Minimum pension liability adjustment (net of tax of $630)		—			—			—			—				—
Comprehensive income
Cash dividends declared ($.16 per share)		—			—			(6,190	)		—				—
Restricted stock grant, net of forfeitures and vested shares		(11,000	)		(49	)		—			—				49
Restricted stock amortization		—			—			—			—				387
Issued upon exercise of stock options (including related income tax benefits of $175) & other		150,494			1,305			—			—				—
Tredegar common stock purchased by trust for savings restoration plan		—			—			10			(10	)			—
Balance December 31, 2005		38,737,016		$	110,706		$	364,427		$	(1,284	)		$	(966	)

	Accumulated Other Comprehensive Income (Loss)															TotalShare-holders’Equity
	UnrealizedGain onAvailable-for-SaleSecurities				ForeignCurrencyTrans-lation			Gain(Loss) onDerivativeFinancialInstruments				MinimumPensionLiability
(In Thousands, Except Share and Per-Share Data)
Balance December 31, 2002		$	586		$	(4,422	)		$	(842	)		$	(3,310	)	$	462,932
Comprehensive income (loss):
Net loss			—			—				—				—			(26,351	)
Other comprehensive income (loss):
Available-for-sale securities adjustment, net of reclassification adjustment (net of tax of $1,228)			2,184			—				—				—			2,184
Foreign currency translation adjustment (net of tax of $7,788)			—			14,419				—				—			14,419
Derivative financial instruments adjustment (net of tax of $715)			—			—				1,286				—			1,286
Minimum pension liability adjustment (net of tax of $1,347)			—			—				—				2,430			2,430
Comprehensive loss																	(6,032	)
Cash dividends declared ($.16 per share)			—			—				—				—			(6,103	)
Repurchases of Tredegar common stock			—			—				—				—			(5,170	)
Issued upon exercise of stock options (including related income tax benefits of $726) & other			—			—				—				—			1,772
Balance December 31, 2003			2,770			9,997				444				(880	)		447,399
Comprehensive income (loss):
Net income			—			—				—				—			29,181
Other comprehensive income (loss):
Available-for-sale securities adjustment, net of reclassification adjustment (net of tax of $1,556)			(2,770	)		—				—				—			(2,770	)
Foreign currency translation adjustment (net of tax of $4,500)			—			8,404				—				—			8,404
Reclassification of foreign currency translation loss realized on the sale of the films business in Argentina (net of tax of $625)			—			1,161				—				—			1,161
Derivative financial instruments adjustment (net of tax of $247)			—			—				440				—			440
Minimum pension liability adjustment (net of tax of $149)			—			—				—				(276	)		(276	)
Comprehensive income																	36,140
Cash dividends declared ($.16 per share)			—			—				—				—			(6,154	)
Restricted stock grant, net of forfeitures			—			—				—				—			—
Restricted stock amortization			—			—				—				—			272
Issued upon exercise of stock options (including related income tax benefits of $868) & other			—			—				—				—			2,785
Tredegar common stock purchased by trust for savings restoration plan			—			—				—				—			—
Balance December 31, 2004			—			19,562				884				(1,156	)		480,442
Comprehensive income (loss):
Net income			—			—				—				—			16,229
Other comprehensive income (loss):
Available-for-sale securities adjustment, net of reclassification adjustment (net of tax of $13)			23			—				—				—			23
Foreign currency translation adjustment (net of tax of $2,933)			—			(5,448	)			—				—			(5,448	)
Derivative financial instruments adjustment (net of tax of $60)			—			—				(108	)			—			(108	)
Minimum pension liability adjustment (net of tax of $630)			—			—				—				(1,278	)		(1,278	)
Comprehensive income																	9,418
Cash dividends declared ($.16 per share)			—			—				—				—			(6,190	)
Restricted stock grant, net of forfeitures and vested shares			—			—				—				—			—
Restricted stock amortization			—			—				—				—			387
Issued upon exercise of stock options (including related income tax benefits of $175) & other			—			—				—				—			1,305
Tredegar common stock purchased by trust for savings restoration plan			—			—				—				—			—
Balance December 31, 2005		$	23		$	14,114			$	776			$	(2,434	)	$	485,362

See accompanying notes to financial statements.

44

NOTES TO FINANCIAL STATEMENTS

Tredegar Corporation and Subsidiaries
(In thousands, except Tredegar share and per-share amounts and unless otherwise stated)

1          SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Organization and Nature of Operations. Tredegar Corporation and subsidiaries (“Tredegar”) are engaged in the manufacture of plastic films and aluminum extrusions. See Note 17 regarding discontinued operations.

Basis of Presentation. The consolidated financial statements include the accounts and operations of Tredegar and all of its majority-owned subsidiaries. Intercompany accounts and transactions have been eliminated. Certain previously reported amounts have been reclassified to conform to the 2005 presentation.

          The preparation of financial statements in conformity with generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.

Foreign Currency Translation. The financial statements of foreign subsidiaries, where the local currency is the functional currency, are translated into U.S. Dollars using exchange rates in effect at the period end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from the translation of these financial statements are reflected as a separate component of shareholders’ equity. We have no foreign subsidiaries where the U.S. Dollar is the functional currency.

          Transaction and remeasurement gains or losses included in income were not material in 2005, 2004 and 2003. These amounts do not include the effects between reporting periods that exchange rate changes have on income of our foreign locations that result from translation into U.S. Dollars.

Cash and Cash Equivalents. Cash and cash equivalents consist of cash on hand in excess of daily operating requirements and highly liquid investments with original maturities of three months or less. At December 31, 2005 and 2004, Tredegar had cash and cash equivalents of $23,434 and $22,994, respectively, including funds held in foreign locations of $14,890 and $21,410, respectively.

          Our policy permits investment of excess cash in marketable securities that have the highest credit ratings and maturities of less than one year. The primary objectives of the policy are safety of principal and liquidity.

Accounts and Notes Receivable. Accounts receivable are stated at cash due from customers less allowances for doubtful accounts and sales returns. Accounts receivable are non-interest bearing and arise from the sale of product to customers under typical industry trade terms. Notes receivable are not significant. Past due amounts are determined based on established terms and charged-off when deemed uncollectible. The allowance for doubtful accounts is determined based on our assessment of probable losses taking into account past due amounts, customer credit profile, historical experience and current economic conditions. Other receivables include insurance recoveries due within one year and value-added taxes related to certain foreign subsidiaries.

Inventories. Inventories are stated at the lower of cost or market, with cost determined on the last-in, first-out (“LIFO”) basis, the weighted average cost or the first-in, first-out basis. Cost elements included in work-in-process and finished goods inventories are raw materials, direct labor and manufacturing overhead.

Property, Plant and Equipment. Accounts include costs of assets constructed or purchased, related delivery and installation costs and interest incurred on significant capital projects during their construction periods. Expenditures for renewals and betterments also are capitalized, but expenditures for repairs and maintenance are expensed as incurred. The cost and accumulated depreciation applicable to assets retired or sold are removed from the respective accounts, and gains or losses thereon are included in income.

45

          Property, plant and equipment include capitalized interest of $1,387 in 2005, $762 in 2004 and $593 in 2003.

          Depreciation is computed primarily by the straight-line method based on the estimated useful lives of the assets, which range from 15 to 40 years for buildings and land improvements and 3 to 25 years for machinery and equipment. The average depreciation period for machinery and equipment is approximately 13 years in Film Products and 15 years in Aluminum Extrusions.

Goodwill and Other Intangibles. The excess of the purchase price over the fair value of identifiable net assets of acquired companies is allocated to goodwill. We assess goodwill for impairment when events or circumstances indicate the carrying value may not be recoverable, or, at a minimum, on an annual basis as of December 1 of each year. Impairment reviews may result in recognition of losses. We have made determinations as to what our reporting units are and what amounts of goodwill, intangible assets, other assets and liabilities should be allocated to those reporting units.

          The components of goodwill and other intangibles at December 31, 2005 and 2004, and related amortization periods are as follows:

December 31	2005		2004		Amortization Periods
Carrying value of goodwill:
Film Products	$	102,732	$	103,788		Not amortized
Aluminum Extrusions		34,544		33,764		Not amortized
AFBS (formerly Therics)		—		3,492		Not amortized
Total carrying value of goodwill		137,276		141,044
Carrying value of other intangibles:
Film Products (cost basis of $1,575 in 2005 and 2004)		712		990		Not more than 17 yrs.
AFBS (formerly Therics) (cost basis of $2,236 in 2004)		—		949		10 years
Total carrying value of other intangibles		712		1,939
Total carrying value of goodwill and other intangibles	$	137,988	$	142,983

          A reconciliation of the beginning and ending balances of goodwill and other intangibles for each of the three years in the period ended December 31, 2005 is as follows:

	2005			2004			2003
Goodwill and other intangibles:
Net carrying value, beginning of year	$	142,983		$	140,548		$	137,339
Amortization		(299	)		(330	)		(268	)
Decrease due to sale of AFBS (formerly Therics) assets		(4,329	)		—			—
(Decrease) increase due to foreign currency translation and other		(367	)		2,765			3,477
Total carrying value of goodwill and other intangibles	$	137,988		$	142,983		$	140,548

Impairment of Long-Lived Assets. We review long-lived assets for possible impairment when events indicate that impairment may exist. For assets to be held and used in operations, if events indicate that an asset may be impaired, we estimate the future unlevered pre-tax cash flows expected to result from the use of the asset and its eventual disposition. Assets are grouped for this purpose at the lowest level for which there are identifiable and independent cash flows. If the sum of these undiscounted pre-tax cash flows is less than the carrying amount of the asset, an impairment loss is recognized. Measurement of the impairment loss is based on the estimated fair value of the asset, generally determined on a discounted after-tax cash flow basis.

          Assets to be disposed of are reported at the lower of their carrying amount or estimated fair value less cost to sell, with an impairment loss recognized for any writedown required.

Pension Costs and Postretirement Benefit Costs Other than Pensions. Pension costs and postretirement benefit costs other than pensions are accrued over the period employees provide service to the company. Our policy is to fund our pension plans at amounts not less than the minimum requirements of the Employee Retirement Income Security Act of

46

1974 and to fund postretirement benefits other than pensions when claims are incurred.

Postemployment Benefits. We periodically provide certain postemployment benefits purely on a discretionary basis. Related costs for these programs are accrued when it is probable that benefits will be paid and amounts can be reasonably estimated. All other postemployment benefits are either accrued under current benefit plans or are not material to our financial position or results of operations.

Revenue Recognition. Revenue from the sale of products, which is shown net of estimated sales returns and allowances, is recognized when delivery of product to the customer has occurred, the price of the product is fixed and determinable, and collectibility is reasonably assured. Amounts billed to customers related to freight have been classified as sales in the accompanying consolidated statements of income. The cost of freight has been classified as a separate line in the accompanying consolidated statements of income.

Research & Development (“R&D”) Costs. R&D costs are expensed as incurred and include primarily salaries, wages, employee benefits, equipment depreciation, facility costs and the cost of materials consumed relating to R&D efforts. R&D costs include a reasonable allocation of indirect costs.

Income Taxes. Income taxes are recognized during the period in which transactions enter into the determination of income for financial reporting purposes, with deferred income taxes being provided at enacted statutory tax rates on the differences between the financial reporting and tax bases of assets and liabilities (see Note 14). We accrue U.S. federal income taxes on unremitted earnings of our foreign subsidiaries.

Earnings Per Share. Basic earnings per share is computed using the weighted average number of shares of common stock outstanding. Diluted earnings per share is computed using the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows:

	2005		2004		2003
Weighted average shares outstanding used to compute basic earnings (loss) per share		38,471,348		38,294,996		38,096,001
Incremental shares attributable to stock options and restricted stock		125,356		211,688		345,009
Shares used to compute diluted earnings (loss) per share		38,596,704		38,506,684		38,441,010

          Incremental shares attributable to stock options and restricted stock are computed using the average market price during the related period. During 2005, 2004 and 2003, 2,024,690, 2,073,990 and 2,425,575 of average out-of-the-money options to purchase shares were excluded from the calculation of incremental shares attributable to stock options and restricted stock.

Stock-Based Employee Compensation Plans. Stock options, stock appreciation rights (“SARs”) and restricted stock grants are accounted for using the intrinsic value method under APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations whereby:

• No compensation cost is recognized for fixed stock option or restricted stock grants unless the quoted market price of the stock at the measurement date (ordinarily the date of grant or award) is in excess of the amount the employee is required to pay; and

• Compensation cost for SARs is recognized and adjusted up through the date of exercise or forfeiture based on the estimated number of SARs expected to be exercised multiplied by the difference between the market price of our stock and the amount the employee is required to pay (there were no SARs outstanding at December 31, 2005).

47

          Had compensation cost for stock option grants been determined in 2005, 2004 and 2003 based on the fair value at the grant dates, our income and diluted earnings per share from continuing operations would have been reduced to the pro forma amounts indicated below:

	2005			2004			2003
Income from continuing operations:
As reported	$	16,229		$	26,260		$	19,327
Stock option-based employee compensation cost, net of tax, based on the fair value method		(1,073	)		(2,133	)		(2,194	)
Pro forma income from continuing operations	$	15,156		$	24,127		$	17,133
Basic earnings per share from continuing operations:
As reported	$	.42		$	.69		$	.51
Pro forma		.39			.63			.45
Diluted earnings per share from continuing operations:
As reported	$	.42		$	.68		$	.50
Pro forma		.39			.63			.45

          Compensation cost related to stock-based compensation (restricted stock grants) included in determining net income from continuing operations was $298 in 2005, $272 in 2004 and $95 in 2003.

          The fair value of each option was estimated as of the grant date using the Black-Scholes options-pricing model. The assumptions used in this model for valuing Tredegar stock options granted in 2004 and 2003 are as follows (there were no Tredegar stock options granted in 2005):

	2004			2003
Dividend yield		1.2	%		1.0	%
Volatility percentage		45.0	%		45.0	%
Weighted average risk-free interest rate		3.1	%		4.0	%
Holding period (years):
Officers		n/a			7.0
Management		5.0			5.0
Other employees		3.0			n/a
Weighted average market prices at date of grant (market price equals exercise price):
Officers and management	$	13.97		$	16.44
Other employees		13.95			n/a

48

          Tredegar Stock options granted during 2004 and 2003 (there were no Tredegar stock options granted in 2005), and related estimated fair value at the date of grant, are as follows:

	2004		2003
Stock options granted (number of shares):
Officers		n/a		10,000
Management		176,950		5,000
Other employees		161,675		n/a
Total		338,625		15,000
Estimated weighted average fair value of options per share at date of grant (exercise price equaled market price on date of grant)
Officers		n/a	$	7.93
Management	$	5.54		6.51
Other employees		4.32		n/a
Total estimated fair value of stock options granted	$	1,679	$	112

          The table above excludes stock options granted to a consultant in 2004. The estimated fair value related to that grant of $50 was expensed in 2004 in conjunction with services rendered. Additional disclosure of Tredegar stock options is included in Note 10.

          AFBS (formerly Therics) stock options granted in 2004 and assumptions used in determining related pro forma compensation expense are as follows (there were no significant grants of AFBS stock options in 2005 and 2003):

Assumptions Used in Determining Pro Forma Comp. Expense for AFBS Stock Options Granted in 2004 & Other Data
Assumptions used in Black-Scholes options-pricing model:
Dividend yield		0.0	%
Volatility percentage (a)		95	%
Weighted average risk-free interest rate		4.1	%
Holding period (years)		7.0
Weighted average estimated fair value per share of underlying stock at date of grant (b)	$	.090
Weighted average estimated fair value of options per share at date of grant	$	.074
Other assumptions and items:
Vesting period (years)		0.4 - 4
AFBS stock options granted:
3rd quarter 2004		7,906,149
1st quarter 2004		30,809,000
Aggregate estimated fair value of options at date of grant:
3rd quarter 2004	$	584
1st quarter 2004	$	2,271

(a)	Volatility estimated for AFBS based on Orthovita, Inc. (NASDAQ: VITA), a comparable company.
(b)	Estimated fair value of underlying stock equaled the stock option exercise price at date of grant.

49

Financial Instruments.We use derivative financial instruments for the purpose of hedging aluminum price volatility and interest rate exposures that exist as part of ongoing business operations. Our derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the balance sheet at fair value. A change in the fair value of the derivative that is highly effective as and that is designated and qualifies as a cash flow hedge is recorded in other comprehensive income. Gains and losses reported in other comprehensive income are reclassified to earnings in the periods in which earnings are affected by the variability of cash flows of the hedged transaction. Such gains and losses are reported on the same line as the underlying hedged item. Any hedge ineffectiveness (which represents the amount by which the changes in the fair value of the derivative exceed the variability in the cash flows of the forecasted transaction) is recorded in current period earnings. There was no hedge ineffectiveness recognized in earnings.

          Our policy requires that we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. We also formally assess (both at the hedge’s inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to remain highly effective in future periods. When it is determined that a derivative is not (or has ceased to be) highly effective as a hedge, we discontinue hedge accounting prospectively.

          As a policy, we do not engage in speculative or leveraged transactions, nor do we hold or issue financial instruments for trading purposes.

          The cash flows related to financial instruments are classified in the statements of cash flows in a manner consistent with those of the transactions being hedged.

Comprehensive Income.Comprehensive income, which is included in the consolidated statement of shareholders’ equity, is defined as net income and other comprehensive income. Other comprehensive income includes changes in unrealized gains and losses on available-for-sale securities, foreign currency translation adjustments, unrealized gains and losses on derivative financial instruments and minimum pension liability adjustments, all recorded net of deferred income taxes directly in shareholders’ equity.

          The available-for-sale securities adjustment included in the consolidated statement of shareholders’ equity is comprised of the following components:

	2005			2004			2,003
Available-for-sale securities adjustment:
Unrealized net holding gains (losses) arising during the period	$	36		$	1,872		$	7,294
Income taxes		(13	)		(655	)		(2,626	)
Reclassification adjustment for net losses (gains) realized in income		—			(6,134	)		(3,851	)
Income taxes		—			2,147			1,367
Available-for-sale securities adjustment	$	23		$	(2,770	)	$	2,184

Recently Issued Accounting Standards. In May 2005, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 154,Accounting Changes and Error Corrections - a replacement of APB Opinion No. 20 and FASB Statement No. 3. This statement provides guidance on the accounting for and reporting of changes in accounting principles and error corrections. It requires retrospective application to prior periods’ financial statements of changes in accounting principle, unless it is impracticable to determine either the period-specific effects or the cumulative effect of the change. The statement is effective for accounting changes and corrections of errors made in fiscal years beginning after December 15, 2005. Early adoption is permitted. The adoption of this standard will have no impact on cash flow, and we do not expect it to have an impact on amounts reported in the consolidated statement of income and balance sheet.

          In December 2004, the FASB revised SFAS No. 123,Share-Based Payment. This statement requires that the

50

cost of employee services received in exchange for equity instruments be measured based on the fair value of the award on the grant date. The statement also requires that the cost be recognized over the employee service period required to receive the award. The statement applies to awards granted after the effective date and to awards modified, repurchased or cancelled after that date. The statement is effective beginning the first fiscal year that begins after June 15, 2005. Early adoption is permitted. The adoption of this standard will have no impact on cash flow. The primary impact of adoption on Tredegar will be the recognition of compensation expense for stock options granted. Currently, we disclose the pro forma effects of treating stock option grants as compensation expense under the fair value-based method (see pages 47-49). We will transition to the new standard during the first quarter of 2006 using the modified prospective method and continue to use the Black-Scholes options-pricing model to determine the estimated fair value of option grants. We believe that the pro forma effects that have been disclosed are not materially different from compensation expense that would have been recognized if this standard had been previously adopted.

          In November 2004, the FASB issued SFAS No. 151,Inventory Costs – An Amendment of ARB No. 43, Chapter 4. This statement clarifies that abnormal amounts of idle facility expense, freight, handling costs and wasted material (spoilage) should be expensed as current-period charges. In addition, this statement requires that allocation of fixed production overheads to the costs of conversion be based on the normal capacity of the production facilities. The statement is effective for inventory costs incurred during the fiscal years beginning after June 15, 2005. Early adoption is permitted. The adoption of this standard will have no impact on cash flow, and we do not expect it to have a significant impact on amounts reported in the consolidated statement of income and balance sheet.

          In October 2004, the American Jobs Creation Act of 2004 (“AJCA”) was signed into law. In December 2004, the FASB issued Staff Position No. 109-1 (“FSP 109-1”),Application of FASB Statement No. 109, Accounting for Income Taxes, to the Tax Deduction on Qualified Production Activities Provided by the American Jobs Creation Act of 2004 and Staff Position No. 109-2 (“FSP 109-2”),Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004. FSP 109-1 clarifies that the manufacturer’s tax deduction provided for under the AJCA should be accounted for as a special deduction in accordance with SFAS No. 109 and not as a tax rate reduction. FSP 109-2 provides accounting and disclosure guidance for the repatriation of certain foreign earnings to a U.S. taxpayer as provided for in the AJCA. We do not expect that the tax benefits resulting from the AJCA will have a material impact on our financial statements.

51

2               ACQUISITIONS AND INVESTMENTS

          On July 23, 2004, a subsidiary of Tredegar purchased the assets of Yaheng Perforated Film Material Co., Ltd. (“Yaheng”) for approximately $1,420. Yaheng, based in Shanghai, China, had 21 employees at the acquisition date and manufactures apertured nonwovens used primarily in personal care markets. The purchase price was allocated to accounts receivable ($26), inventories ($45), property, plant and equipment ($288), patents ($822), employment agreements ($150), goodwill ($215), deferred income tax liabilities ($56) and accrued expenses ($70). Property, plant and equipment is being depreciated on a straight-line basis over approximately 10 years, patents are being amortized on a straight-line basis over approximately 7 years, and employment agreements are being amortized on a straight-line basis over approximately 3 years.

          On November 21, 2003, Tredegar announced that its aluminum extrusions subsidiary, the William L. Bonnell Company, had acquired Apolo Tool and Die Manufacturing Inc. (“Apolo”) of Woodbridge, Ontario. The purchase price consisted of cash consideration of $1,579 (including transaction costs of $110 and net cash acquired of $343). Apolo’s key capabilities include bending, CNC machining, drilling, mitering, punching, riveting, sawing and welding of aluminum extrusions and other materials. The company also has in-house tool and die design and manufacturing capability to support its fabrication services. There was no goodwill (the excess of the purchase price over the estimated fair value of identifiable net assets acquired) associated with the Apolo acquisition.

          The operating results for the acquired businesses have been included in the consolidated statements of income since the date acquired. Pro forma results for these acquisitions are immaterial.

          In August of 2004, we invested $5,000 in Novalux, Inc. In October 2005, we invested an additional $1,095 in a new convertible secured bridge financing for Novalux bringing our aggregate investment to $6,095. As of December 31, 2005, the investment in Novalux was written down to estimated fair value of $1,095. Novalux is a developer of laser technology for potential use in a variety of applications. The reduction in estimated fair value was due to longer than anticipated delays both in bringing the company’s technology to market and in obtaining key development partnerships as well as liquidity issues. The loss from the write-down is included in “Other income (expense), net” in the consolidated statements of income and separately shown in the operating profit by segment table in Note 3.

          In conjunction with our most recent investment, we entered into a forbearance agreement with Novalux pursuant to which we have agreed to forbear our ability to vote that number of shares which accounts for more than 19.5% of the total voting shares of Novalux (our voting interest in Novalux prior to the new financing was approximately 18% on an issued and outstanding basis and 15% on a fully diluted basis). We do not have a seat on the board of directors. We believe that our investment in Novalux does not provide us significant influence over its operating and financial policies. The investment in Novalux, which is included in “Other assets and deferred charges” in the consolidated balance sheet, is being accounted for under the cost method, with any impairment loss recognized and a new cost basis established for write-downs to estimated fair value.

52

3               BUSINESS SEGMENTS

          Information by business segment and geographic area for the last three years is provided below. There are no accounting transactions between segments and no allocations to segments. Net sales (sales less freight) and operating profit from ongoing operations are the measures of sales and operating profit used by the chief operating decision maker for purposes of assessing performance. Film Products’ net sales to The Procter & Gamble Company (“P&G”) totaled $236,554 in 2005, $226,122 in 2004 and $207,049 in 2003. These amounts include plastic film sold to others that convert the film into materials used in products manufactured by P&G.

	Net Sales
	2005		2004		2003
Film Products	$	460,277	$	413,257	$	365,501
Aluminum Extrusions		471,749		425,130		354,593
AFBS (formerly Therics)		252		380		—
Total net sales		932,278		838,767		720,094
Add back freight		24,691		22,398		18,557
Sales as shown in consolidated statements of income	$	956,969	$	861,165	$	738,651

	Operating Profit
	2005			2004			2003
Film Products:
Ongoing operations	$	44,946		$	43,259		$	45,676
Plant shutdowns, asset impairments and restructurings, net of gains on the sale of assets (a)		(3,955	)		(10,438	)		(5,746	)
Aluminum Extrusions:
Ongoing operations		19,302			22,637			15,117
Plant shutdowns, asset impairments and restructurings, net of gains on the sale of assets (a)		122			(10,553	)		(644	)
Gain on sale of land (a)		—			—			1,385
Other (a)		—			7,316			—
AFBS (formerly Therics):
Ongoing operations		(3,467	)		(9,763	)		(11,651	)
Loss on investment in Therics, LLC		(145	)		—			—
Restructurings (a)		(10,318	)		(2,041	)		(3,855	)
Unusual items (a)		—			—			(1,067	)
Total		46,485			40,417			39,215
Interest income		586			350			1,183
Interest expense		4,573			3,171			6,785
Gain on sale of corporate assets (a)		61			7,560			5,155
Loss from write-down of investment in Novalux (a)		5,000			—			—
Corporate expenses, net (a)		11,357			9,674			8,724
Income from continuing operations before income taxes		26,202			35,482			30,044
Income taxes (a)		9,973			9,222			10,717
Income from continuing operations		16,229			26,260			19,327
Income (loss) from discontinued operations (a)		—			2,921			(45,678	)
Net income (loss)	$	16,229		$	29,181		$	(26,351	)

(a)	See Notes 2 and 15 for more information on losses associated with plant shutdowns, asset impairments and restructurings, unusual items, gains from sale of assets, investment write-down and other items, and Note 17 for more information on discontinued operations.
(b)	The difference between total consolidated sales as reported in the consolidated statements of income and segment and geographic net sales reported in this note is freight of $24,691 in 2005, $22,398 in 2004 and $18,557 in 2003.
(c)	Information on exports and foreign operations are provided on the next page. Cash and cash equivalents includes funds held in foreign locations of $14,890, $21,410 and $16,188 at December 31, 2005, 2004, and 2003, respectively. Export sales relate almost entirely to Film Products. Foreign operations in The Netherlands, Hungary, China, Italy, Brazil and Argentina (operations in Argentina were sold in the third quarter of 2004) also relate to Film Products. Sales from our locations in The Netherlands, Hungary and Italy are primarily to customers located in Europe. Sales from our locations in China (Guangzhou and Shanghai) are primarily to customers located in China, but also include other customers in Asia. Foreign operations in Canada relate to Aluminum Extrusions. Sales from our locations in Canada are primarily to customers located in the U.S. and Canada.

53

	Identifiable Assets
December 31	2005		2004		2003
Film Products	$	479,286	$	472,810	$	422,321
Aluminum Extrusions		214,374		210,894		185,336
AFBS (formerly Therics)		2,759		8,613		8,917
Subtotal		696,419		692,317		616,574
General corporate		61,905		54,163		61,508
Income taxes recoverable from sale of venture capital investment portfolio		—		—		55,000
Cash and cash equivalents (c)		23,434		22,994		19,943
Total	$	781,758	$	769,474	$	753,025

	Depreciation and Amortization						Capital Expenditures
	2005		2004		2003		2005		2004		2003
Film Products	$	26,673	$	21,967	$	19,828	$	50,466	$	44,797	$	57,203
Aluminum Extrusions		11,484		10,914		10,883		11,968		10,007		8,293
AFBS (formerly Therics)		437		1,300		1,641		36		275		219
Subtotal		38,594		34,181		32,352		62,470		55,079		65,715
General corporate		195		241		270		73		572		93
Total	$	38,789	$	34,422	$	32,622	$	62,543	$	55,651	$	65,808

		Net Sales by Geographic Area (c)
	2005		2004		2003
United States	$	495,900	$	441,891	$	383,204
Exports from the United States to:
Canada		44,870		27,663		25,188
Latin America		9,428		16,668		17,915
Europe		8,311		15,768		25,157
Asia		40,476		31,617		21,510
Foreign operations:
Canada		144,090		147,145		125,347
The Netherlands		83,649		66,856		43,954
Hungary		33,573		34,721		32,204
China		36,823		25,291		17,426
Italy		15,866		12,423		12,698
Brazil and Argentina		19,292		18,724		15,491
Total (b)	$	932,278	$	838,767	$	720,094

	Identifiable Assets by Geographic Area (c)						Property, Plant & Equipment, Net by Geographic Area (c)
December 31	2005		2004		2003		2005		2004		2003
United States	$	444,144	$	427,240	$	394,415	$	178,154	$	163,383	$	159,127
Foreign operations:
Canada		92,328		92,290		86,564		41,208		38,610		44,179
The Netherlands		67,683		75,449		47,809		54,331		58,370		38,956
Hungary		18,505		27,308		26,815		12,787		19,371		20,449
China		40,599		38,713		29,233		26,104		25,684		22,577
Italy		17,997		20,785		20,951		3,093		3,991		3,826
Brazil and Argentina		15,163		10,532		10,787		5,205		5,037		5,295
General corporate		61,905		54,163		61,508		1,994		2,246		3,067
Income taxes recoverable
from sale of venture
capital investment portfolio		—		—		55,000		n/a		n/a		n/a
Cash and cash equivalents (c)		23,434		22,994		19,943		n/a		n/a		n/a
Total	$	781,758	$	769,474	$	753,025	$	322,876	$	316,692	$	297,476

See footnotes on prior page and a reconciliation of net sales to sales as shown in the consolidated statements of income.

54

4 ACCOUNTS AND NOTES RECEIVABLE

          Accounts and notes receivable consist of the following:

December 31	2005		2004
Trade, less allowance for doubtful accounts and sales returns of $5,423 in 2005 and $5,313 in 2004	$	112,968	$	109,347
Other		6,362		7,967
Total	$	119,330	$	117,314

          The allowance for doubtful accounts and sales returns increased by $110 in 2005 and $865 in 2004 and declined by $1,594 in 2003. The changes in 2005, 2004 and 2003 were comprised of increases to the allowance for charges to expense of $612 and $956 and a decrease to the allowance for income from changes in estimates of $483, respectively, decreases in the allowance for income from recoveries of $15, $5 and none, respectively, decreases in the allowance for write-offs of $403, $413 and $1,150, respectively, and foreign exchange and other adjustments to the allowance of minus $84, plus $327 and plus $39, respectively.

5 INVENTORIES

          Inventories consist of the following:

December 31	2005		2004
Finished goods	$	12,838	$	13,452
Work-in-process		3,685		3,097
Raw materials		33,043		36,567
Stores, supplies and other		12,872		12,244
Total	$	62,438	$	65,360

          Inventories stated on the LIFO basis amounted to $19,843 at December 31, 2005 and $20,837 at December 31, 2004, which are below replacement costs by approximately $29,164 at December 31, 2005 and $20,867 at December 31, 2004. During 2005, inventories accounted for on a LIFO basis declined, which resulted in cost of goods sold being stated at below current replacement costs by approximately $2,300 ($2,100 in Film Products and $200 in Aluminum Extrusions).

6 FINANCIAL INSTRUMENTS

          In the normal course of business, we enter into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge our exposure to aluminum price volatility under these fixed-price arrangements, which generally have a duration of not more than 12 months, we enter into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled deliveries. The futures contracts are designated as and accounted for as cash flow hedges. These contracts involve elements of credit and market risk that are not reflected on our balance sheet, including the risk of dealing with counterparties and their ability to meet the terms of the contracts. The counterparties to our forward purchase commitments are major aluminum brokers and suppliers, and the counterparties to our futures contracts are major financial institutions. Fixed-price forward sales contracts are only made available to our best and most credit-worthy customers. The amount of aluminum futures contracts that hedged fixed-price forward sales contracts was $5,367 (6,393 pounds of aluminum) at December 31, 2005 and $11,253 (14,410 pounds of aluminum) at December 31, 2004.

          We use interest rate swaps to manage interest rate exposure. There were no interest rate swaps outstanding at December 31, 2005 and 2004. Interest rate swaps outstanding during 2003 (there were none outstanding in 2005 and 2004) were designated as and accounted for as cash flow hedges (see Note 8). Counterparties to our interest rate swaps consisted of large major financial institutions.

55

          After-tax gains of $939 in 2005, $1,230 in 2004 and $395 in 2003 were reclassified from other comprehensive income to earnings and were offset by losses, respectively, from transactions relating to the underlying hedged item. As of December 31, 2005, we expect $776 of unrealized after-tax gains on derivative instruments reported in accumulated other comprehensive income to be reclassified to earnings within the next twelve months. We also expect that these gains will be offset by losses from transactions relating to the underlying hedged item.

7 ACCRUED EXPENSES

          Accrued expenses consist of the following:

December 31	2005		2004
Payrolls, related taxes and medical and other benefits	$	6,687	$	7,946
Workmen's compensation and disabilities		4,226		3,806
Vacation		4,488		4,560
Plant shutdowns and divestitures		6,972		8,485
Other		13,658		13,344
Total	$	36,031	$	38,141

          A reconciliation of the beginning and ending balances of accrued expenses associated with plant shutdowns and divestitures for each of the three years in the period ended December 31, 2005 is as follows:

	Severance			Asset Impairments			Accelerated Depreciation*				Other			Total
Balance at December 31, 2002	$	374		$	—		$	—		$	1,034		$	1,408
2003:
Charges		5,505			1,051			1,733			3,137			11,426
Cash spent		(3,773	)		—			—			(1,085	)		(4,858	)
Charged against assets		—			(1,051	)		(1,733	)		—			(2,784	)
Reversed to income		—			—			—			—			—
Balance at December 31, 2003		2,106			—			—			3,086			5,192
2004:
Charges		6,456			11,554			2,572			2,450			23,032
Cash spent		(3,732	)		—			—			(2,112	)		(5,844	)
Charged against assets		—			(11,554	)		(2,572	)		—			(14,126	)
Foreign currency translation		261			—			—			—			261
Reversed to income		—			—			—			(30	)		(30	)
Balance at December 31, 2004		5,091			—			—			3,394			8,485
2005:
Charges		3,620			8,198			353			6,553			18,724
Cash spent		(6,182	)		—			—			(4,290	)		(10,472	)
Charged against assets		—			(8,198	)		(353	)		—			(8,551	)
Foreign currency translation		(8	)		—			—			—			(8	)
Reversed to income		(1,036	)		—			—			(170	)		(1,206	)
Balance at December 31, 2005	$	1,485		$	—		$	—		$	5,487		$	6,972

*        Represents depreciation accelerated due to plant shutdowns based on a remaining useful life of less than one year.

          The amount reversed to income in 2005 relates primarily to changes in estimates for severance and shutdown-related costs at our aluminum extrusions facility in Aurora, Ontario and in connection with the restructuring of the research and development operations in Film Products. See Note 15 for more information on plant shutdowns, asset impairments and restructurings.

56

8 DEBT AND CREDIT AGREEMENTS

          On December 15, 2005, we refinanced our debt with a new $300,000, five-year unsecured revolving credit agreement (the “Credit Agreement”). At December 31, 2005, available credit under the Credit Agreement was approximately $154,300. Total debt due and outstanding at December 31, 2005 is summarized below:

Debt Due and Outstanding at December 31, 2005
Year Due	Credit Agreement		Other		Total Debt Due
2006	$	—	$	—	$	—
2007		—		4,720		4,720
2008		—		381		381
2009		—		391		391
2010		107,000		243		107,243
Remainder		—		315		315
Total	$	107,000	$	6,050	$	113,050

          The credit spread over LIBOR and commitment fees charged on the unused amount under the Credit Agreement at various indebtedness-to-adjusted EBITDA levels are as follows:

Pricing Under Credit Agreement (Basis Points)
	Credit Spread Over LIBOR
Indebtedness-to- Adjusted EBITDA Ratio	($107 Million Outstanding at 12/31/05)	Commitment Fee
> 2.50x but <= 3x	125	25
> 1.75x but <= 2.50x	100	20
> 1x but <= 1.75x	87.5	17.5
<= 1x	75	15

          At December 31, 2005, the interest cost on debt was priced at one-month LIBOR plus the applicable credit spread of 87.5 basis points.

          The most restrictive covenants in the Credit Agreement include:

• Maximum aggregate dividends over the term of the Credit Agreement of $100,000 plus, beginning October 1, 2005, 50% of net income ($100,445 million as of December 31, 2005);

• Minimum shareholders’ equity ($352,363 as of December 31, 2005);

• Maximum indebtedness-to-adjusted EBITDA through December 31, 2008 of 3x and 2.75x thereafter (2.5x on a pro forma basis for acquisitions); and

• Minimum adjusted EBIT-to-interest expense of 2.5x.

          We believe we were in compliance with all of our debt covenants as of December 31, 2005. Noncompliance with any one or more of the debt covenants may have a material adverse effect on financial condition or liquidity in the event such noncompliance cannot be cured or should we be unable to obtain a waiver from the lenders. Renegotiation of the covenant through an amendment to the Credit Agreement may effectively cure the noncompliance, but may have an effect on financial condition or liquidity depending upon how the covenant is renegotiated.

          On April 27, 2001, we entered into a two-year interest rate swap agreement, with a notional amount of $50,000, under which we paid to a counterparty a fixed interest rate of 4.85% and the counterparty paid us a variable interest rate based on one-month LIBOR reset each month. This swap was designated as and accounted for as a cash flow hedge. It effectively fixed the rate on $50,000 of our $250,000 term loan then outstanding at 4.85% plus the applicable credit spread (generally 62.5 basis points at that time).

57

          On June 22, 2001, we entered into another two-year interest rate swap agreement, with a notional amount of $25,000, under which we paid to a counterparty a fixed interest rate of 4.64% and the counterparty paid us a variable interest rate based on one-month LIBOR reset each month. This swap was designated as and accounted for as a cash flow hedge. It effectively fixed the rate on $25,000 of our $250,000 term loan then outstanding at 4.64% plus the applicable credit spread (generally 62.5 basis points at that time).

9 SHAREHOLDER RIGHTS AGREEMENT

          Pursuant to a Rights Agreement dated as of June 30, 1999 (as amended), between Tredegar and National City Bank as Rights Agent, one Right is attendant to each share of our common stock. Each Right entitles the registered holder to purchase from Tredegar one one-hundredth of a share of Participating Cumulative Preferred Stock, Series A (the “Preferred Stock”), at an exercise price of $150 (the “Purchase Price”). The Rights will become exercisable, if not earlier redeemed, only if a person or group acquires 10% or more of the outstanding shares of our common stock or announces a tender offer which would result in ownership by a person or group of 10% or more of our common stock. Any action by a person or group whose beneficial ownership is reported on Amendment No. 4 to the Schedule 13D filed with respect to Tredegar on March 20, 1997, cannot cause the Rights to become exercisable.

          Each holder of a Right, upon the occurrence of certain events, will become entitled to receive, upon exercise and payment of the Purchase Price, Preferred Stock (or in certain circumstances, cash, property or other securities of Tredegar or a potential acquirer) having a value equal to twice the amount of the Purchase Price.

          The Rights will expire on June 30, 2009.

58

10 STOCK OPTION AND STOCK AWARD PLANS

          We have two stock option plans under which stock options may be granted to purchase a specified number of shares of common stock at a price no lower than the fair market value on the date of grant and for a term not to exceed 10 years. One of those option plans is a directors’ stock plan. In addition, we have three other stock option plans under which there are options that remain outstanding, but no future grants can be made. Employee options ordinarily vest one to two years from the date of grant. The outstanding options granted to directors vest over three years. The option plans also permit the grant of stock appreciation rights (“SARs”), stock, restricted stock, stock unit awards and incentive awards. No SARs have been granted since 1992. All SARs outstanding at December 31, 2001, were exercised during 2002.

          A summary of our stock options outstanding at December 31, 2005, 2004 and 2003, and changes during those years, is presented below:

					Option Exercise Price/Share
	Number of Shares
										Wgted.
	Options		SARs		Range					Ave.
Outstanding at 12/31/02	3,160,880			—	$	3.37	to	$	46.63	$	20.16
Granted in 2003	15,000			—		16.19	to		16.57		16.44
Lapsed in 2003	(179,970	)		—		16.55	to		46.63		24.75
Exercised in 2003	(273,300	)		—		3.37	to		8.38		4.68
Outstanding at 12/31/03	2,722,610			—		3.37	to		46.63		21.39
Granted in 2004	348,425			—		13.95	to		14.50		13.97
Lapsed in 2004	(102,175	)		—		7.38	to		46.63		23.28
Exercised in 2004	(306,870	)		—		3.37	to		19.75		6.99
Outstanding at 12/31/04	2,661,990			—		4.17	to		46.63		22.01
Granted in 2005	—			—		n/a	to		n/a		n/a
Lapsed in 2005	(274,575	)		—		13.95	to		46.63		21.90
Exercised in 2005	(137,075	)		—		4.17	to		16.55		7.51
Outstanding at 12/31/05	2,250,340			—	$	7.38	to	$	46.63	$	22.90

          The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2005:

					Options Outstanding at December 31, 2005				Options Exercisable at December 31, 2005
						Weighted Average
Range of Exercise Prices					Shares	Remaining Contract- ual Life (Years)	Exercise Price		Shares	Weighted Average Exercise Price
$	7.38	to	$	9.67	64,460	0.1	$	8.70	64,460	$	8.70
	9.68	to		17.88	555,775	3.5		15.23	288,875		16.39
	17.89	to		19.75	716,650	2.2		19.22	716,650		19.22
	19.76	to		25.65	348,800	0.8		22.93	348,800		22.93
	25.66	to		34.97	322,655	0.6		31.51	322,655		31.51
	34.98	to		46.63	242,000	0.0		43.72	242,000		43.72
$	7.38	to	$	46.63	2,250,340	1.8	$	22.90	1,983,440	$	24.11

          Stock options exercisable totaled 2,316,390 shares at December 31, 2004 and 2,127,610 shares at December 31, 2003. Stock options available for grant totaled 1,998,300 shares at December 31, 2005, 2,030,300 shares at December 31, 2004 and 642,625 shares at December 31, 2003.

          During 2005, we granted 19,000 shares of restricted Tredegar common stock to senior management. During the first quarter of 2004, we granted 125,000 shares of restricted Tredegar common stock to senior management

59

(15,000 shares were cancelled in connection with employees leaving the company prior to full vesting). The weighted average price was $12.60 per share for grants in 2005 and $13.95 per share for grants in 2004. Compensation expense of approximately $240 for grants in 2005 and $1,535 for grants in 2004 (net of shares cancelled) is being amortized over weighted average vesting periods of approximately two years for grants in 2005 and five years for grants in 2004, subject to accelerated vesting based on meeting certain financial targets.

11 RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS

          We have noncontributory and contributory defined benefit (pension) plans covering most employees. The plans for salaried and hourly employees currently in effect are based on a formula using the participant’s years of service and compensation or using the participant’s years of service and a dollar amount.

          In addition to providing pension benefits, we provide postretirement life insurance and health care benefits for certain groups of employees. Tredegar and retirees share in the cost of postretirement health care benefits, with employees retiring after July 1, 1993, receiving a fixed subsidy to cover a portion of their health care premiums. On December 8, 2003, the Medicare Prescription Drug Improvement and Modernization Act of 2003 (the “Act”) was signed into law. Our prescription drug benefits are not actuarially equivalent to the Act and therefore we do not expect that any federal subsidies will apply.

          Assumptions used for financial reporting purposes to compute net benefit income or cost and benefit obligations, and the components of net periodic benefit income or cost, are as follows:

	Pension Benefits									Other Post- Retirement Benefits
	2005			2004			2003			2005			2004			2003
Weighted-average assumptions used to determine benefit obligations:
Discount rate		5.70	%		6.00	%		6.25	%		5.70	%		6.00	%		6.25	%
Rate of compensation increases		4.00	%		4.00	%		4.00	%		4.00	%		4.00	%		4.00	%
Weighted-average assumptions used to determine net periodic benefit cost:
Discount rate		6.00	%		6.25	%		6.75	%		6.00	%		6.25	%		6.75	%
Rate of compensation increases		4.00	%		4.00	%		4.50	%		4.00	%		4.00	%		4.50	%
Expected long-term return on plan assets, during the year		8.40	%		8.40	%		8.60	%		n/a			n/a			n/a
Rate of increase in per-capita cost of covered health care benefits:
Indemnity plans, end of year		n/a			n/a			n/a			6.00	%		6.00	%		6.00	%
Managed care plans, end of year		n/a			n/a			n/a			6.00	%		6.00	%		6.00	%
Components of net periodic benefit income (cost):
Service cost	$	(6,469	)	$	(5,519	)	$	(5,851	)	$	(109	)	$	(115	)	$	(101	)
Interest cost		(12,661	)		(12,283	)		(11,842	)		(576	)		(562	)		(584	)
Employee contributions		468			443			323			—			—			—
Other		12			(212	)		(98	)		—			—			—
Expected return on plan assets		22,050			22,678			23,003			—			—			—
Amortization of:
Net transition asset		—			7			8			—			—			—
Prior service costs and gains or losses		(738	)		(491	)		(89	)		2			53			43
Net periodic benefit income (cost)	$	2,662		$	4,623		$	5,454		$	(683	)	$	(624	)	$	(642	)

60

          The following tables reconcile the changes in benefit obligations and plan assets in 2005 and 2004, and reconcile the funded status to prepaid or accrued cost at December 31, 2005 and 2004:

	Pension Benefits						Other Post- Retirement Benefits
	2005			2004			2005			2004
Change in benefit obligation:
Benefit obligation, beginning of year	$	214,037		$	196,460		$	9,994		$	9,440
Service cost		6,469			5,519			109			115
Interest cost		12,661			12,283			576			562
Plan amendments		1,372			88			—			—
Effect of discount rate change		10,424			6,997			326			377
Employee contributions		468			443			—			—
Other		3,500			2,087			(290	)		25
Benefits paid		(10,398	)		(9,840	)		(645	)		(525	)
Benefit obligation, end of year	$	238,533		$	214,037		$	10,070		$	9,994
Change in plan assets:
Plan assets at fair value, beginning of year	$	247,505		$	233,759		$	—		$	—
Actual return on plan assets		18,487			22,428			—			—
Employee contributions		468			443			—			—
Employer contributions		1,158			830			645			525
Other		(119	)		(115	)		—			—
Benefits paid		(10,398	)		(9,840	)		(645	)		(525	)
Plan assets at fair value, end of year	$	257,101		$	247,505		$	—		$	—
Reconciliation of prepaid (accrued) cost:
Funded status of the plans	$	18,568		$	33,468		$	(10,070	)	$	(9,993	)
Unrecognized net transition (asset) obligation		—			—			—			—
Unrecognized prior service cost		4,303			3,421			—			—
Unrecognized net (gain) loss		62,776			44,859			(8	)		(20	)
Prepaid (accrued) cost, end of year	$	85,647		$	81,748		$	(10,078	)	$	(10,013	)
Amounts recognized in the consolidated balance sheets:
Prepaid benefit cost	$	85,647		$	81,748		$	—		$	—
Accrued benefit liability		(4,832	)		(3,000	)		(10,078	)		(10,013	)
Intangible asset		1,145			1,222			—			—
Deferred tax liability		1,253			622			—			—
Accumulated other comprehensive loss		2,434			1,156			—			—
Net amount recognized	$	85,647		$	81,748		$	(10,078	)	$	(10,013	)

          Net benefit income or cost is determined using assumptions at the beginning of each year. Funded status is determined using assumptions at the end of each year.

          At December 31, 2005, the effect of a 1% change in the health care cost trend rate assumptions would be immaterial.

61

          Expected benefit payments over the next five years and in the aggregate for 2011-2015 are as follows:

Years	Pension Benefits		Other Post- Retirement Benefits
2006	$	10,600	$	481
2007		11,063		516
2008		11,934		551
2009		12,535		589
2010		13,038		630
2011 - 2015		75,632		3,542

          Prepaid pension cost of $85,647 at December 31, 2005 and $81,748 at December 31, 2004, is included in “Other assets and deferred charges” in the consolidated balance sheets. The accrued benefit liability of $4,832 and the intangible asset of $1,145 at December 31, 2005, and the accrued benefit liability of $3,000 and the intangible asset of $1,222 at December 31, 2004, are also included in “Other assets and deferred charges” in the consolidated balance sheets. Accrued postretirement benefit cost of $10,078 at December 31, 2005 and $10,013 at December 31, 2004, is included in “Other noncurrent liabilities” in the consolidated balance sheets.

          The percentage composition of assets held by pension plans at December 31, 2005 and 2004, and the current expected long-term return on assets are as follows:

	% Composition of Plan Assets						Expected
							Long-term
December 31	2005			2004			Return %
Pension plans related to operations in the U.S.:
Low-risk fixed income securities		14.1	%		18.1	%		5.0	%
Large capitalization equity securities		19.1			19.6			9.2
Mid-capitalization equity securities		7.3			7.3			9.8
Small-capitalization equity securities		4.3			4.1			10.4
International equity securities		22.4			19.1			10.4
Total equity securities		53.1			50.1			9.9
Hedge and private equity funds		21.0			20.9			7.8
Other assets		2.3			2.5			4.0
Total for pension plans related to operations in the U.S.		90.5			91.6			8.5
Pension plans related to operations in Canada		9.5			8.4			7.0
Total		100.0	%		100.0	%		8.4	%

          Our targeted allocation percentage for pension plan assets is in the range of the percentage composition that existed at December 31, 2005. Expected long-term returns are estimated by asset class and generally are based on inflation-adjusted historical returns, volatilities and risk premiums. For pension plans related to operations in the U.S., the portfolio of fixed income securities is structured with maturities that generally match estimated benefit payments over the next three years. We believe that over the long term a diversified portfolio of equity securities, hedge funds and private equity funds have a better risk-return profile than fixed income securities. The average remaining duration of benefit payments for our pension plans is about 14 years. We expect our required contributions to approximate $800 in 2006.

          The accumulated benefit obligation was $223,821 at December 31, 2005 and $196,715 at December 31, 2004. The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for plans with accumulated benefit obligations in excess of plan assets were $13,200, $13,200 and $10,607, respectively, at December 31, 2005, and $10,132, $10,132 and $8,199, respectively, at December 31, 2004.

          We also have a non-qualified supplemental pension plan covering certain employees. Effective December 31, 2005, further participation in this plan was terminated and benefit accruals for existing participants were frozen. The

62

plan was designed to restore all or a part of the pension benefits that would have been payable to designated participants from our principal pension plans if it were not for limitations imposed by income tax regulations. The projected benefit obligation relating to this unfunded plan was $2,655 at December 31, 2005 and $2,081 at December 31, 2004. Pension expense recognized was $256 in 2005, $275 in 2004 and $249 in 2003. This information has been included in the preceding pension benefit tables.

          Approximately 150 employees at our films manufacturing facility in Kerkrade, The Netherlands are covered by a collective bargaining agreement that includes participation in a multi-employer pension plan. Pension expense recognized for participation in this plan, which is equal to required contributions, was $364 in 2005, $281 in 2004 and $216 in 2003. This information has been excluded from the preceding pension benefit tables.

12 SAVINGS PLAN

          We have a savings plan that allows eligible employees to voluntarily contribute a percentage (generally up to 10%) of their compensation. Under the provisions of the plan, we match a portion (generally 50%) of the employee’s contribution to the plan with shares of our common stock. We also have a non-qualified plan that restores matching benefits for employees suspended from the savings plan due to certain limitations imposed by income tax regulations. Charges recognized for these plans were $1,889 in 2005, $2,716 in 2004 and $2,697 in 2003. Our liability under the restoration plan was $782 at December 31, 2005 (consisting of 60,674 phantom shares of common stock) and $1,288 at December 31, 2004 (consisting of 63,730 phantom shares of common stock) valued at the closing market price on those dates.

          The Tredegar Corporation Benefits Plan Trust (the “Trust”) purchased 7,200 shares of our common stock in 1998 for $192 and 46,671 shares of our common stock in 1997 for $1,020, as a partial hedge against the phantom shares held in the restoration plan. There have been no shares purchased since 1997 except for re-invested dividends. The cost of the shares held by the Trust is shown as a reduction to shareholders’ equity in the consolidated balance sheets.

13 RENTAL EXPENSE AND CONTRACTUAL COMMITMENTS

          Rental expense for continuing operations was $3,987 in 2005, $4,549 in 2004 and $3,822 in 2003. Rental commitments under all non-cancelable operating leases as of December 31, 2005, are as follows:

Year	Amount
2006	$	3,608
2007		3,475
2008		3,088
2009		2,070
2010		2,073
Remainder		1,920
Total	$	16,234

          AFBS, Inc. (formerly known as Therics, Inc.), a wholly-owned subsidiary of Tredegar, has future rental commitments under noncancelable operating leases through 2011 (most of which contain sublease options) totaling $8,338. These future rental commitments are included in the above table. Sublease rental commitments relating to excess space at AFBS total about $1,300 (excluded from the above table).

          Contractual obligations for plant construction and purchases of real property and equipment amounted to $14,628 at December 31, 2005 and $16,108 at December 31, 2004.

63

14 INCOME TAXES

          Income from continuing operations before income taxes and income taxes are as follows:

	2005			2004			2003
Income from continuing operations before income taxes:
Domestic	$	19,709		$	27,875		$	16,605
Foreign		6,493			7,607			13,439
Total	$	26,202		$	35,482		$	30,044
Current income taxes:
Federal	$	1,853		$	(2	)	$	4,345
State		811			1,105			368
Foreign		(1,908	)		6,996			2,689
Total		756			8,099			7,402
Deferred income taxes:
Federal		7,900			3,385			649
State		600			1,198			936
Foreign		717			(3,460	)		1,730
Total		9,217			1,123			3,315
Total income taxes	$	9,973		$	9,222		$	10,717

          The decline in foreign income from continuing operations is primarily due to higher intercompany royalty charges. Operating profit from foreign operations excluding intercompany transactions increased in 2005 and 2004.

          The significant differences between the U.S. federal statutory rate and the effective income tax rate for continuing operations are as follows:

	Percent of Income Before Income Taxes for Continuing Operations
	2005			2004			2003
Income tax expense at federal statutory rate		35.0			35.0			35.0
State taxes, net of federal income tax benefit		3.5			4.2			2.8
Unremitted earnings from foreign operations		2.3			(.1	)		1.5
Valuation allowance for capital loss carry-forwards		2.2			—			—
Valuation allowance for foreign operating loss carry-forwards		1.6			1.7			—
Non-deductible expenses		.6			.8			1.0
Foreign rate differences		—			1.0			—
Research and development tax credit		(1.6	)		(1.9	)		(1.7	)
Tax-exempt income		(1.6	)		—			(1.0	)
Extraterritorial Income Exclusion		(2.4	)		(2.3	)		(2.8	)
Reversal of income tax contingency accruals		—			(11.3	)		—
Other		(1.5	)		(1.1	)		.9
Effective income tax rate		38.1			26.0			35.7

64

          Deferred tax liabilities and deferred tax assets at December 31, 2005 and 2004, are as follows:

December 31	2005		2004
Deferred tax liabilities:
Depreciation	$	37,438	$	37,057
Pensions		30,595		29,885
Foreign currency translation gain adjustment		7,686		10,619
Amortization of goodwill		11,627		7,975
Unrealized gain on available-for-sale securities		12		—
Derivative financial instruments		437		497
Other		351		779
Total deferred tax liabilities		88,146		86,812
Deferred tax assets:
Employee benefits		5,244		5,810
Tax benefit on U.S. foreign and R&D tax credits and NOL carryforwards		7,895		10,979
Asset write-offs, divestitures and environmental accruals		2,602		4,547
Allowance for doubtful accounts and sales returns		1,086		1,119
Tax in excess of book basis for venture capital and other investments (net of valuation allowance of $577 in 2005)		1,863		638
Inventory		329		131
Other (net of valuation allowance of $1,020 in 2005 and $600 in 2004)		2,618		2,628
Total deferred tax assets		21,637		25,852
Net deferred tax liability	$	66,509	$	60,960
Included in the balance sheet:
Noncurrent deferred tax liabilities in excess of assets	$	74,287	$	71,141
Current deferred tax assets in excess of liabilities		7,778		10,181
Net deferred tax liability	$	66,509	$	60,960

          As of December 31, 2005, Tredegar had net operating loss, foreign tax credit and R&D tax credit carry-forwards in the U.S. that expire as follows:

U.S. Tax Carry-Forward Items at December 31, 2005 by Year of Expiration
	Deferred Income Tax Assets						Estimated Minimum Future Taxable Income Required to Realize Deferred Income Tax Assets
Year of Expiration	Foreign Tax Credits		R&D Tax Credits		Total		Foreign Tax Credits		R&D Tax Credits		Total
2013	$	205	$	—	$	205	$	586	$	—	$	586
2014		2,917		—		2,917		8,334		—		8,334
2021		—		1,403		1,403		—		4,009		4,009
2022		—		1,185		1,185		—		3,386		3,386
2023		—		690		690		—		1,971		1,971
2024		—		551		551		—		1,574		1,574
2025		—		415		415		—		1,186		1,186
Total	$	3,122	$	4,244	$	7,366	$	8,920	$	12,126	$	21,046

          The table above excludes U.S. federal alternative minimum tax credit carry-forwards and state income tax carry-forwards totaling $529. We believe that it is more likely than not that the timing of future taxable income in the U.S. will be sufficient to cover future tax deductible amounts related to the deferred income tax assets for carry-forward items. Accordingly, no valuation allowance has been recognized for these items. However, a valuation allowance of approximately $1,020 is included in other deferred tax assets that offsets an amount included in that line item relating to

65

possible future tax benefits on operating losses generated by certain foreign subsidiaries that may not be recoverable in the carry-forward period. In addition, a valuation allowance of $577 was established in 2005 in conjunction with the write-down of our investment in Novalux (see Note 2) for expected limitations on the utilization of assumed capital losses. At December 31, 2005, we had current and non-current income taxes recoverable of $7,163 and $5,803, respectively. The current portion primarily relates to income taxes recoverable at Film Products’ subsidiary in The Netherlands. The non-current portion, included in “Other assets and deferred charges” in the consolidated balance sheets, primarily relates to U.S. federal income taxes receivable resulting from filing various refund claims for foreign tax credit, capital loss and net operating loss carry backs to prior years still under review by the U.S. Internal Revenue Service. We do not expect the review to be completed before 2007. Accordingly, this portion of our income taxes recoverable has been classified as non-current.

15 LOSSES ASSOCIATED WITH PLANT SHUTDOWNS, ASSET IMPAIRMENTS AND RESTRUCTURINGS, UNUSUAL ITEMS, GAINS FROM SALE OF ASSETS AND OTHER ITEMS

Losses associated with plant shutdowns, asset impairments and restructurings, net of gains on sale of related assets, in 2005 totaled $14,606 ($9,372 after taxes) and include:

• A fourth-quarter charge of $269 ($174 after taxes) and a second-quarter charge of $10,049 ($6,532 after taxes) related to the sale or assignment of substantially all of AFBS’ (formerly Therics) assets, including asset impairment charges of $5,638, lease-related losses of $3,326 and severance (31 people) and other transaction-related costs of $1,354 (see below for additional information on the transaction);

• Fourth-quarter charges of $397 ($256 after taxes), third-quarter charges of $906 ($570 after taxes), second-quarter charges of $500 ($317 after taxes) and first-quarter charges of $418 ($266 after taxes) related to severance and other employee-related costs associated with restructurings in Film Products ($1,118 before taxes) and Aluminum Extrusions ($648 before taxes) and at corporate headquarters ($455 before taxes; included in “Corporate expenses, net” in the operating profit by segment table in Note 3) (an aggregate of 21 people were affected by these restructurings);

• A fourth-quarter charge of $2,101 ($1,263 after taxes) related to the planned shutdown of the films manufacturing facility in LaGrange, Georgia, including asset impairment charges of $1,615 and severance (15 people) and other costs of $486 (we anticipate recognizing additional shutdown-related costs of about $1,700 in the first half of 2006);

• A fourth-quarter gain of $1,862 ($1,193 after taxes), a third-quarter charge of $198 ($127 after taxes), a second-quarter net gain of $71 ($46 after taxes) and a first-quarter charge of $470 ($301 after taxes) related to the shutdown of the aluminum extrusions facility in Aurora, Ontario, including a $1,667 gain on the sale of the facility (included in “Other income (expense), net” in the consolidated statements of income) and $1,111 of shutdown-related costs partially offset by the reversal to income of certain accruals associated with severance and other costs of $709;

• A second-quarter charge of $27 ($16 after taxes) and a first-quarter gain of $1,618 ($973 after taxes) related to the shutdown of the films manufacturing facility in New Bern, North Carolina, including a $1,816 gain on the sale of the facility (included in “Other income (expense), net” in the consolidated statements of income), partially offset by shutdown-related expenses of $225;

• A first-quarter charge of $1,019 ($653 after taxes) for process reengineering costs associated with the implementation of a global information system in Film Products (included in “Costs of goods sold” in the consolidated statements of income);

• Fourth-quarter charges of $118 ($72 after taxes), third-quarter charges of $595 ($359 after taxes), second-quarter charges of $250 ($150 after taxes) partially offset by a net first-quarter gain of $120 ($72 after taxes) related to severance and other employee-related accruals associated with the restructuring of the research and development operations in Film Products (of this amount, $1,366 in pretax charges for employee relocation and recruitment is included in SG&A expenses in the consolidated statements of income);

• A second-quarter gain of $653 ($392 after taxes) related to the shutdown of the films manufacturing facility in Carbondale, Pennsylvania, including a $630 gain on the sale of the facility (included in “Other income (expense), net” in the consolidated statements on income), and the reversal to income of certain shutdown-related accruals of $23.

• Fourth-quarter charges of $583 ($351 after taxes) for asset impairments in Film Products;

66

• A net fourth-quarter charge of $495 ($310 after taxes) in Aluminum Extrusions, including an asset impairment of $597, partially offset by the reversal to income of certain shutdown-related accruals of $102;

• Fourth-quarter charges of $31 ($19 after taxes), third-quarter charges of $117 ($70 after taxes), second-quarter charges of $105 ($63 after taxes) and first-quarter charges of $100 ($60 after taxes) for accelerated depreciation related to restructurings in Film Products; and

• A fourth-quarter charge of $182 ($119 after taxes) in Film Products related to the write-off of an investment.

          On June 30, 2005, substantially all of the assets of AFBS, Inc. (formerly known as Therics, Inc.), a wholly-owned subsidiary of Tredegar, were sold or assigned to a newly-created limited liability company, Therics, LLC, controlled and managed by an individual not affiliated with Tredegar. AFBS received a 17.5% equity interest in Therics, LLC, valued at $170 and a 3.5% interest in Theken Spine, LLC, valued at $800, along with potential future payments based on the sale of certain products by Therics, LLC. AFBS retained substantially all of its liabilities in the transaction, which included customary indemnification provisions for pre-transaction liabilities. Tredegar has no obligation or intent to fund any future losses that may occur at Therics, LLC or Theken Spine, LLC. The ownership interest in Therics, LLC is accounted for under the equity method of accounting with losses limited to its initial carrying value of $170. The ownership interest in Theken Spine, LLC is accounted for under the cost method, with an impairment loss recognized and a new cost basis established for any write-down to estimated fair value, if necessary. The potential future payments due from Therics, LLC based on the sale of certain products will be recognized as income when earned. AFBS had operating losses of $3,467 during the first six months of 2005 and $9,763 in 2004.

          See Note 2 for information regarding the write-down in 2005 of our investment in Novalux, Inc.

          Gain on sale of corporate assets in 2005 includes a pretax gain of $61 related to the sale of corporate real estate. This gain is included in “Other income (expense), net” in the consolidated statements of income and separately shown in the operating profit by segment table in Note 3.

          During the first quarter of 2005, we recognized a pretax gain for interest receivable on tax refund claims of $508 ($327 after taxes) (included in “Other income (expense), net” in the consolidated statements of income and “Corporate expenses, net” in the operating profit by segment table in Note 3).

          Losses associated with plant shutdowns, asset impairments and restructurings in 2004 totaled $23,032 ($15,192 after taxes) and include:

• A fourth-quarter charge of $84 ($56 after taxes), a third-quarter charge of $828 ($537 after taxes), a second-quarter charge of $994 ($647 after taxes) and a first-quarter charge of $666 ($432 after taxes) related to accelerated depreciation from plant shutdowns and restructurings in Film Products;

• A fourth-quarter charge of $569 (of this amount, $59 for employee relocation is included in selling, general and administrative expenses in the consolidated statements of income) ($369 after taxes) and a third-quarter charge of $709 ($461 after taxes) related to severance for 30 people and other employee-related costs associated with the restructuring of the R&D operations in Film Products, including costs associated with relocating R&D functions to Richmond, Virginia;

• A fourth-quarter charge of $639 ($415 after taxes), a third-quarter charge of $617 ($401 after taxes), a second-quarter charge of $300 ($195 after taxes) and a first-quarter charge of $537 ($349 after taxes) primarily related to severance (63 people) and other employee-related costs associated with the shutdown of the films manufacturing facility in New Bern, North Carolina (the shut down was completed in the fourth quarter of 2004);

• A third-quarter charge of $357 ($329 after taxes) and a second-quarter charge of $2,665 ($1,858 after taxes) for the loss on the sale of the films business in Argentina (proceeds net of transaction costs were $803 ($401 net of cash included in business sold));

• A fourth-quarter charge of $352 ($228 after taxes), a third-quarter charge of $195 ($127 after taxes) and a first-quarter charge of $9,580 ($6,228 after taxes) related to the planned shutdown of an aluminum extrusions facility in Aurora, Ontario, including asset impairment charges of $7,130 and severance and other employee-related costs of $2,450 (these costs were contractually-related for about 100 people and have been immediately accrued);

• A third-quarter charge of $170 ($111 after taxes) for additional costs incurred related to a plant shutdown in Film Products;

• A second-quarter charge of $300 ($195 after taxes), partially offset by a fourth-quarter gain of $104 ($68 after

67

	taxes), related to the loss on the sale of the previously shutdown films manufacturing facility in Manchester, Iowa;
•	A fourth-quarter charge of $427 ($277 after taxes) and a second-quarter charge of $879 ($571 after taxes) related to the estimated loss on the sub-lease of a portion of the AFBS facility in Princeton, New Jersey;
•	Second-quarter charges of $575 ($374 after taxes) in Film Products and $146 ($95 after taxes) in Aluminum Extrusions related to asset impairments; and
•	Fourth-quarter charges of $1,402 ($912 after taxes) related to severance and other employee-related costs associated with restructurings in Therics ($590 before taxes), Film Products ($532 before taxes) and Aluminum Extrusions ($280 before taxes) and a second-quarter charge of $145 ($94 after taxes) related to severance at AFBS (an aggregate of 24 people were affected by these restructurings).

          Gain on sale of corporate assets in 2004 includes a fourth-quarter gain on the sale of land of $1,013 ($649 after taxes and proceeds of $1,271), a second-quarter gain on the sale of land of $413 ($268 after taxes and proceeds of $647) and a first-quarter gain on the sale of public equity securities of $6,134 ($3,987 after taxes and proceeds of $7,182). These gains are included in “Other income (expense), net” in the consolidated statements of income and separately shown in the operating profit by segment table in Note 3.

          Income taxes in 2004 include a third-quarter tax benefit of $4,000 related to the reversal of income tax contingency accruals upon the favorable conclusion of IRS and state examinations through 2000.

          The other gain of $7,316 ($4,756 after taxes) included in the Aluminum Extrusions section of the operating profit by segment table in Note 3 is comprised of the present value of an insurance settlement of $8,357 (future value of $8,455) associated with environmental matters related to prior years, partially offset by accruals for expected future environmental costs of $1,041. The company received $5,143 of the $8,455 insurance settlement in September of 2004 and recognized receivables at present value for future amounts due ($1,497 received in February of 2005 and $1,717 received in February 2006). The gain from the insurance settlement is included in “Other income (expense), net” in the consolidated statements of income, while the accruals for expected future environmental costs are included in “Cost of goods sold.”

          In 2003, losses associated with plant shutdowns, asset impairments and restructurings totaling $11,426 ($7,350 after taxes) included:

• A fourth-quarter charge of $875 ($560 after taxes) for asset impairments in the films business, including charges of $466 ($298 after taxes) relating to accelerated depreciation of assets at the films manufacturing facility in New Bern, North Carolina;

• A fourth-quarter charge of $611 ($391 after taxes) for approximately 50% of the total severance costs for 63 people and other employee-related costs in connection with the shutdown of the films manufacturing facility in New Bern, North Carolina;

• A third-quarter charge of $945 ($605 after taxes) relating to accelerated depreciation of assets at the films manufacturing facility in New Bern, North Carolina;

• A third-quarter charge of $299, a second-quarter charge of $53 and a first-quarter charge of $85 (collectively $280 after taxes) for additional costs incurred related to the shutdown of the films plants in Tacoma, Washington, Carbondale, Pennsylvania and Manchester, Iowa;

• A third-quarter charge of $322 ($206 after taxes) for additional severance and other employee-related costs in connection with a previously announced restructuring in Film Products;

• A third-quarter charge of $2,151 ($1,398 after taxes) and a second-quarter charge of $549 ($357 after taxes) related to the estimated loss on the sub-lease of a portion of the AFBS facility in Princeton, New Jersey;

• A third-quarter charge of $256 ($163 after taxes) for severance for seven people and other employee-related costs in connection with restructurings in Aluminum Extrusions;

• A second-quarter charge of $3,936 ($2,530 after taxes) for severance for 47 people and other employee-related costs in connection with restructurings in Film Products ($1,600 before taxes), corporate headquarters ($1,181 before taxes and included in “Corporate expenses, net” in the operating profit by segment table in Note 3) and AFBS ($1,155 before taxes);

• A second-quarter charge of $956 ($612 after taxes) for asset impairments in the films business, including charges of $312 ($200 after taxes) related to accelerated depreciation of assets at the films manufacturing facility in New Bern, North Carolina; and

• A second-quarter charge of $388 ($248 after taxes) related to an early retirement program for 10 people in

68

Aluminum Extrusions.

          The loss from unusual items in 2003 of $1,067 ($694 after taxes) relates to a first-quarter charge to adjust depreciation and amortization at AFBS based on Tredegar's decision to suspend divestiture efforts. Results for 2003 also included a fourth-quarter gain of $1,385 ($886 after taxes) on the sale of land at the facility in Richmond Hill, Ontario (total proceeds of approximately $1,800), and gains totaling $5,155 ($3,325 after taxes) on the sale of corporate assets. The gains from the sale of corporate assets included:

• A fourth-quarter gain of $2,554 ($1,647 after taxes) from the sale of 547,500 shares of Illumina, Inc. common stock (NASDAQ: ILMN) for total proceeds of $3,791;

• A fourth-quarter gain of $355 ($229 after taxes) from the sale of 64,150 shares of Vascular Solutions, Inc. common stock (NASDAQ: VASC) for total proceeds of $403;

• A third-quarter gain of $942 ($608 after taxes) from the sale of 200,000 shares of VASC for total proceeds of $1,092; and

• A third-quarter gain of $1,289 and fourth-quarter gain of $15 (collectively $841 after taxes) from the sale of corporate real estate (total proceeds of approximately $1,800).

          The gains from the sale of land and corporate assets are included in “Other income (expense), net” in the consolidated statements of income and separately shown in the segment operating profit table in Note 3.

16 CONTINGENCIES

          We are involved in various stages of investigation and remediation relating to environmental matters at certain current and former plant locations. Where we have determined the nature and scope of any required environmental remediation activity, estimates of cleanup costs have been obtained and accrued. As we continue efforts to maintain compliance with applicable environmental laws and regulations, additional contingencies may be identified. If additional contingencies are identified, our practice is to determine the nature and scope of those contingencies, obtain and accrue estimates of the cost of remediation, and perform remediation. We do not believe that additional costs that could arise from those activities will have a material adverse effect on our financial position. However, those costs could have a material adverse effect on quarterly or annual operating results at that time.

          We are involved in various other legal actions arising in the normal course of business. After taking into consideration legal counsels’ evaluation of these actions, we believe that we have sufficiently accrued for probable losses and that the actions will not have a material adverse effect on our financial position. However, the resolution of the actions in a future period could have a material adverse effect on quarterly or annual operating results at that time.

          From time to time, we enter into transactions with third parties in connection with the sale of assets or businesses in which we agree to indemnify the buyers or third parties involved in the sale for certain liabilities or risks related to the assets or business. Also, in the ordinary course of our business, we may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, we are unable to estimate the maximum potential amount of the potential future liability under the indemnity provisions of these agreements. We do, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable. We disclose contingent liabilities if the probability of loss is reasonably possible and significant.

17 DISCONTINUED OPERATIONS

          On March 7, 2003, Tredegar Investments, Inc. (“Tredegar Investments”) reached definitive agreements to sell substantially all of its portfolio of private equity partnership interests to GS Vintage Funds II, which are investment partnerships managed by Goldman Sachs Asset Management’s Private Equity Group. On the same date and in a separate transaction, Tredegar Investments also agreed to sell to W Capital Partners, an independent private equity manager, the

69

subsidiary funds that hold substantially all of Tredegar Investments’ direct venture capital investments. The sale of these fund interests included the assumption by the buyer of Tredegar Investments’ obligations to make additional capital contributions to those funds in the future.

          The sale to W Capital Partners of the subsidiary funds that hold the direct investments occurred on March 7, 2003. The sale of the private equity fund interests occurred in a series of closings. Net proceeds from the sales totaled $21,504. Additionally, in the first quarter of 2004 we received income tax recoveries of approximately $55,000 from the carry-back of 2003 capital losses generated by these sales against gains realized in 2000 by Tredegar Investments.

          The agreements governing these transactions contain customary contingent indemnification provisions that Tredegar believes will not have a material effect on its financial position or results of operations.

          The operating results associated with venture capital investment activities have been reported as discontinued operations. A summary of venture capital investment activities through disposal in 2003 is provided below:

(In Thousands)	2003
Carrying value of venture capital investments, beginning of period	$	93,765
Venture capital investment activity for period:
(pre-tax amounts):
New investments		2,807
Proceeds from the sale of investments, including broker receivables at end of period		(21,504	)
Realized gains		—
Realized losses, write-offs and write-downs		(70,256	)
(Decrease) increase in unrealized gain on available-for-sale securities		(917	)
Carrying value of public securities retained by Tredegar Investments*		(3,895	)
Carrying value of venture capital investments, end of period	$	—
Summary of amounts reported as discontinued operations in the consolidated statements of income:
Pretax gains (losses), net	$	(70,256	)
Operating expenses (primarily management fee expenses)		(599	)
Loss before income taxes		(70,855	)
Income tax benefits		24,286
Loss from venture capital investment activities	$	(46,569	)

* At December 31, 2003, Tredegar Investments held 596,492 shares of Vascular Solutions, Inc. (NASDAQ: VASC) and 265,955 shares of Illumina, Inc. (NASDAQ: ILMN). These securities, which were related to Tredegar Investments' earlier venture capital investment activities, were sold in 2004 for $7,182, including gains recognized of $6,134 ($3,987 after taxes).

          Loss from venture capital investment activities in 2003 of $70,855 ($46,569 after taxes) includes a loss on the sale of $70,256 ($46,269 after taxes). Discontinued operations in 2004 include an after-tax gain associated with venture capital investment activities of $2,921 primarily related to the reversal of business and occupancy tax contingency accruals upon favorable resolution.

          On July 2, 2002, the operations at Molecumetics, a healthcare-related biotech company, ceased. The operating results of Molecumetics have been reported as discontinued operations. Discontinued operations include a gain of $1,393 ($891 after taxes) in 2003 on the sale of intellectual property of Molecumetics.

          Cash flows for discontinued operations have not been separately disclosed in the accompanying statement of cash flows.

70

SELECTED QUARTERLY FINANCIAL DATA

Tredegar Corporation and Subsidiaries

(In thousands, except per-share amounts)

(Unaudited)

	First		Second		Third		Fourth
	Quarter		Quarter		Quarter		Quarter		Year
2005
Sales	$	232,757	$	243,724	$	240,716	$	239,772	$	956,969
Gross profit		28,462		33,245		32,518		27,432		121,657
Income from continuing operations		5,550		2,132		7,657		890		16,229
Income (loss) from discontinued operations		—		—		—		—		—
Net income (loss)		5,550		2,132		7,657		890		16,229
Earnings (loss) per share:
Basic:
Continuing operations		.14		.05		.20		.02		.42
Discontinued operations		—		—		—		—		—
Net income (loss)		.14		.05		.20		.02		.42
Diluted:
Continuing operations		.14		.05		.20		.02		.42
Discontinued operations		—		—		—		—		—
Net income (loss)		.14		.05		.20		.02		.42
Shares used to compute earnings (loss) per share:
Basic		38,440		38,453		38,465		38,527		38,471
Diluted		38,636		38,592		38,565		38,594		38,597
2004
Sales	$	195,919	$	216,053	$	222,515	$	226,678	$	861,165
Gross profit		27,348		33,102		31,669		29,528		121,647
Income from continuing operations		2,429		5,179		15,292		3,360		26,260
Income (loss) from discontinued operations		—		—		—		2,921		2,921
Net income (loss)		2,429		5,179		15,292		6,281		29,181
Earnings (loss) per share:
Basic:
Continuing operations		.06		.14		.40		.09		.69
Discontinued operations		—		—		—		.08		.08
Net income (loss)		.06		.14		.40		.17		.77
Diluted:
Continuing operations		.06		.14		.40		.09		.68
Discontinued operations		—		—		—		.07		.08
Net income (loss)		.06		.14		.40		.16		.76
Shares used to compute earnings (loss) per share:
Basic		38,229		38,235		38,317		38,398		38,295
Diluted		38,435		38,427		38,519		38,655		38,507

71

SIGNATURES

          Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TREDEGAR CORPORATION (Registrant)
Dated: March 1, 2006	By	/s/ John D. Gottwald
		John D. Gottwald
		President and Chief Executive Officer

          Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on March 1, 2006.

Signature	Title
/s/ John D. Gottwald	President, Chief Executive Officer and Director
	(Principal Executive Officer)
(John D. Gottwald)
/s/ D. Andrew Edwards	Vice President, Chief Financial Officer and Treasurer
	(Principal Financial and Accounting Officer)
(D. Andrew Edwards)
/s/ Richard L. Morrill	Chairman of the Board of Directors
(Richard L. Morrill)
/s/ William M. Gottwald	Vice Chairman of the Board of Directors
(William M. Gottwald)
/s/ N. A. Scher	Vice Chairman of the Board of Directors
(Norman A. Scher)
/s/ Horst R. Adam	Director
(Horst R. Adam)
/s/ Austin Brockenbrough, III	Director
(Austin Brockenbrough, III)
/s/ Donald T. Cowles	Director
(Donald T. Cowles)

72

/s/ Thomas G. Slater, Jr.	Director
(Thomas G. Slater, Jr.)
/s/ R. Gregory Williams	Director
(R. Gregory Williams)

73

EXHIBIT INDEX

3.1	Amended and Restated Articles of Incorporation of Tredegar (filed as Exhibit 3.1 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
3.2	Amended By-laws of Tredegar (filed as Exhibit 3.01 to Tredegar’s Current Report on Form 8-K, filed January 17, 2006, and incorporated herein by reference)
3.3	Articles of Amendment (filed as Exhibit 3.3 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
4.1	Form of Common Stock Certificate (filed as Exhibit 4.1 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
4.2	Rights Agreement, dated as of June 30, 1999, by and between Tredegar and American Stock Transfer & Trust Company, as Rights Agent (filed as Exhibit 4.2 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
4.2.1	Amendment and Substitution Agreement (Rights Agreement) dated as of December 11, 2002, by and among Tredegar, American Stock Transfer and Trust Company and National City Bank (filed as Exhibit 4.2.1 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2002, and incorporated herein by reference)
4.3	Credit Agreement among Tredegar Corporation, as borrower, the domestic subsidiaries of Tredegar that from time to time become parties thereto, as guarantors, the several banks and other financial institutions as may from time to time become parties thereto, Wachovia Bank, National Association, as administrative agent, SunTrust Bank, as syndication agent, and Bank of America, N.A., KeyBank National Association, and JPMorgan Chase Bank, N.A., as documentation agents, dated as of December 15, 2005 (filed as Exhibit 10.16 to Tredegar’s Current Report on Form 8-K, filed December 20, 2005, and incorporated herein by reference)
10.1	Reorganization and Distribution Agreement dated as of June 1, 1989, between Tredegar and Ethyl (filed as Exhibit 10.1 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.2	Employee Benefits Agreement dated as of June 1, 1989, between Tredegar and Ethyl (filed as Exhibit 10.2 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
10.3	Tax Sharing Agreement dated as of June 1, 1989, between Tredegar and Ethyl (filed as Exhibit 10.3 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
10.4	Indemnification Agreement dated as of June 1, 1989, between Tredegar and Ethyl (filed as Exhibit 10.4 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.5	Tredegar 1989 Incentive Stock Option Plan (filed as Exhibit 10.5 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.5.1	Amendment to the Tredegar 1989 Incentive Stock Option Plan (filed as Exhibit 10.5.1 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.6	Tredegar 1992 Omnibus Stock Incentive Plan (filed as Exhibit 10.6 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.6.1	Amendment to the Tredegar 1992 Omnibus Incentive Plan (filed as Exhibit 10.6.1 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.7	Tredegar Industries, Inc. Retirement Benefit Restoration Plan (filed as Exhibit 10.7 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.7.1	Amendment to the Tredegar Retirement Benefit Restoration Plan (filed as Exhibit 10.7.1 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.8	Tredegar Industries, Inc. Savings Plan Benefit Restoration Plan (filed as Exhibit 10.8 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.8.1	Resolutions of the Executive Committee of the Board of Directors of Tredegar Corporation adopted on December 28, 2004 (effective as of December 31, 2004) amending the Tredegar Corporation Retirement Savings Plan Benefit Restoration Plan (filed as Exhibit 10.9.1 to Tredegar’s Current Report on Form 8-K, filed on December 30, 2004, and incorporated herein by reference)

74

*10.9	Tredegar Industries, Inc. Amended and Restated Incentive Plan (previously included as Exhibit 99.2 to the Form S-8 Registration Statement No. 333-88177, filed on September 30, 1999, and refiled herewith)
*10.10	Tredegar Industries, Inc. Directors’ Stock Plan (filed as Exhibit 10.11 to Tredegar’s Annual Report on Form 10-K for the year ended December 31, 2004, and incorporated herein by reference)
*10.11	Tredegar Corporation’s 2004 Equity Incentive Plan (filed as Exhibit 10.13 to the Form S-8 Registration Statement No. 333-115423, filed on May 12, 2004 (incorporating from the Annex to Tredegar Corporation’s Definitive Proxy Statement on Schedule 14A filed on March 4, 2004 (No. 1-10258) and incorporated herein by reference)
*10.12	Leave of Absence, Separation and Non-Competition Agreement, dated May 16, 2005, between Tredegar Film Products Corporation and Thomas G. Cochran (filed as Exhibit 10.16 to Tredegar’s Current Report on Form 8-K, filed May 18, 2005, and incorporated herein by reference)
*10.13	Transfer Agreement, by and between Old Therics and New Therics, dated as of June 30, 2005 (filed as Exhibit 10.17 to Tredegar’s Current Report on Form 8-K, filed July 1, 2005, and incorporated herein by reference)
10.14	Intellectual Property Transfer Agreement, by and between Old Therics and New Therics, dated as of June 30, 2005 (filed as Exhibit 10.18 to Tredegar’s Current Report on Form 8-K, filed July 1, 2005, and incorporated herein by reference)
10.15	Unit Purchase Agreement, by and between Old Therics, New Therics and Randall R. Theken, dated as of June 30, 2005 (filed as Exhibit 10.19 to Tredegar’s Current Report on Form 8-K, filed July 1, 2005, and incorporated herein by reference)
10.16	Payment Agreement, by and between Old Therics and New Therics, dated as of June 30, 2005 (filed as Exhibit 10.20 to Tredegar’s Current Report on Form 8-K, filed July 1, 2005, and incorporated herein by reference)
*10.17	Form of Stock Award Agreement (filed as Exhibit 10.21 to Tredegar’s Current Report on Form 8-K, filed September 1, 2005, and incorporated herein by reference)
*10.18	Summary of Compensation for the President and Chief Executive Officer and each of the Named Executive Officers for Fiscal 2006 (filed as Item 1.01 to Tredegar’s Current Report on Form 8-K, filed on February 22, 2006, and incorporated herein by reference)
*10.19	Description of Cash Incentive Plans for fiscal 2006 (filed as Item 1.01 to Tredegar’s Current Report on Form 8-K, filed on February 22, 2006, and incorporated herein by reference)
*10.20	Summary of Director Compensation for Fiscal 2006
21	Subsidiaries of Tredegar
23.1	Consent of Independent Registered Public Accounting Firm
31.1	Section 302 Certification of Principal Executive Officer
31.2	Section 302 Certification of Principal Financial Officer
32.1	Section 906 Certification of Principal Executive Officer
32.2	Section 906 Certification of Principal Financial Officer

* Denotes compensatory plans or arrangements or management contracts.

75